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ABSTRACT

Voice is produced by the conversion of aerodynamic energy from exhalation to
acoustical energy for voice production by the vocal folds (membranous connective tissue)
located in the larynx. The quality of voice depends on the biomechanical properties of
the multi-layered vocal fold tissue which derive from its extracellular matrix (ECM)
organization and composition. The wound healing response to vocal fold injuries is
characterized by scarring and subsequent dysphonia due to alterations in the
biomechanical properties of the tissue.
The work presented here is motivated by the importance of voice in maintaining
quality of life and the inability of current treatment techniques to restore long-term,
normal phonatory voice following injury induced scarring. We hypothesize that vibration
is the epigenetic stimulus regulating the unique extracellular matrix (ECM) composition
of the human vocal fold tissue and that rapid restoration of the vibratory
microenvironment using mechano-mimetic scaffolds will facilitate:- (a) inhibition of
scarring and (b) stimulation of fibroblast regeneration of the normal vocal fold tissue
architecture/ECM composition and thereby restore long-term, normal phonaory voice.
Our objective was to create in situ photopolymerizable, degradable, mechano-mimetic
hydrogels/semi-interpenetrating networks (semi-IPNs) which may be introduced into
critical size vocal fold defects using minimally invasive methods.
Towards this end, we created hyaluronic acid (HA) based hydrogels and
polyethylene glycol (PEG)-diacrylate based hydrogels/semi-IPNs, which were found to
approximate the viscoelastic mechanical properties of the native human vocal mucosa
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(vibratory component) and the vocal ligament (strain component), respectively. Cell
culture studies indicated that these hydrogel/semi-IPN materials supported cell spreading,
cell proliferation, and ECM deposition throughout the 3-dimensional crosslinked
network. In an attempt to assess the ability of the HA-based hydrogels to support human
fibroblast formation of vocal mucosa-specific matrix in response to physiologically
relevant high frequency vibration, fibroblast encapsulated hydrogels were subjected to 2
hrs of vibration per day using a custom built vibrational bioreactor. Our results indicated
that the exposure of HA hydrogel-encapsulated fibroblasts to physiologically relevant
high frequency vibration stimulated a pattern of gene expression and ECM synthesis
(upregulation of GAGs, downregulation of fibrous matrix proteins) consistent with the
composition of the human vocal mucosa.

In the future, these HA-based hydrogels

introduced into the human vocal mucosa during the acute phase of wound healing by
minimally invasive methods may bring about regeneration of the native human vocal
mucosa ECM composition and thereby restore normal phonation.
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CHAPTER ONE
INTRODUCTION

Voice is critical to the quality of life and is the primary „tool of trade‟ for 25% of
the US work force (teachers, singers, sales personnel etc) [1].

Phonation (voice

production) is a co-ordinated biological process involving the vocal folds, lungs, brain,
peripheral nervous system, and muscles of the respiratory tract synergistically
transducing aerodynamic energy from exhalation to acoustic energy. The vocal folds are
the dynamic mechanical element of the phonatory system and possess a spatially
organized ECM composition that is fundamental to the tissue biomechanics and in turn
the quality of voice [2]. The highly differentiated human vocal fold tissue is comprised
of a matrix rich lamina propria anchored to the vocalis muscle, and covered by a
squamous epithelium. The fibroblast is the primary matrix producing cell type in the
vocal fold tissue and is responsible for maintaining tissue homeostasis and regulating
injury response [2]. The squamous epithelium and the superficial lamina propria together
form the vocal mucosa (vibratory component) which is abundant in hyaluronic acid, and
proteoglycans like fibromodulin, decorin and versican which regulate the water content
of the tissue and impart viscous shear properties to it [3, 4]. The vocal mucosa vibrates at
frequencies between 100 – 1000Hz, and amplitudes of ~1mm [5]. The intermediate and
deep layers of the lamina propria together form the vocal ligament (strain component).
The vocal ligament ECM is comprised mainly of elastin fibers which impart flexibility to
the tissue and collagen fibers which impart resistance to tensile stresses [6, 7]. The
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human vocal ligament operates at low strain levels (0 – 15%) during normal phonation
[8]. Vocalization times can vary between 1 to 2hrs per day for heavy voice users like
classroom teachers and opera singers [9-12].
Vocal fold damage can be brought about by a multitude of factors like chronic
vocal overuse, chemical/thermal trauma, non phonatory mechanical trauma such as
surgical intubation and surgical treatment of infectious laryngeal diseases, laryngeal
cancer, and benign pathologies like vocal folds polyps, nodules and edema [13-15].
Injury of the lamina propria elicits a wound healing response that is characterized by the
replacement of native parenchymal matrix with fibrous scar tissue. This change in the
ECM composition leads to alterations in the tissue biomechanics which subsequently
leads to dysphonia. Approximately 23% of the voice dependent USA workforce is
afflicted by problems like increased effort to sustain phonation, decrease in the quality of
voice and total loss of audible voice as a result of vocal pathologies [16].

Vocal

pathologies can jeopardize social interaction, job security, and employment opportunities.
Dysphonia secondary to vocal pathologies is a result of hoarseness, breathy voice, stridor
(high pitched, loud respiration), and dyspnea. Incidence of voice related problems is as
high as 20% amongst teachers [17].
Treatment of scarring related voice probems is a major challenge faced by
otolaryngologists today [18]. Voice therapy combined with the administration of steroids
is the first line of therapy when presented with vocal fold defects and scars [13, 18].
However, voice therapy is ineffective when presented with scars in combination with
pathologies like vocal polyps, nodules and edema despite rigorous adherence to the
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prescribed habits [19].

Synthetic, non degradable materials like teflon [20-22],

polyhydroxyethylmethacrylate (pHEMA) hydrogels [23], ePTFE [24, 25], calcium
hydroxyapatite [26], dacron [27], polydimethylsiloxane [28-31] have been injected into
the vocalis muscle in an attempt to overcome scarring-induced glottic incompetence
through vocal fold medialization. However, physiological limitations such as migration
from the site of implantation, foreign body granuloma formation, and fibrous
encapsulation posed by these materials, and the theoretical advantages of natural,
degradable biomaterials injected into the lamina propria have led to the use of materials
like collagen, fat, fascia and HA for vocal fold augmentation purposes.

In human

subjects, though evaluations after six months of collagen injections indicated
improvements in vibrational amplitude of the mucosal wave and amelioration of glottic
incompetence, no perceptual improvement (acoustic analyses) was recorded [32].
Autologous fat [33-36] and fascia [37] injections yielded positive results short term but
reports of these studies are inconsistent in terms of evaluations of glottic closure,
amplitude of the mucosal wave and the effect on the stiffness of scar tissue. Injectable
crosslinked HA gels (Hylan B gels) have been shown to improve mucosal wave
amplitudes and glottic closure for approximately 12 months [38-40]. Material resorption
and the need for re-injection were the disadvantages associated with the use of natural
materials like collagen, fat, fascia, and HA [41]. Current regeneration strategies have
investigated the use of crosslinked composites of polyethylene glycol diacrylate
(PEGDA)/derivatized HA [42, 43], composite collagen hydrogels [44], and HA-based
microgels [45] as scaffolds for cell transplantation and matrix formation, as well as the
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administration of hepatocyte growth factor (HGF) [46-48] and basic fibroblast growth
factor (bFGF) [49] to reduce scarring during natural healing. The above mentioned
current treatment techniques, although effective in improving short term voice quality,
have been unable to achieve complete restoration of voice due to their inability to bring
about regeneration of the native vocal fold tissue architecture/ECM composition.
Matrix composition and mechanical properties of human tissues are influenced by
their mechanical environment [50, 51]. Physiologically relevant mechanical loading not
only upregulates synthesis of tissue-specific ECM proteins but also plays a vital role in
matrix modeling (native tissue homeostasis) or remodeling (tissue engineering scaffolds)
and cellular organization [51].

Recently, Min and co-workers reported that

physiologically relevant compressive loading of chondrocyte seeded, mechano-mimetic
poly (l-lactide-co-ɛ -caprolactone) scaffolds upregulated the synthesis of cartilage
specific ECM proteins like collagen II and proteoglycans like aggregan [52]. Studies
performed by Hsieh and co-workers indicated that mRNA levels of collagens type I and
III produced by anterior cruciate ligament (ACL) and medial collateral ligament (MCL)
fibroblasts showed significant differences in after physiologically relevant biaxial
stretching [53]. Durante and co-workers reported an increase in collagen I synthesis by
smooth muscle cells in response to 10% cyclic strain [54]. The effect of cyclic strain on
gene/protein expression in cell seeded substrates is widely investigated but that of
physiologically relevant high frequency vibration is relatively less explored. Studies
reported previously by Tanaka and co-workers indicated that the effects of vibration on in
vitro cell culture are varied. For example, mRNA expression levels of MMP-9 were
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upregulated when osteoblasts were cultured in 3D collagen gels under conditions of
broad frequency vibration (0-50Hz) 3min/day for 4 to7 days [55]. Contrastingly, the
mRNA expression levels of MMP-9 were unaffected by a single frequency (3Hz)
vibration 3min/day for 4 to 7 days. Titze and co-workers [11] highlighted the importance
of the vibratory epigenetic stimulus in the vocal fold tissue by indicating a similarity
between the normal matrix composition of the human vocal mucosa and the gene
expression levels of fibroblasts cultured under vibratory stimulation within 3D, porous,
elastomeric tecoflex substrates. Thus one may infer that the type of mechanical regimen
dictates alterations in protein expression which ultimately influences matrix remodeling.
We therefore hypothesize that the rapid restoration of the vibratory
microenvironment using mechano-mimetic scaffolds will facilitate vocal fold-like ECM
deposition by the transplanted/endogenous cells. This will potentially yield improved
functional outcomes by preventing the onset of fibrosis during the acute stage of wound
healing. Towards this end, the objective of our research was:- (a) to create injectable,
photopolymerizable, hydrogel formulations matching the viscous and elastic mechanical
properties of the vocal mucosa and vocal ligament, respectively, (b) to investigate the
cytocompatibility of the potential scaffold materials in terms of encapsulated cell
viability, proliferation, and de novo ECM synthesis under static conditions, and (c) to
assess the ability of the methacrylated HA (GMHA) based hydrogels to support human
fibroblast formation of vocal mucosa-specific matrix in response to physiologically
relevant high frequency vibration using a custom-built vibrational bioreactor.
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CHAPTER TWO
LITERATURE REVIEW

Vocal folds are the same as vocal cords. The two terms refer to the exact same
part of the body performing the exact same functions. Scientists and otolaryngologists
refer to this organ as “vocal folds” whereas “vocal cords” is a widely used lay term. The
term “vocal cords” lacks technical accuracy. Many years ago the vocal folds were
thought of as being two cords stretched across the airway in the trachea akin to the strings
of a musical instrument. In 1974, pioneering research by Hirano led to the understanding
that the vocal folds are multilayered folds of tissue that are continuous with other tissues
in the laryngeal framework [56]. Therefore, vocal "folds" is a more accurate term.

2.1 Anatomy of the vocal folds & physiology of voice production
2.1.1 Anatomy of the larynx
The larynx is located anteriorly in the human neck immediately below the
pharyngeal division which gives rise to the trachea (windpipe) and the gullet (food pipe).
Figure 2.1 illustrates the longitudinal section of the human larynx. The larynx comprises
the cricoid cartilage (smaller), thyroid cartilage (larger), arytenoid cartilages, vocal folds,
glottis, epiglottis and the hyoid bone. In males the prominent anterior bulge of the
thyroid cartilage is known as the Adam’s apple. The vocal fold tissue is located anterioposteriorly in the center of the laryngeal framework. Figure 2.2 indicates that the vocal
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fold tissue in an intermediate position is a symmetrical “V” shaped structure when
viewed from the top. Posteriorly the vocal folds are attached to the arytenoid cartilage.
The vocal folds tissue is ~11 – 15mm long in females and ~17 – 21mm in males
[57, 58]. Below the age of 10 there is no difference in the length of the vocal folds
between men and women [57]. The membranous vocal fold tissue is ~8.5 – 12 mm long
in females and ~14.5 – 18mm in males [57, 58].

In newborns the length of the

membranous vocal fold is 1.3 – 2.0mm [57]. The cartilaginous vocal fold tissue is ~2.0 –
3.0mm long in females and 2.5 – 3.5mm long in males [57]. In newborns the length of
the cartilaginous vocal fold is 1.0 – 1.4mm [57].
The space between the vocal folds is known as the glottis. The glottis opens when
the vocal folds adduct and closes when the vocal folds abduct i.e. vibration causes high
frequency glottal opening and closure. The epiglottis (soft cartilage) which lies superior
to the vocal folds serves to protect the larynx during deglutition (swallowing) and
prevents aspiration of food particles. It is not involved in normal voice production. The
hyoid bone positioned above the thyroid cartilage provides an attachment site for many
muscles of the tongue, jaw and neck. It is the only bone that is not connected to another
bone in the body.
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Figure 2.1 Longitudinal section of the human larynx which houses the vocal folds
(http://www.hopkinsmedicine.org/voice/anatomy.html)

Figure 2.2 Top view of the human vocal folds housed in the laryngeal framework
(http://www.hopkinsmedicine.org/voice/anatomy.html)

8

2.1.2 Laryngeal muscles
There are two types of laryngeal muscles namely, intrinsic and extrinsic. The
intrinsic and extrinsic laryngeal muscles together open and close the vocal folds as well
as shape the vocal tract during phonation.
(a) Intrinsic laryngeal muscles - These muscles serve to position the vocal folds during
the phonatory cycle. They are paired and symmetrically arranged on both sides of the
larynx. The five intrinsic laryngeal muscles and their functions are as follows:Posterior cricoarytenoids - These are the only muscles involved in abduction
(“abduction” - process of pulling the vocal folds away from each other or vocal fold
opening).

These muscles achieve glottal opening by pulling the back ends of the

arytenoid cartilages together. This pulls the front ends (where the vocal folds attach)
apart, thus pulling the vocal folds apart.
Lateral cricoarytenoids - These muscles are involved in adduction (“adduction” process of medialization of the vocal folds or vocal fold closure). These muscles achieve
glottal closure by pulling the back ends of the arytenoid cartilages apart. This pulls the
front ends together, thus medializing the vocal folds.
Thyroarytenoids - These muscles form the “body” of the vocal folds. They are also
known as the “vocalis muscle”. These muscles bring about vocal fold shortening by
pulling the arytenoid (back) end of the vocal folds toward the thyroid (front) end. This
manner of shortening causes the vocal folds to vibrate more slowly thus lowering the
frequency (pitch). The thyroarytenoid muscles provide force to strengthen glottic closure
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in an attempt to resist the exhaled airstream from the lungs in order to buildup subglottic
air pressure to initiate phonation.
Cricothyroid - These muscle are antagonists to the thyroarytenoid muscles. The
cricothyroid muscles serve to lengthen the vocal folds. They lengthen the vocal folds by
pulling the thyroid cartilage down, which increases the distance between the arytenoid
and the Adam's apple.

This causes the vocal folds to vibrate faster, thus raising

frequency (pitch).
Interarytenoid - The transverse and oblique arytenoid are the two sets of arytenoid
muscles.

These muscles bring the two arytenoid cartilages together to provide

compression medialization for the vocal folds which along with the forces provided by
the lateral cricoarytenoid and thyroarytenoid muscles allow buildup of the subglottic
pressure necessary for the onset of phonation.
(b) Extrinsic laryngeal muscles - These muscles are also known as the “strap” muscles
since they are responsible for moving the entire larynx up and down during respiration,
phonation and deglutition. The extrinsic laryngeal muscles can be classified as the
infrahyoid and the suprahyoid muscles. The infrahyoid muscles comprise omohyoid,
sternohyoid, sternothyroid and thyrohyoid muscles. The suprahyoid muscles comprise
digastric, geniohyoid, myohyoid, stylohyoid and stylopharyngeus muscles.

2.1.3 Laryngeal innervation
The vagus nerve which arises from the medulla oblongata in the brainstem
provides control over the intrinsic laryngeal muscles. The vagus nerve branches into the
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superior laryngeal nerve and the recurrent laryngeal nerve. The superior laryngeal nerve
divides into the internal and external branches. The internal branch further subdivides
into two branches, one which innervates the epiglottis and the other which descends to
anastomose with the posterior ramus of the recurrent laryngeal nerve. This branch of the
superior laryngeal nerve also serves as a pharyngeal sensory nerve. The external branch
supplies the cricothyroid muscle as the motor nerve. The recurrent laryngeal nerve
divides into two branches at the level of the second tracheal ring. The first branch called
the posterior ramus anastomoses with the superior laryngeal nerve as mentioned earlier.
The second branch called the anterior ramus supplies the vocalis muscle [59]. All the
intrinsic laryngeal muscles are innervated by the recurrent laryngeal nerve except the
cricothyroid muscle which is innervated by the external branch of the superior laryngeal
nerve.

2.1.4 Arterial blood supply
The larynx receives blood supply from the superior and inferior laryngeal arteries
and to a small extent from the cricothyroid artery. The superior laryngeal artery is a
branch of the superior thyroid artery which originates from the carotid artery. The
inferior laryngeal artery is a branch of the inferior thyroid artery which originates from
the subclavian artery. The cricothyroid artery branches from the superior thyroid artery.
The three laryngeal arteries freely anastomose with each other.
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2.1.5 Venous blood drainage
The superior laryngeal vein drains into the superior and middle thyroid veins
which eventually empties into the jugular vein. The inferior laryngeal vein empties into
the middle and inferior thyroid veins which eventually empties into the superior vena
cava.

2.1.6 Lymphatic drainage
The larynx except the free margins of the vocal folds (which is our focus area for
research) is richly supplied with lymphatic drainage. The area above the vocal folds
drains into the superior and middle jugular nodes. The remaining part drains into the
paratracheal lymph nodes, middle and inferior jugular nodes.

2.1.7 Physiology of phonation
Conceptual statement :- The biomechanics of the vocal fold tissue underlies the quality
of voice.
The vocal folds are connective tissues located in the larynx which function to
transduce aerodynamic energy from exhalation to acoustical energy for voice production.
A healthy voice is contingent upon the balance maintained between the pressure exerted
by the pulmonary system and the resistance offered by the vocal fold tissue [60]. In
engineering terms, voice is a result of synchronous activity of the power source, oscillator
and resonators [13].

The lungs, thoracic muscles, back muscles, diaphragm and

abdominal muscles together constitute the power source which forces out the air during
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exhalation. The larynx functions as the oscillator. The parts of the larynx above the
glottis comprising pharynx, nasal cavity, oral cavity and paranasal sinuses together form
the resonators. Phonation is the net result of the co-ordination of a multitude of factors
like subglottic air pressure, glottal air flow, glottal resistance, vocalis muscle contraction,
vocal fold tissue biomechanics, Bernoulli‟s effect, and acoustic coupling of the cavities
above and below the glottis [61]. During quiet respiration the vocal folds are in an
intermediate position with slight glottal widening during inspiration [59]. The vocal
folds are medialized and elongated at the beginning of each phonatory cycle. The
subglottic air pressure needed to initiate phonation is defined as the phonation threshold
pressure [61, 62]. A rise in subglottic pressure just above the phonation threshold level
which is approximately 7cm of water for conversational speech [13] pushes the vocal
folds apart by progressively straining the vocal ligament (elastic component of the vocal
folds) until a gap develops and the exhaled air begins to flow out thus vibrating the vocal
mucosa (vibratory component of the vocal folds). The vibrating vocal mucosa gives rise
to a mucosal wave (shear wave) which underlies the quality of voice. At this point the
elastic properties of the vocal folds and the Bernoulli‟s forces generated by the air flow
between the vocal folds begin to medialize the vocal ligament even as the vocal mucosa
is still vibrating. One phonatory cycle is completed when the vocal mucosa snaps back to
the midline eventually. Subglottic air pressure builds up again initiating yet another
phonatory cycle. Movement of the lips and tongue change this sound to create individual
speech sounds. The phonation threshold pressure is linearly related to the vocal fold
tissue viscoelastic properties [7].

The fundamental frequency (pitch) of phonation
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depends upon length and stiffness of the vocal fold tissue (mechanical properties),
exhaled air pressure, and the mass of the vocal fold tissue [13]. Formant frequencies are
achieved by altering vocal tract shapes with the help of extrinsic laryngeal muscles
(formant frequencies are four or five resonant frequencies of the vocal tract [13]. The
vocal fold tissue (vocal mucosa) vibrates at frequencies of 100 to 1000Hz at amplitudes
of 1mm [11]. The vocal ligament experiences approximately 15% strain at normal
phonatory frequencies [63].

2.2 ECM and biomechanics of phonation
Conceptual statement :- The ECM composition of the vocal fold tissue is fundamental
to the biomechanics of voice production.
Briefly, the vocal fold tissue is a good example of a tissue whose form and
function are inter-related.

Most vocal pathologies arise from an altered ECM

composition [2].
In engineering terms, the viscoelastic properties of the vocal fold tissues are purely
responsible for the normal vocal fold vibratory behavior.
In biological terms, the unique matrix composition of the vocal fold tissue underlies the
quality of human voice.
In layman terms, the quality of human voice depends upon the vocal fold tissue
architecture.
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Figure 2.3 The multi-layered structure of the human vocal folds

The range of sounds a single pair of adult human vocal folds can produce is simply
amazing especially in comparison to that of a musical instrument [64]. This ability or
rather versatility stems from the fact that the matrix composition of the vocal fold tissue
has tremendous functional significance in the context of phonation [65]. As indicated in
figure 2.3, the adult human vocal fold is a highly differentiated membranous structure
consisting of a lamina propria sandwiched between the stratified squamous epithelium
and the vocalis muscle (thyroarytenoid muscle) [66]. Histologically the adult human
vocal folds comprise six different layers :- epidermis (the outer epithelium), the basement
membrane zone (BMZ), the superficial (LPs) , intermediate (LPi), and deep (LPd) layers
of the lamina propria and the vocalis muscle [2, 66-69]. The LPs is also known as the
“Reinke‟s space”. The biomechanical performance of the vocal fold tissue correlates
with the anatomic arrangement of structural scaffolding proteins and this leads to a
“cover-body” theory of vibration [68, 69]. The epidermis and LPs together constitute the
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vocal fold “cover” which is popularly known as the vocal mucosa [69]. The LPi and LPd
together constitute the vocal ligament. The vocalis muscle (thyroarytenoid muscle) forms
the “body” of the cover-body structure. Animals and new born infants lack the vocal
ligament [70-72].

2.2.1 Epidermis
The stratified squamous epithelium forms the epidermis or the outer cover of the
vocal fold tissue whereas ciliated pseudocolumnar epithelium forms the outer covering of
the remaining parts of the larynx [2]. This epidermis serves as the protective covering
which gives shape and consistency to the underlying lamina propria. The epidermis is
primarily cellular with the cells attached to each other through desmosomes (attachments
between cytoskeleton of the adjacent cells). The ability to resist repetitive collisions the
vocal folds are subjected to over several decades can be attributed to the presence of the
desmosomes.

The stratified squamous epithelial cells are metabolically active until

desquamation unlike epithelial cells of the skin. Desquamated cells in the uppermost
layer are replenished by the dividing basal cells. The luminal surface of these epithelial
cells is covered with a microridge pattern.

The microridged pattern may assist in

increased mucus adherence, water absorption (due to an effective increase in surface
area) and increased traction during vocal fold vibration. A mucociliary blanket (layer of
mucus) which comprises the mucinous layer and the serous layer covers the epithelial
lining [2, 73]. The mucinous layer which is the luminal layer prevents dehydration of the
underlying serous layer and the epithelial cells. The serous layer which has a much
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higher degree of hydration (in comparison to the mucinous layer) is in direct contact with
the cilia which can beat freely within the less viscous serous layer than when it is in
contact with the thick, viscous mucinous layer. This mucociliary blanket travels upwards
in a circular fashion at the rate of 4 to 21 mm/minute in a normal person. One puff of
cigarette, cold and dry conditions can slow down mucociliary clearance enough to expose
the mucus to inhaled environmental toxins, inflammatory agents, allergens and
dehydration [2, 74]. Thereby the mucociliary blanket is responsible for keeping the vocal
fold healthy, moist and lubricated under normal conditions.

2.2.2 Basement membrane zone (BMZ)
It is also referred to as the submucosal BMZ. The BMZ is necessary for the
ordered development of the multilayered vocal fold tissue [75]. The BMZ secures the
overlying epidermis (stratified squamous epithelial cells) to the underlying lamina propria
(primarily acellular amorphous ECM components) through anchoring fibers composed of
collagen types IV and VII [2]. The BMZ is a four layered structure comprising the
plasma membrane of the basal epithelial cells, the lamina lucida (immediately below the
basal cells of the epidermis), the lamina densa and the sub lamina densa (above the LPs)
[2, 75-78].

The anchoring filaments composed of collagen type IV anchor the

hemidesmosome of the basal cells to the lamina lucida and the lamina densa [75]. The
anchoring fibers composed of collagen type VII loop from the lamina densa through the
sub lamina densa to the LPs and back again to the lamina densa. The concentration i.e.
population density of anchoring fibers is genetically influenced [79, 80]. An average
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person may have 80 to 120 anchoring fibers per unit area of BMZ whereas a person with
a recessive gene for collagen VII may have only 40 to 50 anchoring fibers per unit area of
BMZ.

A person who is homozygous for the recessive gene will have almost no

anchoring fibers [81]. Heparan sulfate proteoglycan is found in the BMZ, and it serves to
bind collagen type IV, laminin, and fibronectin [4].

It is reported that in normal

conditions the BMZ appears rectilinear but pathology lends a non uniform distorted
appearance to the BMZ [75]. The extent of non uniformity explains the degree of
structural tissue damage.

2.2.3 Lamina propria
In adults the lamina propria is a hypocellular structure whose ECM
composition plays a significant role in maintaing normal phonatory voice. However,
in newborns the lamina propria is characterized as a single layer of cells [82]. In
adults the lamina propria is a loose connection of ECM components which comprises
structural glycoproteins, fibrous proteins, non fibrous proteoglycans, glycosaminoglycans
(GAGs) like HA, sparsely interspersed fibroblasts, myofibroblasts (differentiated
fibroblast), and occasionally macrophages [2, 68, 69]. In 2001, Sato and co-workers,
confirmed that some cells which had a stellate (star like) morphology with slender
cytoplasmic processes (broadly classified as fibroblasts) were distinctly different from the
conventional fibroblasts both in terms of morphology and differentiated functions i.e.
protein expression [83-87]. These cells came to be known as vocal fold stellate cells
named after their peculiar star-like morphology. The vocal fold stellate cells are widely

18

distributed in the macula flavae (junction/transition region between the vocal ligament
and thyroid cartilage which bears maximum tension in the vocal ligament) but are absent
in the LPs [83]. It is reported that the stellate cells actively synthesize elastic and
collagen fibers and are responsible for the development of the vocal ligament after birth
[71, 88, 89]. The interaction between structural glycoproteins like fibronectin and fibrous
proteins like elastin and collagen serves to stabilize the matrix

scaffolding of the

biomechanically important lamina propria [2, 68, 83, 90]. Conventional fibroblasts are
found in the vocal mucosa interspersed within the ECM. Originally, it was widely
accepted that the bipolar spindle shaped fibroblasts produced the vocal fold tissue matrix
[64, 65, 70, 91, 92]. However, in 1996 Pawlak and co-workers demonstrated cytoplasmic
staining for proteoglycans in macrophages and myofibroblasts [4]. It was observed that
the concentration of macrophages and myofibroblasts was highest in the superficial fifth
and that of the conventional fibroblasts was maximum in the deepest fifth of the lamina
propria [65].

Interestingly, women have a significantly higher concentration of

macrophages in the superficial fifth of the lamina propria [65]. Macrophages are the cells
which respond to and may cause inflammation.

They are mainly found in the

submuscosal BMZ (between the epidermis and the LPs).

The location of the

macrophages suggests that they are present to counter agents like bacteria, viruses and
other inhalants that cross the epithelium and can be harmful to the vocal fold tissue [2].
Macrophages produce and release the cytokine IL-1 which plays a central role in the
mediation of inflammation. IL-1 causes the vocal fold fibroblasts to produce more HA
and less versican [93, 94]. The myofibroblasts are a differentiated form of fibroblasts
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containing smooth muscle alpha actin and are found in areas of damage and function as
repair cells [95]. They are anchored to the matrix by a transmembrane complex between
the intracellular and extracellular fibronectin fibers called a fibronexus [96]. The actin
and fibronectin aid myofibroblasts in reorganization of the tissue during the reparative
stage [97]. Interestingly, these cells are also found in normal human vocal folds. The
concentration of myofibroblasts decreases as the depth of the vocal fold tissue increases
(highest in the LPs and absent in the LPd) [2].

This indicates the presence of

microtrauma and constant repair efforts in the vocal fold tissue as a result of the constant
impact from phonation (normal use of vocal folds) [2, 65].
From the above observations one may infer that the synergistic action of the
following helps in restoring the microscopic injury without any significant alteration in
the vocal fold ECM composition :-

myofibroblasts (elevate collagen levels leading to scar formation)

-

increased synthesis of HA due to IL-1 activity (helps in retaining elevated levels of
HA during the acute phase of wound healing to prevent scarring)

-

deposition of fibronectin (mediates wound healing by acting as a chemoattractant
for monocytes and fibroblasts, by promoting cell-matrix interactions through its cell
and matrix macromolecule binding domains) [2, 90, 93, 94, 98, 99].

It is reported that microinjury repair can take up to 48 hours to heal [2]. However chronic
vocal abuse may lead to the onset of vocal pathology due to a vigorous (macroscopic)
unresolvable injury to the vocal fold tissue catalyzed by inadequate healing time.
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One may thus infer that the macrophages, myofibroblasts, conventional fibroblasts
and the vocal fold stellate cells together are actively involved in matrix synthesis of the
vocal fold tissue.

2.2.3.1 Vocal mucosa
(a) ECM composition of the human vocal mucosa - The matrix of the vocal mucosa
(epithelium and LPs) is abundant in glycoproteins like fibronectin, small interstitial
proteoglycans like decorin, large proteoglycans like versican, GAGs like HA, and small
amounts of elastic fibers like elaunin and oxytalan [2-4, 6, 7, 90, 100]. Fibronectin is a
ubiquitous glycoprotein which plays a vital role in cellular functions and presents binding
sites for matrix macromolecules as well as cells [19, 90]. Fibroblasts deposit fibronectin
in response to interstitial tissue damage [19]. Fibronectin binds to fibrous proteins like
collagen and proteoglycans and thereby plays a vital role in vocal fold tissue matrix
assembly. However, it was reported in 1999 by Chan and co-workers [101] that although
abundant in the vocal fold tissue, fibronectin does not play a vital role in the maintenance
of the vocal fold tissue viscoelasticity. It is counterintuitive that though fibronectin has
binding sites for HA it does not affect the biomechanics of the tissue. The reason behind
this may be the use of an inappropriate isoform, a smaller molecular weight or a lower
approximation of the biological concentration of fibronectin [90]. On the other hand the
sole function of fibronectin may be to assemble and maintain the matrix and the cells in
the vocal fold tissue [90]. Decorin is found mainly in the LPs and its main function is to
bind and regulate the thickness of collagen fibrils [2, 4, 7, 15]. Decorin mainly binds
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collagen types I and II [4]. The presence of decorin in the LPs not only delays but also
reduces the concentration of collagen fibrils in the vocal mucosa. HA differs from other
GAGs in that it does not occur covalently bound to proteins, and is usually considered
unique though it is described along with the proteoglycans in the context of the vocal
folds [7]. HA is the only GAG present in the vocal fold tissue. HA is a porous, high
molecular weight, polyanionic molecule which is responsible for regulation of osmosis
by attracting sodium ions and therefore water. HA in turn controls the tissue viscosity by
regulating the hydration levels of the vocal mucosa [2, 7]. Thereby HA lends the vocal
fold tissue ability to resist the pounding and vibratory shocks sustained during phonation
[7]. Thus, the viscoelastic properties of the mucosal wave (shear wave) which underlies
the quality of voice is largely dependent upon the levels of HA in the vocal mucosa. HA
is a space filling molecule which serves to regulate the fibrillogenesis of collagen in
combination with decorin and thereby helps in regulating the size of the vocal mucosa [2,
4, 7]. In short, HA contributes to tissue viscosity and the initiation and propogation of
vocal fold oscillations [102]. Versican appears to play a vital role in the lamina propria
of the vocal fold. Versican possesses an HA binding domain and thus interacts with HA
in the matrix of the vocal mucosa [4]. The HA levels in the vocal mucosa seem to
correlate more with gender than with age. Males are reported to have three times more
HA than females and subsequently have a thicker lamina propria [3].

This may

contribute to increased molecular interactions leading to an increase in tissue elasticity
and viscosity [103].

Elastic fibers like oxytalan and elaunin are believed to be

interruptions in elastogenesis varying in the degree of crosslinking [3, 104, 105].
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Oxytalan, a fibrillar, hydrophilic protein contains very little amorphous elastic material
and hence does not elongate under mechanical stress [105, 106].

Elaunin is an

intermediary between fibrillar hydrophilic oxytalan and large amorphous hydrophobic
elastic fibers. Elaunin fibers are shorter and smaller than complete elastic fibers [107].
Elaunin exhibits elastic properties intermediate to those of oxytalan and complete elastic
fibers [105].
(b) Biomechanics of the human vocal mucosa - In terms of biomechanics, the vocal
mucosa is isotropic due to the random arrangement of the matrix macromolecules [103].
The vocal mucosa (surface of the vocal fold tissue) propogates in the form of a shear
wave (mucosal wave) during phonation. Steady shear deformation and oscillatory shear
deformation are the two standard rheological techniques to assess the viscoelastic shear
properties of materials. The human vocal mucosa is neither “Hookean elastic” (ideal
solid) nor “Newtonian viscous” (ideal liquid) [103]. For a Newtonian fluid like water the
steady-state viscosity is independent of the strain rate (it is dependent only on
temperature).

But non-Newtonian materials like biological tissues and polymeric

materials have viscoelastic properties that depend upon the strain rate. The vocal mucosa
is viscoelastic, exhibiting both elastic and viscous properties. Thereby, the viscoelastic
properties of the human vocal mucosa are characterized rheologically using sinusoidal
oscillatory shear deformation [103]. Rheological properties of the human vocal mucosa
are a macroscopic manifestation of the microscopic and molecular arrangements. The
viscoelastic shear properties of the human vocal mucosa are quantified in terms of
complex shear modulus which includes the elastic shear modulus and the viscous shear
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modulus. The elastic shear modulus is also known as the storage modulus and is a
measure of the amount of energy stored in the vocal fold tissue during one cycle of
oscillation/phonation. The viscous shear modulus is also known as the loss modulus
which is a measure of the amount of energy dissipated in the form of heat during one
cycle of oscillation/phonation. The viscoelastic shear properties of the vocal mucosa are
often reported in terms of dynamic viscosity which is obtained by dividing the viscous
shear modulus by angular frequency over the entire range of frequencies tested. The
dynamic viscosity response of the human vocal mucosa shows a „shear thinning‟
response (decrease in frequency is linear on a log scale) [103]. In some cases an order of
magnitude difference has been reported between males and females [103]. This may be
attributed to the gender related difference in ECM composition. The phonation threshold
pressure and dynamic viscosity of the vocal mucosa share a linear relationship [7]. Vocal
fold tissue viscosity and elasticity depend upon the ease with which slippage can occur
between and within molecules.

This in turn depends upon the intermolecular and

intramolecular interactions between matrix macromolecules such as:-

hydrogen bonds (electrostatic bonds)

-

physicochemical interactions (covalent crosslinks)

-

hydrophilic and hydrophobic interactions (interactions between polar and non
polar functional groups)

Thereby, the concentration, molecular weight, and molecular structure of the matrix
macromolecules which contribute to the 3D tissue architecture are the most important
factors in regulating the viscoelastic properties of the vocal mucosa.
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2.2.3.2 Vocal ligament
(a) Matrix composition of the human vocal ligament - The human vocal ligament
comprises the LPi and LPd. It forms the transition region between the cover (vocal
mucosa) and the body (vocalis muscle) of the vocal fold tissue. The vocal ligament runs
between the anterior and posterior macula flavae [89].

The macula flavae is the

junction/transition region between the vocal ligament and the thyroid cartilage, which
bears the maximum tension in the vocal ligament. The anterior and posterior macula
flavae are connected to the thyroid and arytenoid cartilages, respectively, and are 1.5mm
x 1.5mm x 1.0mm in size. Conventional fibroblasts and vocal fold stellate cells make up
the matrix producing cellular component of the macula flavae [89]. The cell density of
the macula flavae is lesser than that of the LPs [64]. The fibroblasts and vocal fold
stellate cells actively produce an ECM rich in elastic and collagen fibers. At the macula
flavae ends of the vocal ligament, there are gradual changes in the stiffness of the
junction region between the vocal ligament and the hard cartilages [108]. The macula
flavae is present in new born infants but the vocal ligament is absent [70, 89]. The cell
density in the macula flavae of infants is much higher than that of an adult [71]. It is
widely accepted that phonation after birth stimulates the fibroblasts in the macula flavae
which eventually leads to the development of the vocal ligament [89]. The human vocal
ligament matures after puberty [109].

The macula flavae is essential for growth,

development, and aging of the vocal fold tissue [71, 88, 89]. One might infer that the
fibroblasts in the macula flavae produce collagen and elastic fibers in response to
mechanical stress which is the epigenetic stimulus regulating the matrix composition of
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the macula flavae itself and thereby the vocal ligament. The ECM of the vocal ligament
is abundant in small interstitial proteoglycans like fibromodulin and fibrous proteins like
elastin and collagen, small amounts of HA and glycoproteins like fibronectin [2-4, 6, 7,
14, 65, 90, 100]. Fibromodulin is concentrated in the vocal ligament and it serves to bind
and regulate the thickness of collagen fibrils [2, 4, 7]. Interactions between glycoproteins
like fibronectin and fibrous proteins like elastin and collagen provide scaffolding to the
vocal fold tissue. The elastin and collagen fibers of the vocal ligament are also produced
by the vocal fold stellate cells located in the macula flavae [83, 89]. The concentration of
elastin fibers is reported to correlate more with age than with gender [110]. Native
elastin which can otherwise be stretched to five times its original length without any loss
of resilience can be stretched to only twice its normal length in the vocal fold tissue due
to its association with collagen [92, 111, 112]. Collagen imparts tensile strength to the
vocal ligament. Tensile strength arises from the crosslinking present within collagen
which is due to covalent bonds formed between the lysine and hydroxylysine residues on
adjacent molecules [111]. Lack of elastin and collagen may result in unco-ordinated
vibration of the vocal fold tissue resulting in dysphonia [110]. Proteoglycans influence
the interaction between elastin and collagen fibers [6]. Therefore, interactions between
fibronectin, fibromodulin, HA, and primarily elastin and collagen impart elasticity and
tension bearing properties to the vocal ligament.
(b) Biomechanics of the human vocal ligament - Young‟s modulus (elastic modulus)
accurately represents the elasticity of the human vocal ligament [8]. Elasticity of the
vocal ligament plays a key role in control of phonation since the mucosal wave first
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begins from the deeper layers of the lamina propria, then propogates to (transverse
direction), and along the surface (vertical direction). It was reported that the vocal fold
tissue stress-strain relationship is linear at low strain levels (<15% strain) and non linear
at higher strain levels [63]. Low strain levels (<15% strain) represent normal phonatory
strain levels [8]. Min and co-workers, characterized the longitudinal elasticity of the
human vocal ligament using excised tissue from human larynges and reported the
Young‟s modulus to be approximately 33kPa at low strains (<15%) [63]. At higher
strains (>15%) the Young‟s modulus values were 135kPa (25% strain), and 600kPa (40%
strain).

The elastic moduli of the human vocal ligament at higher strains (>15%)

predominates over the vocal mucosal stress thereby playing a fundamental role in
controlling frequency at high strain.

Tran and co-workers, reported the transverse

elasticity of the human vocal ligament using an in vivo measurement technique on human
patients‟ vocal fold tissue under general anesthesia [8]. The recurrent laryngeal nerve
was stimulated with 2 different currents 3.8mA and 3.2mA at 80Hz for a pulse duration
of 1.5ms. At high stimulation the transverse elasticity was reported to be approximately
21kPa and at low stimulation it was reported to be 19kPa. Though there is a significant
difference in the values of the longitudinal moduli and transverse moduli, one cannot
infer that the vocal ligament is anisotropic (longitudinal vs transverse). Further studies
need to be performed in order to characterize the transverse moduli at varying levels of
stimulation. It is important to characterize transverse elastic moduli of the vocal ligament
because initial mucosal wave movement (LPd to LPs) is in the transverse direction
(though the surface mucosal wave propogates in the vertical direction).
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From the ECM composition of the vocal mucosa and the vocal ligament it is
evident that the vocal mucosa is sparsely populated with elastin and collagen fibers
whereas the vocal ligament has an abundance of these fibers. The linear and non linear
elasticity at low and high strains correlate to the unique collagen ultrastructure of the
human vocal ligament [113]. The helical collagen fibers function as a buffer at low
strains so that elongations of the vocal ligament occur without much resistance [113]. At
high strains, the unique collagen structure absorbs the stress and serves as a shock
absorber along the length of the fibers.
From these observations one might wonder what causes the matrix producing
cells to produce a certain kind of matrix in the vocal mucosa (~1mm below the surface)
and yet another different matrix in the vocal ligament (~3 to 4mm below the surface of
the vocal folds). Chemical signals in different tissues are thought to determine the
location and extent of ECM protein deposition [114]. However, bearing in mind the
mechanical function and vibratory microenvironment of the vocal fold tissue, one might
hypothesize that vibration and strain are the epigenetic stimuli regulating the unique
matrix composition of the human vocal fold tissue (especially the lamina propria). In
other words, differences in gene expression (ultimately leading to a correspondingly
different protein expression assuming there are no factors causing post translational
modifications) in the vocal mucosa and vocal ligament may be a direct result of
differences in the magnitude of mechanical stimulation experienced by the vocal mucosa
(vibration) and the vocal ligament (strain).
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2.3 Aging and matrix regulation by fibroblasts
2.3.1 Why does our voice change (presbyphonia) as we age?
As we age, the membranous vocal folds shorten in males, the vocal mucosa
thickens in females and edema develops in the LPs of both males and females [115]. It
had been reported that non pathological loss of voice quality sets in every five years for
males above fifty years of age [116]. Aging causes matrix producing fibroblasts to
senesce thereby resulting in less efficient functions. In other words, as we age the density
of cells in the vocal fold tissue and their cytoplasmic components like golgi apparatus and
rough endoplasmic reticulum (site for active protein synthesis) decrease in number [88].
The number of fibrous proteins (elastin and collagen fibers) synthesized by the senescent
resident cells of the macula flavae also decreases. This alteration in balance leads to a
change in the biomechanical performance of the tissue, ultimately leading to an aging
voice. The process of degrading old proteins and synthesis of new proteins is referred to
as “ECM turnover”. ECM turnover slows down as age progresses. Fibroblasts are
implicated in ECM turnover by virtue of the enzymes they secrete which in turn degrade
the matrix proteins. These enzymes are called matrix metalloproteases (MMPs). MMPs
include collagenases, gelatinases, and elastases. MMP-1 (collagenase) degrades collagen
types I and III. MMP-2 (gelatinase) degrades collagen type IV and VII which are BMZ
proteins. Elastases degrade elastin molecules. The catabolic activity of the MMPs is
inhibited by the tissue inhibitors of metalloproteases (TIMPs) [117]. Vocal fold tissue
ECM regulation involves the interplay between MMPs (degrade matrix proteins) and
TIMPs (inhibit the activity of the MMPs) [2]. Unfortunately, studies examining the
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interaction between the MMPs and TIMPs in the human vocal fold have not been
performed [2]. However, such studies have been performed in animal models. In these
models the production of collagen and MMPs decreases with age but the production of
TIMPs remains relatively constant throughout the life span [2].

The cumulative

physiologic effect of decreased protein and MMPs expression coupled with a constant
TIMPs secretion is slower protein turnover. This causes the existing proteins to become
older (more crosslinked in case of collagen and elastin) before they are replaced. A
higher degree of crosslinking further delays degradation by normal processes due to
increased intra and intermolecular bond formation and also hampers biological activity of
these molecules [2]. Elastin molecules become less elastic and the collagen molecules
become stiffer due to increased crosslinking [118]. Fibronectin concentration in the
vocal fold tissue increases as a result of constant repair throughout a lifetime [90]. In the
context of the vocal fold tissue, as one ages, slower matrix turnover coupled with
elevated levels of fibronectin causes the vocal fold tissue to become less elastic and more
stiff, signaling a change in the biomechanical properties of the tissue which ultimately
leads to slight a change in voice or in more chronic cases leads to dysphonia. For
example, a stiffer, thinner vocal fold tissue will cause the vocal folds to vibrate faster and
with smaller amplitude.
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2.3.2 Collagen and senescence
As mentioned earlier, collagen types I, II and III are found in the lamina propria
and collagen types IV and VII are found in the BMZ. As we age, increased collagen
crosslinking and reduced ECM turnover rate makes the lamina propria stiffer [6]. It was
reported that infant vocal folds had about 51% of the collagen found in all adults and in
geriatrics.

There was no significant difference between adult and geriatric folds.

However, female adult and geriatric vocal folds had approximately 59% of the collagen
found in male adult and geriatric vocal folds i.e. male vocal ligaments showed about
twice the concentration of collagen in the female vocal ligament [119]. Thereby, the
concentration of collagen fibers correlates more with gender than with age.

2.3.3 Elastin and senescence
Hammond and co-workers, reported that infants (smaller, thinner elastic fibers)
had approximately 23% and geriatrics (larger, thicker elastic fibers) had approximately
879% of the elastin found in a normal adult human vocal fold [110]. Consistent with this
finding the geriatric vocal ligament was reported to be larger than that of infants and
adults [110]. However, Sato and Hirano, reported that the concentration of elastic fibers
in geriatrics is lesser than that of normal adults [120]. Hirano and co-workers, also
reported a similar reduction in elastin levels when geriatrics were compared to adults
[109]. These contradictory results have not been discussed by these groups in later
publications. Gray and co-workers, hypothesized that variable observations could be
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attributed to differences in the quantitation techniques, specimen number and racial
variations among subjects [6].

2.3.4 Hormones and aging
Newman and co-workers, reported the presence of androgen, estrogen, and
progesterone in the human vocal fold tissue in varying concentrations and locations thus
lending a hormonal angle to the aging voice [121]. The concentration of the progesterone
receptor was higher in younger subjects across both genders in comparison to older
subjects.

It was also reported that variations in the estrogen/androgen ratio was

responsible for voice changes in post menopausal women.

The concentration of

androgen and progesterone receptors is higher in males than in females. It must be stated
that the relation between hormone levels and aging is yet to be fully understood.

2.4 Vocal fold damaging factors
Vocal fold tissue damage can be brought about by a multitude of factors such as
[2, 13-15, 65, 122, 123] :(a) Vocal misuse/overuse
-

chronic vocal overuse

-

excessive exposure to cold and dry environments

-

smoking

(b) Non phonatory mechanical injury
-

trauma (head or neck injuries)
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-

surgical intubation

-

improper use of CO2 laser during surgery

(c) Vocal pathology
-

benign lesions (nodules, polyps and Reinke‟s edema)

-

laryngeal cancer

-

medical problems like allergies of the upper respiratory tract, nasal and sinus
regions, and laryngophayrngeal reflux (gastroesophagal reflux)

-

infectious laryngeal diseases, for example - respiratory papillomatosis

2.5 Diagnosis/Assessment of vocal fold tissue damage
(a) Vocal fold tissue examination - Assessment of voice problems includes a detailed
evaluation of patient history, perceptual voice assessments, laryngeal endoscopy (rigid
endoscopy or transnasal flexible endoscopy), examination of the vocal fold tissue
vibratory pattern using a videolaryngostroboscope, evaluation of aerodynamic efficiency
(information about the efficiency of the larynx), pulmonary function and acoustical voice
analysis (information about the physical aspects of voice) [18, 60].
(b) Vibratory tests - Vibratory tests are conducted with the help of videolaryngostroboscopes, fiberoptic-laryngoscopy, electroglottography / laryngomyography
or ultra-high speed photography [13, 18, 60].

This kind of physical examination

facilitates detection of asynchronous vibrations, vibration asymmetries, structural
abnormalities like small masses and submucosal scars. Transnasal flexible laryngoscopy
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helps identify compensatory behavior of the extrinsic laryngeal muscles by detecting
muscle tension dysphonia arising secondary to glottic incompetence [18].
(c) Aerodynamic studies - Aerodynamic efficiency of the vocal fold tissue is examined
using a pneumotachograph which measures air volume, air flow rate and phonation time
[60]. Respiratory function is analyzed using a plethysmograph. Increase in vocal fold
tissue stiffness results in a decrease in both the mean air flow rate and air volume.
(d) Voice analysis - Minor changes in the vibratory pattern of the vocal fold tissue can be
detected by careful voice/acoustic analysis [60]. Vocal pathologies tend to contract the
vocal frequency range in an adult human patient.

The patient‟s normal phonatory

frequency (pitch) and vocal range can be assessed using frequency measurements.

2.6 Vocal pathologies
Rapid strides in communications during the 20th century and in the ongoing 21st
century involving media like radio, television, telephone and computers which have
brought about upliftment of our society are based on the impact of voice [60]. Urban
pollution and high stress levels can cause irritation to the fine lining of the vocal fold
tissues [60]. Rapid transportation resources result in lack of time for globe trotting
performers (singers, actors and teachers) to acclimatize their voice producing organ.
The six most frequently reported dysphonia-inducing vocal pathologies are vocal
fold scarring, nodules, polyps, Reinke‟s edema, laryngeal cancer, and vocal fold paralysis
[124]. The three most commonly diagnosed vocal pathologies are benign lesions like
vocal fold polyps, nodules and Reinke‟s edema [125].
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2.6.1 Vocal fold scar
Scarring is implicated as the single largest cause for the loss of voice quality after
surgery [18]. Scarring of the vocal fold tissue is a result of blunt trauma, penetrating
neck injuries, iatrogenic injuries, surgical intubation, radiation therapy for removal of
lesions, pro-inflammatory conditions like laryngopharyngeal reflux and laryngeal
infections [13]. Vocal fold scar may or may not co-exist with benign lesions. The
functional result of a vocal fold scar is dysphonia due to decreased ability of the stiff
unresponsive vocal fold tissue to vibrate freely and rapidly during phonation coupled
with complications like aspiration (related to glottic incompetence). When viewed by a
stroboscope the mucosal wave produced by the scarred tissue appears to be irregular and
reduced in both frequency and amplitude as compared to that of a normal vocal fold
tissue. Scarring-induced reduction in vibrational amplitude of the mucosal wave leads to
decreased intensity of voice.

The phonation threshold pressure (subglottic pressure

required to initiate phonation) is increased as a result of an altered ECM composition of
the vocal fold tissue. Thereby, in addition to dysphonia, patients complain of vocal
fatigue, breathlessness, and increased phonatory effort [18]. The subject will attempt to
overcome scar induced voicing difficulties by :- (a) altering the length and tension
(mechanical properties) of the vocal fold tissue with the help of the intrinsic laryngeal
muscles and (b) by changing the position and shape of the larynx with the extrinsic
laryngeal muscles to increase the phonation threshold pressure [13].

This leads to

compensatory muscle tension induced dysphonia secondary to scar induced dysphonia at
a later stage [18].
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Scar tissue is seldom diagnosed in the nascent stage due to virtually no evidence
of mass lesion or visible abnormality. Treatment of the scarred vocal fold tissue is one of
the most challenging voice problems faced by otolaryngologists today [18]. Any kind of
injury to the vocal fold lamina propria elicits a wound healing response which is
characterized by disorganized deposition of collagen which eventually results in scar
formation. The acute phase of wound healing which includes the proliferative phase is
very important in the context of scar formation [48, 126]. The proliferative phase begins
2 to 3 days after initial injury and lasts for 2 to 3 weeks [48]. During the proliferative
phase fibroblasts migrate into the site of injury and actively synthesize matrix comprising
mainly collagen. HA being a space occupying molecule in the matrix, affects collagen
fibrillogenesis [127]. The balance between matrix molecules (collagen vs HA) produced
during the proliferative phase is the defining difference between scar formation and
regenerative-type wound healing [128]. Adult dermal wound healing is characterized by
scar formation attributed to decreased HA levels by day 10 [129]. Scarless fetal wound
healing is attributed to consistent elevated levels of HA leading to regenerative repair
[128, 130]. It has been reported that HA levels in the vocal fold wounds decrease to sub
normal levels after day 5 of injury resulting in vocal fold scarring [131]. However,
chronic vocal fold scars (2 to 6 months post injury) reveal HA levels similar to that of
normal tissue [132-134]. As mentioned earlier, elevated levels of HA throughout the
wound healing process would help in regulating the fibrillogenesis of collagen and could
thus play a vital role in averting scar formation primarily due to its space occupying
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property. In addition to being disorganized and scattered, elastin levels are decreased in
matured scars (2 to 6 months post injury) [132, 133].

Physiological effects of scar formation :- Thus scar formation leads to an altered matrix
composition of the vocal folds tissue which subsequently causes dysphonia.

2.6.2 Benign vocal fold lesions
Injuries like vocal fold polyps, nodules, and Reinke‟s edema (also known as vocal
fold granulomas) arising out of chronic vocal overuse and inadequate hydration affect the
lamina propria [14, 19, 65, 75, 135-137]. Vocal fold polyps and nodules are benign
convex lesions along the midline of the vocal folds caused by increased mechanical stress
generated by high velocity impact between the vocal folds during phonation [14].
Mechanical stress coupled with structural disruptions of the BMZ is the main cause of
benign lesions which have a purely negative impact on the quality of voice. Among
otolaryngologists there is no uniformity of vocabulary regarding benign vocal fold
lesions like polyps, nodules, and Reinke‟s edema. This arises from the fact that clinical
diagnosis is hampered by the varying macroscopic appearances of these non life
threatening pathologies [125, 137].

Transformation of vocal polyps, nodules, and

Reinke‟s edema from one form to another (for example from polyps to nodules) does not
occur [137].
(a) Vocal fold polyps - Vocal polyps are defined as lesions on the anterior third of the
vocal folds, often on the free edge, sessile or pedunculated, and very mobile when
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pedunculated [136] (peduncle is a stalklike base to which a polyp or tumor is attached).
The polyp-inducing phonotrauma is often an acute event which causes capillary damage
leading to edema, bleeding, and fibrin leakage. Complete repair and recovery is often
hampered by recurrent movements of the lesion during phonation, inducing recurrent
capillary trauma. From these observations one might hypothesize that the age of the
lesion cannot be estimated accurately since signs of recent/fresh bleeding could be
misleading. Accumulation of HA [137] and fibronectin [135] around blood vessels is a
unique feature of vocal fold polyps. A possible reason for elevated levels of HA around
vasculature is the induction of fibroblasts and smooth muscle cells to deposit HA in
response to inflammation and mechanical stress/trauma [138, 139]. The thickness of the
submucosal BMZ remains unaltered [135].

Increased vasculature due to capillary

proliferation lends a reddish color to the vocal polyps [136]. Severe disruptions of the
endothelial lining are characteristic of vocal polyps.

The combination of signs of

recent/fresh bleeding, depositions of iron and fibrin, and thrombosis confirms the clinical
diagnosis of vocal fold polyps [136].
(b) Vocal fold nodules - Vocal nodules are defined as small lesions occurring on both
sides of the larynx, strictly symmetric on the border of the anterior and middle third of
the vocal fold, and usually immobile during phonation [136]. These superficially located
lesions move as fast as the frequency of phonation. Medially directed tearing forces
generated as a sequelae of the Bernoulli‟s forces generated during the phonatory cycle are
primarily responsible for vocal nodules. Glottic incompetence which preexists in this
pathologic condition serves to increase the tearing forces/Bernoulli‟s forces [136]. Vocal
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nodules cause submucosal BMZ thickening and less often capillary wall thickening [56].
Nodules are characterized by increased amounts of collagen type IV and fibronectin in
the BMZ and the LPs [2, 135]. This kind of protein deposition is indicative of a
repetitive injury to the tissue which results in abnormal and incomplete healing
eventually leading to scar formation [2]. Elevated fibronectin levels in vocal nodules
cause a reduction in mucosal wave motion [90]. Vocal nodules is a pathology that is
more common in women than in men [3]. The combination of BMZ thickening, absence
of hemorrhage, and absence of edematous lakes (increased levels of vasculature)
confirms the clinical diagnosis of vocal fold nodules [136]. Women have a higher
fundamental frequency of vibration than men. The higher frequency leads to shocks of
higher impact when the vocal folds collide during the phonatory cycle. Also, three times
higher HA content in the vocal fold tissue plays a vital role in preventing vocal nodules in
men [3].

Increased capillary proliferation is not observed in vocal nodules [136].

Increased capillary thickness and disorganized fibronectin deposition is characteristic of
vocal nodules [135]. No endothelial lining disruptions were observed in vocal nodules
[136]. It is hypothesized that the perpendicular orientation of the elastic fibers in these
lesions may be induced by the tearing/Bernoulli‟s forces [137].
(c) Reinke’s edema - Reinke‟s edema is defined as a unilateral or bilateral swelling of
the vocal fold, filled with fluid, sessile, and very mobile during phonation [136].
Reinke‟s edema swellings are reported to be white in color. During phonation the motion
of this lesion is far more coordinated than that of a polypoid lesion. The edematous
outgrowth is observed to roll over the medial edge of the vocal fold once every phonatory
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cycle. Talkative people and heavy smokers are almost exclusively vulnerable to Reinke‟s
edema though smoking has not been implicated as the leading trauma to this pathology
[137]. This pathology is not gender specific. Reinke‟s edema is characterized by an
increase in the thickness of the vocal mucosa, a decrease in tissue viscosity, an increase
in fibrin and fibronectin deposition [7, 75, 90, 135-137]. Reinke‟s edema is associated
with an increased mucosal wave pliability which can be attributed to elevated levels of
fibronectin.

It may seem counterintuitive that elevated levels of fibronectin in two

different pathologies are responsible for two contrasting outcomes. Fibronectin isoforms
could be a possible explanation for this observation [90].

Increased capillary

proliferation is not observed in Reinke‟s edema [136]. But the vessel walls show an
increase in thickness i.e thickness of the vessel wall is greater than the normal capillary
basement membrane. Pericyte recruitment is also observed [136] (Pericytes are slender,
contractile, mesenchymal-like cells found in close association with capillary walls. They
are relatively undifferentiated and may differentiate into fibroblasts, macrophages, or
smooth muscle cells (from Stedman‟s Medical Dictionary, 26th edition)).

Slight

disruptions of the endothelial cell lining are observed but these disruptions are much
smaller than the those observed in case of polyps [136]. Smoke induced trauma is not
severe enough to induce endothelial lining damage. The combination of submucosal
BMZ thickening, edematous lakes, erythrocyte extravasation, and increased thickness of
submucosal vessel walls confirms the clinical diagnosis of Reinke‟s edema.
Histological evaluations of vocal fold tissues afflicted by polyps, nodules, and
Reinke‟s edema reveal increased or decreased levels of fibronectin. Increased fibronectin
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deposition is a precursor for increased collagen deposition which heralds the onset of scar
formation [19]. Interestingly, benign vocal lesions like polyps, nodules and Reinke‟s
edema may or may not exhibit scar formation [19]. Abnormal levels of fibronectin in
these pathologies indicate that a sufficient extent of matrix disruption had been caused
and that the cellular response to bring about matrix repair was initiated. This fibroblastic
response (increased fibronectin deposition) may be downregulated before scar formation
sets in. But it must be noted that these benign neoplastic lesions can co-exist with vocal
fold tissue scarring.
(d) Vocal fold cyst - A vocal fold cyst is defined as a unilateral undulation with a smooth
surface, immobile during phonation, usually on the middle third of the vocal fold [136].
It is characterized by a normal or slightly thickened submucosal BMZ and a fairly normal
distribution of fibronectin [135].
(e) Vocal fold pseudocyst - A vocal fold pseudocyst is defined as a swelling resembling
a cyst, usually located on the junction of the anterior and the middle third of the vocal
fold, the macroscopic wall of which is thin and translucent [136].
These observations suggest that the initiating trauma for vocal polyps is acute
phonotrauma, cigarette smoke for Reinke‟s edema and tearing forces (Bernoulli‟s forces)
for vocal nodules [136]. Vocal polyps are mechanically the most compromised of the
three common vocal pathologies. Continual forces maintaining these lesions could cause
thickening of the capillary basement membrane and persistent endothelial damage may
lead to platelet adhesion and thrombosis. In summary, these vocal pathologies are the
human vocal fold tissue (primarily the lamina propria and BMZ) response to
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phonotrauma.

Another striking observation is that the degree of BMZ disruptions

witnessed in vocal pathologies is more severe than that witnessed in pathologies of any
other organ. This reveals the extent of the destructive nature of repetitive mechanical
stresses the vocal fold tissues are subjected to during a lifetime of phonation which
hampers the wound healing process.
Finally, phonotrauma to the vocal fold tissues induces BMZ disruption and injury
to the vocal mucosa. Vocal pathologies arising out of incomplete wound healing lead to
dysphonia secondary to altered mucosal wave pliability or decreased vocal fold tissue
vibration brought about by either scar formation (disorganized collagen deposition) or
excessive fibronectin deposition (biological characteristics of strength, binding and
adhesion do not contribute to efficient tissue pliability [19]). Benign vocal fold lesions
may or may not co-exist with scarred vocal fold tissue.

Physiological effects of benign vocal fold lesions:- Polyps, nodules, and Reinke‟s edema
lead to dysphonia secondary to an altered ECM composition of the vocal fold tissue.

2.6.3 Malignant vocal fold lesions and infectious diseases
Malignant tumors due to neoplastic lesions are detected by biopsy, direct
laryngoscopy, and physical examinations. Early and advanced neoplastic lesions may
partially or completely prevent (metastasis into vocalis muscle) vocal fold motion.
Treatments include surgical removal of lesions and non surgical options such as radiation
and chemotherapy. Surgical removal of malignant lesions may be followed by dysphonia
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secondary to scar formation. Radiation therapy induced swelling and dryness results in
destruction of the mucosal lining thereby exposing the vocal fold tissue to toxic inhalants
and inflammatory agents which eventually damage the tissue. Respiratory papillomatosis
is an infectious disease characterized by wart-like growths (papillomas) on the surface
lining of the respiratory tract, which includes the throat, larynx, and trachea. The human
papilloma viruses also known as genital warts cause respiratory papillomas. These
papillomas may be mobile and pedunculated (slim stalk) or sessile (stalkless). Treatment
methods include surgical removal of the papillomas and therapies to slow or stop viral
regrowth. Till date none of the techniques have been able to prevent recurrence of
respiratory papillomatosis. Surgical removal of the papillomas may cause dysphonia
secondary to scar formation due to lack of regenerative-type wound healing.

2.6.4 Sulcus vocalis
Sulcus vocalis, a genetic disease/condition reveals bowed vocal folds [140]. This
pathology presents a total loss of the LPs or a depression or vergeture extending into the
vocal ligament or sometimes even into the vocalis muscle. Also in some cases of sulcus
vocalis, the epithelium is directly attached to the vocal ligament [141]. Sulcus vocalis
pathology presents increased BMZ thickness and a lack of normal elastic and collagen
fibers in the lamina propria [140]. Sulcus vocalis is classified into three types of which
types II and III can be treated clinically and are characterized by replacement of normal
lamina propria by scar tissue [142]. Clinically, sulcus vocalis presents bowed shaped
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vocal folds leading to glottic incompetence, breathy voice, decrease in maximum
phonation time, and vocal fatigue.

2.6.5 Vocal fold paralysis
Branches of the vagus nerve which innervate the intrinsic laryngeal muscles are
susceptible to injury due to trauma, surgery, or other causes. Unilateral vocal fold
atrophy occurring secondary to recurrent laryngeal nerve paralysis results in highly
attenuated motion of the mucosal wave. Partial existence of the mucosal wave could be
attributed to the cricothyroid muscle which serves to adjust the tension of the vocalis
muscle (thyroarytenoid muscle) [143]. Vocal fold paralysis also results in bowed vocal
folds due to symmetric muscular atrophy eventually causing dysphonia (absent mucosal
wave) and aspiration due to glottic incompetence.

It is thereby evident that vocal

pathologies arising out of muscular dysfunction/dystrophy mostly have a neuromuscular
basis. Such disease conditions are beyond the scope of this review since our research
objective does not focus on pathologies of neurologic origin.

2.7 Current treatment techniques
A normal phonatory voice is contingent upon the existence of near perfect
approximation of the following four vocal fold tissue properties such as:- (i) mass, (ii)
elasticity (stiffness), (iii) resistance, and (iv) symmetry. A variety of techniques have
been developed for restoration, preservation, and improvement of laryngeal and vocal
fold tissue function. Currently, voice/speech therapy, laryngeal reinnervation, and vocal
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fold medialization/augmentation (injections) procedures are used to treat vocal
pathologies. The various surgical procedures for voice improvements are collectively
termed as “phonosurgery”. Phonosurgial techniques include implantation of prosthetics,
plastics, and reconstructive laryngoplasty using both synthetic and natural materials.

2.7.1 Voice therapy
Voice therapy combined with the use of antibiotics and steroids is the initial line
of treatment for vocal fold scars [13]. Mild scar-related loss of frequency, and voice
quality can sometimes be ameliorated with voice therapy.

Under conditions of

significant scarring (scars take approximately six months to mature into a stiff white
mass) voice therapy may not be very effective. Voice therapy is effective in treating
dysphonias secondary to compensatory behavior of the extrinsic laryngeal muscles [18].
Voice therapy is ineffective when presented with pathologies like vocal nodules, polyps
and Reinke‟s edema despite rigorous adherence to the prescribed habits [19]. Surgical
procedures immediately followed by a voice therapy program can effectively help in
improving and restoring normal vocal behavior [13]. The voice therapy program takes
into account scar-induced factors like vocal fold incompetence due to increased stiffness
of vocal mucosa, reduction of mechanical decoupling of the vocal mucosa and vocalis
muscle, and turbulence in the exhaled air stream. Singing voice therapy in combination
with conventional voice therapy is a new method of voice rehabilitation [18]. This
method involves warm-up exercises traditionally used by vocalists to enhance voice
efficiency.
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2.7.2 Laryngeal reinnervation
Injuries to the superior or the recurrent laryngeal nerves may result in
compromised glottic function. The superior and/or recurrent laryngeal nerves can be
injured during surgical procedures or may be subjected to traumatic crush or stretch
injuries [144]. This technique involves use of a highly modified diagnostic microscope to
detect small lesions in the vocal fold tissue [60]. Laryngeal reinnervation involves a
careful microscope-aided search for the two severed ends of the nerve and precise
approximation of the freshened nerve endings [60]. Currently, various research groups
are focused on implantation of nerves into the different muscles and the indentification of
specific nerve bundles in the vagus nerve for reconstructive surgery. Reinnervation of
the paralyzed vocal fold tissue is achieved by anastomosing the recurrent laryngeal nerve
to the ansa hypoglossi (bunch of nerves which innervate the extrinsic laryngeal muscles)
[145]. This method is reported to yield good voice quality since it restores tension to the
vocal ligament and maintains bulk of the vocalis muscle.

This method facilitates

adduction of the vocal folds by pulling the back ends of the arytenoid cartilages apart.
Thereby motion of the paralyzed vocal folds may be restored.

One disadvantage

associated with laryngeal reinnervation is that the ends of the nerves to be anastomosed
may not be readily available, for example the posterior stump of the recurrent laryngeal
nerve may be deeply embedded in a scar tissue following tissue response to the inducing
trauma. Laryngeal reinnervation procedures do not result in immediate improvement of
glottic functions [143]. Therefore resorbable gelfoam paste is injected into the paralyzed
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vocal fold tissue to provide temporary medialization of the vocal fold tissue. Benefits of
laryngeal reinnervation procedures usually manifest themselves within 2 to 4 months.

2.7.3 Vocal fold medialization/augmentation procedures
Vocal fold augmentation procedures involve medialization surgeries and
augmentation injections.

Payr in 1915, for the first time brought about vocal fold

medialization by a technique called laryngeal framework surgery using a medially
depressed pedicled cartilage flap [146]. Thereafter, Isshiki reintroduced, and popularized
laryngeal framework surgical techniques (Thyroplasty type I ) in 1974 [147], and also
refined it in 1989 [148]. Koufman refined the technique involved in laryngeal framework
surgery and popularized it in the USA [149]. Thyroplasty type I necessitates external or
internal incisions and the procedure is carried out under general anesthesia. Thyroplasty
type I involves creation of an incision in the thyroid cartilage which facilitates insertion
of a space filling material (usually an inert substance) to push the atrophied vocalis
muscle (thyroarytenoid muscle) thereby medializing the vocal folds. In other words, this
technique is used for ameliorating glottic incompetence arising out of pathologies such as
unilateral paralysis and vocalis muscle dystrophy using silastic and autologous cartilage
[147]. Thyroplasty type I is effective in realizing vocal fold medialization and thus
restoring laryngeal function when injection augmentation fails to bring about a reparative
effect. The positive effects of this kind of medializaton surgery are limited since the
normal viscoelastic properties of the vocal mucosa are not restored [150]. Vocal fold
medialization surgeries aim to restore original vocal fold tissue geometry in an attempt to
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cure voice impairment. Medialization procedures entail the use of a non physiological,
alloplastic implant which may result in problems like obstruction of airway due to
migration or extrusion of the implant [151]. Vocal fold medialization procedures are
recommended for patients presenting glottic incompetence of 1.5mm or more [13]. It
must be noted that these medialization procedures are aimed at vocal improvement by
ameliorating glottal incompetence and are not aimed at alleviating pathology [18]. It is
widely accepted that only post voice therapy must scar tissue be subjected to
medialization (augmentation) procedures. Medialization procedures achieve a reduction
in phonatory effort associated with glottic incompetence but have no improvement in
voice quality. For glottal gaps measuring lesser than 1.5mm augmentation injections are
recommended [13]. Medialization procedures serve to increase the mass of the vocal fold
tissue. Medialization procedures must be followed by voice and singing therapy during
the immediate post-operative period [18].

Medialization surgeries and injection

augmentation procedures have employed a wide variety of natural and synthetic materials
to achieve glottic closure and restoration of the mucosal wave. Vocal fold medialization
procedures began in 1911 when a German scientist, Bruning, injected paraffin into the
vocal fold tissue seeking a cure for voice impairment [152]. The medialization materials
are assessed in terms of Arnold‟s criterion which states that an ideal vocal fold
augmentation material should be easily injectable, long lasting and well tolerated by the
host tissues [153]. Material resorption and need for re-injection were the disadvantages
associated with the use of natural materials like collagen, fat, fascia, and HA [41]. The
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synthetic and natural materials used for vocal fold medialization will be discussed in the
following section.

2.7.3.1 Synthetic materials and metals used for vocal fold medialization purposes
Injection laryngoplasty to correct glottic incompetence began in 1910 – 11 when a
German otolaryngologist, Wilhelm Brunings injected paraffin into the vocal folds [144].
Since then paraffin injections have been discarded due to problems associated with
implant extrusion and paraffinoma formation [154, 155]. The injected paraffin also
caused problems by migrating to other tissues of the head and neck via the lymph nodes.
This led to the discontinuation of vocal fold injections. The criterion for an ideal vocal
fold implant as described by Godfrey Arnold is that the injected material should be
injectable, long lasting and well tolerated by the host tissues. In 1955, Godfrey Arnold
revived the dormant technique of vocal fold tissue rehabilitation by injecting autologous
cartilage paste into the vocal fold tissue using the Brunings injector. However, problems
like donor site morbidity and tedious purification processes led to the need for synthetic
materials. Teflon was the first synthetic material to be injected into the vocal fold tissue.
Teflon paste injections for vocal fold applications were introduced by Arnold in 1962.
Teflon did not satisfy the criterion for an ideal vocal fold implant. Thereafter, collagen,
fat, fascia, silicone, and HA have been used for vocal fold injection augmentation. In
1985, Ward and co-workers [144], developed a new technique for injecting augmentative
(space fillers) materials into the vocal fold tissue.

This technique which involves

introduction of the material into the vocal fold tissue via transcutaneous placement of a
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needle through the cricothyroid membrane allows vocal fold injection in almost any
patient. A wide variety of materials like ceramics, hydroxyapatite, Teflon, ePTFE, PET,
silicon, titanium, and vitalium have been used for vocal fold medialization procedures.
(a) Teflon (polytetrafluoroethylene - PTFE) - Teflon paste was first injected into the
vocal folds by Arnold and co-workers., 1962, in an attempt to bring about vocal fold
medialization [20, 21]. Since then Teflon (Teflon®, Mentor, Santa Barbara, CA) has
been used to cure glottic incompetence and restore mucosal wave motion in paralyzed
vocal fold tissues [41]. If the amount and technique of Teflon injected are perfect then
excellent phonatory results follow [143]. Under-injection results in a hoarse breathy
voice while over-injection may cause breathlessness and problems associated with
reduction in glottic aperture. Excessively injected Teflon may be removed by a spot
curing CO2 laser or tracheotomy which may eventually lead to dysphonia secondary to
scar formation. Extrusion from the implant site can cause obstruction of the airway [22,
156-159].

Migration from the implant site into regional lymph nodes resulted in

granuloma formations.

Teflon injections result in foreign body reactions (due to

phagocytosis of Teflon particles by macrophages) and tissue fibrosis [160, 161]. Once
injected, removal from the injected site is very difficult due to significant soft tissue
reaction. Teflon injections were dispensed by a Bruning‟s injector and were targeted at
the vocalis muscle (thyroarytenoid muscle) [162]. The main disadvantage of Teflon and
most other non physiological materials is that they can never restore the normal mass and
tension (mechanical properties) of the native vocal fold.
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(b) ePTFE (expanded PTFE) - ePTFE (Gore-Tex®, WL Gore, Flagstaff, Az) is
implanted into the vocalis muscle (thyroarytenoid muscle) and not injected like Teflon.
Thus ePTFE implantation is classified as a laryngeal framework surgery or more
popularly thyroplasty type I. ePTFE was widely used for cosmetic purposes but in 199798 its application was extended to curing vocal fold insufficiencies by McCulloch and coworkers [25]. This group implanted a 25mm long, 2mm wide, and 0.6mm thick strip of
ePTFE, folded over 5 times into the vocalis muscle (thyroarytenoid muscle). Histological
analysis of the explanted graft revealed the presence of isolated foreign body giant cells
and a thin fibrous capsule around the ePTFE implant. It was reported that after 6 months
when the rabbits were sacrificed, the implants were removed fairly easily but with
application of slight traction. From these observations one may infer that the slight
amount of tissue ingrowth (due to the porous nature of ePTFE) prevents implant
extrusion. It was observed that unlike Teflon, ePTFE is less susceptible to granuloma
formation. In 2000, Tamplenizza and co-workers [163], injected rolled ePTFE tubes
(2.5mm average diameter) through a 4mm fenestration in the thyroid cartilage into the
vocalis muscle (thyroarytenoid muscle). The tubular shape combined with the porous
nature of the implant facilitated extensive tissue ingrowth which in turn anchored the it to
the implantation site and prevented problems like airway obstruction associated with
migration and extrusion [164].

Thus implanted ePTFE was reported to provide

appreciable phonatory improvement over traditional thyroplasty (using Teflon) [165].
The ePTFE implant is easy to handle, and unlike other materials its shape can be altered
even after placement in the implant site [24]. Implantation of ePTFE can be easily
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combined with another procedure like arytenoid adduction to restore glottic closure and
its easy removal from the site of implantation is a real advantage. Zeitels and co-workers
[166], and Giovanni and co-workers [124], have reported vocal fold medialization
procedures with minimal complications [24]. None of the above studies have reported
problems associated with implant extrusion and migration.
(c) Calcium hydroxyapatite - Calcium hydroxyapatite is a biologically inert ceramic
composed of phosphorous and calcium [167]. Calcium hydroxyapatite gel (Radiance®,
BioForm, Frankesville, WI) is FDA approved for vocal fold augmentation applications
[168].

This preparation comprises calcium hydroxyapatite spherules dispersed in a

mixture of water and glycerin and is easily injectable and non resorbable [41]. Calcium
hydroxyapatite spherules of varying sizes are available :- (a) Standard radiance spherules
measure between 75 and 125µm and can be injected through a 21 gauge needle, (b)
Radiance FN measures between 25 and 45µm and can be injected through a 27 gauge
needle. These particle sizes prevent phagocytosis of the implant material. One of the
main indications for calcium hydroxyapatite based injections is unilateral paralysis and
presbyphonia due to bowed vocal folds [168]. Calcium hydroxyapatite gel is injected
deep into the lateral portion of the vocalis muscle (thyroarytenoid muscle). Calcium
hydroxyapatite is reported to be non inflammatory and non antigenic since it is formed
from calcium and phosphate ions which exist normally in our body [167]. Chhetri and
co-workers, performed a time course study evaluating the calcium hydroxyapatite gel
(Coaptite®, BioForm, Frankesville, WI) implant performance in canine vocal folds upto
a period of 12 months [26]. The spherules were 38 to 63µm in size dispersed in a
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hydrogel (70% volume) comprising water, glycerin, and 3% carboxymethylcellulose
which could be injected with a 23 gauge needle. Histological evaluation revealed some
foreign body giant cells but no other signs of chronic inflammation. Post implantation, a
decrease in the degree of medialization/increase in glottic incompetence was observed
progressively over the various time points (1, 2, 3, 6, 9, and 12 months). This is due to
resorption of the aqueous based carrier vehicle leading to increasing compactness of the
implant material.
Thereby, one may infer that since over-injection may cause airway obstruction
and associated problems, re-injection may be the only way to circumvent increasing
glottic incompetence. But unlike injecting natural materials which are resorbed by the
body calcium hydroxyapatite can be injected a certain limited number of times since it is
not resorbed by the body. Contrasting opinions exist about the need for over-injection of
calcium hydroxyapatite into the lateral aspect of the vocalis muscle (thyroarytenoid
muscle). One might infer that experience is the best teacher with calcium hydroxyapatite
injections for vocal fold medialization procedures.
Rosen and Thekdi, used both the endoscopic vocal fold injection (EVFI) and
percutaneous vocal fold injection technique (PVFI) in an attempt to compare the efficacy
of both the techniques for calcium hydroxyapatite injections into the vocalis muscle
(thyroarytenoid muscle) or the thyroid cartilage [167]. They reported that the EVFI
provided more precise placement of the implant material.
(d) Polydimethylsiloxane (PDMS) – PDMS was first used for vocal fold augmentation
laryngoplasty in 1983 [169].

PDMS gel (Bioplastique ®, Bioplasty, Geleen ,
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Netherlands) is both readily injectable and non resorbable. Unlike Teflon, the PDMS
particles do not cause granuloma formation since they are too large to be taken up by
macrophages [41]. PDMS gels alleviate glottic incompetence but the improvement in
physical aspects of voice is not significant due to reduced mucosal wave pliability. This
occurs due to the lack of approximation of the implant viscoelastic properties to that of
the human vocal mucosa. Therefore, PDMS injections were limited to the LPd. PDMS
based implants elicit minimal to no soft/host tissue response and can be removed fairly
easily from the implant site. PDMS based materials are widely used in Europe but do not
have FDA approval for use in the USA [41].
(e) Silicon - Silicon is one of the most frequently employed materials for vocal fold
medialization [149]. Silicon poses problems with positioning and placing the implant in
the site of interest [27]. If the implant dimensions do not match those of the implantation
site then a new implant has to be prepared. Problems associated with migration of silicon
from the implant site have also been reported [13]. Carcinogenic properties lend yet
another disadvantage to silicon based vocal fold medialization.
(f) Titanium - In 1999, for the first time titanium was implanted into the vocalis muscle
(thyroarytenoid muscle) and anchored to the thyroid cartilage (to prevent implant
migration) by Friedrich and co-workers [170]. The rationale behind using titamium for
medialization of the vocal fold tissue was retention of the lamina propria tissue
architecture. Unilateral vocal fold paralysis and bowed vocal folds were indications for
titanium based medialization of vocal folds.

Titanium implants may be used in

combination with another technique like arytenoid adduction to bring about glottic
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closure and thereby improvements in voice.

Schneider and co-worers, reported

observations from a study involving titanium implants in human subjects suffering from
incomplete glottic closure secondary to unilateral vocal fold paralysis [171]. The length
of the implant was 15mm for men and 13mm for women.

They observed an

improvement in the motion of the mucosal wave of all patients 1 week after the
procedure. The fundamental frequency of normal phonation and the voice intensity were
unaffected by the medialization procedure.
(g) Dacron (polyethylene terephthalate - PET) – Keskin and co-workers reported
observations from a study involving injection of PET into the vocal fold tissue of a rabbit
model [27].

Histological evaluation on excised tissue 6 months after implantation

revealed a discontinuous fibrous capsule surrounding the implant. Macrophages invaded
the network structure of PET through the areas where capsule continuity was
compromised which eventually resulted in foreign body giant cells surrounding PET
fibrils. This study concluded that PET is inferior to titanium in terms of vocal fold tissue
implant applications.
(h) Gelfoam - Gelfoam powder (prepared from gelatin) is mixed with saline and injected
into the vocal fold tissue for temporary medialization [172].

Gelfoam (UpJohn,

Kalamazoo, MI) has been used to cure glottic incompetence in vocal fold tissues afflicted
by paralysis. However, it is reported to last only for approximately 2 months before it is
resorbed (6 to 8 weeks). This entails over-correction or even multiple re-injections.
(i) Lactosorb (Polylactic acid (PLA)/Polyglycolic acid (PGA) copolymer) - Lactosorb
is a PLA/PGA copolymer [173]. PLA (MW 180 – 530kDa) is a pale, semicrystalline
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material whereas PGA (MW 20 – 145kDa) is a hard, crystalline polymer which is
insoluble in most solvents.

A PLA/PGA copolymer has variable degradation rates

depending upon the ratio of PLA to PGA. Copolymer degradation occurs via cleavage
(hydrolysis) of the ester bonds. Additionally, molecular weights of the participating
polymers, crystallinity, and degree of purity of the material contribute to the degradation
rates. PLA has a longer half-life and lesser strength in comparison to PGA which has
shorter half-life and more strength. Lactosorb comprises 20% PGA and the remaining
80% is PLA, thereby it retains 80% of its strength after 6 weeks.

Dufresne and

Lafreniere, implanted Lactosorb into the vocalis muscle of rabbits and evaluated the
implant morphology (implant resorption), host tissue response, maintenance of vocal fold
medialization, and airway patency after 1, 3, 6 and 9 months [173]. Briefly, the recurrent
laryngeal nerve was transected, a Lactosorb implant of dimensions 5mm x 4 mm x 3mm
was introduced into the vocalis muscle (thyroarytenoid muscle) and secured to the
thyroid cartilage using nylon sutures. Gross examination revealed a thick fibrous capsule
surrounding the implant post 1 and 3 months. A foreign body response characterized by
the presence of small number of macrophages and multinucleated giant cells was
observed in addition to cells like lymphocytes, and fibroblasts. One might infer that these
macrophages and giant cells were functioning to resorb the implant. Yet there was no
significant change in the implant bulk volume and vocal fold medialization was
maintained. Replacement of muscle tissue by adipose tissue, and a decrease in muscle
fiber size suggested vocalis muscle atrophy. Post 6 months of implantation, a thin fibrous
capsule surrounded the barely visible implant. A large number of macrophages and
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foreign body giant cells were once again identified at the host-implant interface
suggesting further implant degradation was in progress. Post 9 months of implantation
the implant was completely resorbed (macroscopically and histoligically invisible) yet the
augmented vocal fold maintained both its bulk volume and airway patency. The authors
hypothesized that the observed adipose cell invasion, muscle cell swelling, and
thyroarytenoid hypertrophy may have contributed to sustained vocal fold medialization
despite complete resorption of the implant.
This material does possess some disadvantages in terms of processability.
Lactoborb is very hard and brittle which makes shaping at the time of implantation
impossible, for example heating may cause the material to melt away. Lactosorb will
need to be manufactured according to specific dimensions dictated by patient needs and
the slightest need for alteration entails preparation of a new implant.
The above study reports the presence of huge amounts of uncharacterized
intercellular material within the implanted muscle tissue. One might hypothesize that this
is an inflammatory response to the acidic degradation products produced by the
copolymer degradation.

Since the study spanned nine months it is not possible to

comment on the long-term fate and efficiency of vocal fold tissue medialization. Also,
implantation in a canine model will throw some light on the effect of Lactosorb
implantation on the physical aspects of voice.

Considering a hypothetical situation

wherein Lactosorb is implanted into the vocalis muscle of a patient with severe
gastroesophagal reflux. Acidic conditions (pH of gastroesophagal reflux is between 3
and 6) could bring about an autocatalytic effect i.e. degrade the implant faster than
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normal.

Degradation of the implant material could result in a heightened local

inflammatory response which may eventually lead to scar formation. This may cause
dysphonia secondary to scar and glottic incompetence.
(j) Botulinum toxin - Benign lesions like polyps, nodules, and Reinke‟s edema as
mentioned earlier are the result of increased mechanical stress due to the „hammer-onanvil‟ pounding effect on the vocal fold tissue during phonation. Otolaryngologists seek
to alleviate vocal impairments arising from these lesions through surgical or CO2 laser based excision of these convex lesions. But it must be stated that surgical or cold
excisions of these lesions aim to cure the symptom and not the cause. In other words,
excision based methods eliminate the lesion but leave the cause unaltered. In the case of
these vocal fold granulomas the main cause is chronic vocal abuse. Even complete vocal
rest does not prevent vocal fold adduction and arytenoid contact which occurs during
coughing and swallowing. In an attempt to completely avoid contact between the two
vocal folds Orloff and Goldman [174], injected botulinum toxin into the vocalis muscle
(thyroarytenoid muscle) aiming to provide much needed rest and recovery time to the
abused vocal fold tissue.
Briefly, botulinum toxin is a very toxic peptide protease that binds to nerve
endings at the point where the nerves join muscles [174]. This blocks the release of
acetylcholine and thereby prevents the nerves from signaling the muscles to contract.
The result is weakness and paralysis in the injected muscle. They also reported that the
inhibitory effects of botulinum toxin are gradually overcome as axonal outgrowth, which
occurs by collateral and non collateral sprouting, leads to reinnervation. It was observed
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that botulinum toxin injection induced rest period helped cure vocal granulomas and
prevented recurrence in patients who had previously reported instances of lesion
recurrence post surgical excision. Orloff and Goldman recommend the use of botulinum
toxin (Botox A; Allergan Inc, Irvine, CA) in combination with excisional surgery and
voice therapy to yield optimum results. One of the proven disadvantages of botulinum
toxin injections into the vocal fold tissue is the potential to permanently alter a patient‟s
voice [174]. Evaluation of observations mentioned above must be carried out bearing in
mind that botulinum toxin is one of the most poisonous substances known to mankind.
The above study suggests no dosage limits and advocates multiple injections to achieve
complete muscular relaxation in an attempt to prevent vocal fold apposition. Excessive
levels of the toxin may have deleterious effects on other muscles of the body especially
the respiratory muscles which could be fatal.
(k) Mitomycin-C - Garrett and co-workers, injected an antibiotic mitomyocin-C into
injured vocal folds in an attempt to cure scarring [175]. The results were not encouraging
since the site of injury demonstrated poor healing, reduced number of fibroblasts
subsequently leading to a decrease in the collagen concentration. It is hypothesized that
mitomycin-C causes a reduction in the number of fibroblasts which leads to reduction in
the amounts of protein synthesized [150]. Thereby wound healing was compromised for
want of adequate proteins that bring about resolution of wounds.
The above study promotes the understanding that alleviation of scarring
associated pathologies can be achieved by stimulating fibroblasts to synthesize the
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appropriate amounts of proteins in the appropriate locations and not by reducing
the fibroblast cell number.

2.7.3.2 Natural and synthetic biomaterials used for
vocal fold augmentation purposes
Physiological limitations of non degradable synthetic materials and theoretical
advantages of natural degradable biomaterials have led to the use of materials like
collagen, fat, fascia and HA for vocal fold augmentation purposes.
(a) Collagen - Collagen is useful in treating atrophied vocal fold tissue, scarred vocal
fold tissue, minimal glottic incompetence, and focal fibrosis [162]. Collagen injections
can be placed anywhere in the lamina propria or the vocalis muscle (thyroarytenoid
muscle) [153, 176].

These collagen injections (approximately 0.75ml) can be

administered with a 26 or 27 gauge needle which allows precise placement in the plane of
interest [153, 162]. Ford and co-workers, administered collagen injections by indirect
laryngoscopy or direct microlaryngoscopy with topical anesthesia [162].
Bovine collagen preparations - The various forms of available bovine collagen
preparations are Zyderm, Zyplast, Phonagel, Koken Atelocollagen, Gelfoam, Collastat,
and Avitene [177]. Of these the biological properties of Zyderm, Zyplast, and Phonagel
are the most suitable for vocal fold applications.

ZCI-collagen (Zyderm collagen

implant) :- ZCI-I and ZCI-II (Zyderm, Collagen Corp, Palo Alto, CA) are composed of
35mg/ml and 65mg/ml of highly purified bovine dermal collagen in PBS with 0.3%
lidocaine [153].

Zyderm collagen was first used in 1985 [178].

60

GAX-collagen

(Gluteraldehyde crosslinked collagen) is 35mg/ml bovine dermal collagen crosslinked by
0.0075% glutaraldehyde [179]. GAX-collagen is marketed as Phonagel® (Palo Alto,
CA). These collagen preparations contain approximately 95% collagen type I and 5%
collagen type II [153]. Zyplast-collagen (Collagen Corp, Palo Alto, CA) is the same as
Phonagel but for the lidocaine concentrations [180].

Indication for use was glottic

incompetence due to vocal fold paralysis. It was reported that GAX-collagen injections
into the vocal ligament [153] as well as the LPd alone [181] were well tolerated. Also,
these collagen injections into the LPs do not have any negative effect on mucosal wave
pliability [182, 183]. Since 1986, ZCI-collagen has been replaced by GAX-collagen
which is advantageous due to crosslinking [181]. Crosslinking provides the following
advantages :- (a) heightened insensitivity against collagenase thereby minimizing risk of
resorption (b) no loss of injected volume due to in situ consolidation and (c) less
antigenicity. Thereby, there is no need for over correction or re-injection. GAX-collagen
induces minimal necrosis and inflammation in the surrounding tissues [179].

Both

collagen injections into the vocal ligament showed varying degrees of cellular infiltration
and minimal inflammatory response [153]. Histological examination after two months of
injection reveals a higher degree of both structural homogeneity and cellular infiltration
in ZCI collagen than GAX collagen. The reason behind increased structural homogeneity
of ZCI collagen is that once injected the saline solution is resorbed and the collagen
fibers are arranged into a homogenous mass. Crosslinking in GAX collagen prevents any
such volume reduction. Increased resistance to collagenase activity and crosslinking is
the reason behind the relatively acellular appearance of the GAX collagen. But Ford and
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co-workers, reported a significantly higher degree of cellular colonization of GAX
collagen after two months of injection [179]. This discrepancy may be explained in
terms of reliance of homogeneity, function, fate, and future of collagen implants upon the
location of injection [179]. It must be noted that Remacle and co-workers, injected GAX
collagen into the vocal ligament [153], where muscular activity is more in comparison
with the LPs which was the location for injection by Ford and co-workers [179].
Increased muscular activity caused the collagen fibers to break resulting in faster
resorption. Also, it is thought that when injected into the vocal ligament the collagen
fibers may get dispersed due to muscular activity and may migrate into less compact
tissue [176]. On the contrary, collagen injection into the LPs minimizes breakdown of
collagen fibers and facilitates cellular colonization of the implant. Most investigators
have injected collagen into the LPs due to problems of rapid resorption associated with
injection in the deeper layers of the vocal mucosa [162]. Also, since the superficial
layers of the vocal fold tissue are devoid of lymphatic drainage it contributes to the
longevity of the injected collagen [180]. Inherently, GAX-collagen may also impair
cellular function to a certain degree due to the presence of small amounts of the
glutaraldehyde crosslinker. At time periods of over one year, GAX collagen showed an
appreciable increase in cellular infiltration and neovascularization.

3 to 4% of the

patients treated with ZCI-collagen showed hypersensitivity reaction whereas only 1% of
the patients treated with GAX-collagen showed a similar reaction [184].

Collagen

injections have been used to correct irregular free edges of the scarred vocal fold tissues
post Teflon granuloma removal [162]. Failure to gain FDA approval due to concerns
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regarding immune reactions has limited the number of clinical trials in USA but this
technique has been used successfully elsewhere in the world [162].
GAX-collagen yielded good results even after 4.5 years of initial injection [180].
It was widely accepted that GAX-collagen (and later Zyplast) is a better vocal fold tissue
bioimplant than ZCI-collagen because of properties like reduced antigenicity, no need for
over correction (no loss of volume in situ), increased resistance to collagenase and
subsequent long-term stability [153]. These collagen implants come close to fulfilling
Arnold‟s criterion of being easily injectable, long lasting and well tolerated by the host
tissue. Collagen is the first material that was aimed at softening the vocal fold scar tissue
[162] since it has been shown to reduce dermal scarring [185].
Allogeneic collagen preparations - Alloderm and Dermalogen are cadaveric
acellular human dermal (collagen + elastin) preparations which provide advantages of
autologous grafts and nullify problems associated with donor site morbidity.

The

Alloderm and Dermalogen injections vary in terms of modes of preparation and
concentrations of collagen and elastin particles [176]. A micronized version of Alloderm
called Cymetra (Lifecell ©, Branchburg, NJ) is used for vocal fold tissue augmentation
[186]. It is an acellular dermal allograft that can be injected into the vocal fold tissue
whose

collagen

and

elastin

framework

facilitates

cellular

colonization

and

neovascularization. Unlike bovine collagen preparations, a test injection is not necessary
for delayed allergic reaction assessment. Though long-term data is unavailable, Cymetra
is believed to provide better long-term biointegration than bovine collagen preparations
[41].

Alloderm based augmentation of the vocal fold tissue shows peak cellular
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(fibroblast) infiltration at day 4 which declines at day 7 and levels off by day 30 [176].
Contrastingly, Dermalogen (Collagenesis, Beverly, MA) [18] based injectables showed
peak cellular infiltration at day 30 which eventually leveled off by day 60 [176]. The
Dermalogen graft remained stable until day 180 when fat cells were observed peripheral
to the graft and neovascularization was detected within the graft. The Alloderm and the
Dermalogen grafts became progressively more compact by day 7 due to resorption of
water. Unlike what was mentioned earlier, Alloderm and Dermalogen based collagen
injections into the vocalis muscle (thyroarytenoid muscle) caused a change in the normal
vibratory patterns of the vocal folds. Allogeneic cadaveric collagen preparations last
twice as long as bovine collagen injectables.

The intact telopeptides in allogeneic

collagen preparations increase resistance to proteolytic degradation.
(b) Autologous fat - Autologous fat implantation for vocal fold tissue augmentation is a
safe technique since neither short term nor long-term complications have been reported
till date [187].

Autologous fat injections are directed into the vocalis muscle

(thyroarytenoid muscle), with overinjection to correct for loss of bulk due to resorption.
One must be careful to avoid injection into the subglottic space. Indication for fat
injection is unilateral paralysis. The first reported autologous fat injection (1991) was
performed in the vocalis muscle (thyroarytenoid muscle) of 3 patients, the location being
similar to that of Teflon injection [188]. Sataloff and co-workers, performed autologous
fat implantation in a pocket created above the scarred tissue along the vibratory margin
and co-workers [36]. Both these techniques yielded improved voice intensity, lower
phonation threshold pressures and better stability in terms of acoustic output. It is
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observed that 40% of the fat cells survive for approximately a year [13].

The

unpredictable nature of fat resorption entails overinjection/overcorrection and also reinjections. Long-term studies have been unable to ascertain whether the fat cells in the
graft were from the host or surviving cells from the initial injection. Studies by Shindo
and co-workers, suggest that injected autologous fat does survive for 6 months but the
intensity of voice is lowered after the first 3 months which is indicative of loss in tissue
bulk due to resorption [187]. Autologous fat graft survival depends upon the survival of
fat cells which in turn is contingent upon the harvesting process, microinjection technique
(18 gauge needle) and mechanical stress [187, 189]. Purification process results in
reduced fat graft survival.

During purification, the fat cells are subjected to

homogenization which destroys the fibrovascular scaffolding of the fat cells thus making
neovascularization of the graft more difficult [189].

The two fat cell processing

techniques are :- (a) morselization, centrifugation and aspiration of resulting pure fat cells
and (b) liposuction. It is observed that the liposuction derived fat cells had better survival
rates [190]. Since there are no adverse side effects, fat injections may be performed as a
temporary procedure to improve vocal performance until a permanent procedure like
thyroplasty or arytenoid adduction is performed [187]. The size of the autologous fat
cells depends upon the body mass index (BMI) [189]. Smaller fat cells maintain graft
volume better than large spaced out fat cells i.e. large fat cells are resorbed faster. The
rate of fat resorption and decrease in graft bulk volume depends upon the size and density
of fat cells and matrix around it. Fat injections satisfy Arnold‟s criterion only partly since
they are resorbed fairly quickly.
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(c) Autologous fascia - Injection augmentation with collagen and fat posed problems
associated with reduction of bulk volume due to resorption. Since the early 20th century
fascia had been used for facial surgery but only in 1998 was its application extended to
vocal fold tissue augmentation [191]. Fascia implantation was first introduced in 1998
for curing glottic incompetence [191]. Indications for fascia injection augmentation are
glottic incompetence due to recurrent laryngeal nerve paralysis. Fascia can be easily
harvested and is very stable.

Fascia comprises mainly fibroblasts interspersed in a

collagen matrix. Similar to autologous fat, fascia injections were placed in the vocalis
muscle (thyroarytenoid muscle).

Insufficiencies arising out of unilateral vocal fold

paralysis require only very small amounts of space filling materials. Thereby, chopped
autologous fascia injections which do not enhance tissue 3D bulk significantly can be
used to ameliorate minimal glottic incompetence. Unlike autologous fat injections, fascia
injections are not over corrected. Care is taken to prevent fascia extrusion into the vocal
mucosa. Since the metabolic requirements of the fibroblasts in fascia tissue are low the
free fascia graft can survive as a living tissue. Fascia processing techniques can affect the
physiological viability of the fascia to be implanted [141]. The procedure for fascia
injection is short and is done as an outpatient procedure. It is assumed that autologous
fascia is free of infection and immunologically safe [141]. Long-term (3 years) results
suggest that fascia injections are infection free, immunologically safe, bring about an
increase in maximum phonation time.

Temporal fascia is highly suitable for

transplantation into the Reinke‟s space (LPs). Even though fascia is not considered to
add to 3D bulk as mentioned earlier, long-term results showed a restoration of the vocal
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fold tissue bulk. Based on the above observations it has been hypothesized by Tsunoda
and co-workers [141] that fascia implantation facilitates regenerative-type repair of the
vocal mucosa by a mechanism similar to stem cell transplantation in other organs.
(d) Autologous cartilage - Caballero and co-workers, conducted studies on rabbit
models and suggested that implantation of autologous auricular cartilage by thyroplasty
type I is desirable for correction of vocal impairments arising out of incorrect tissue
geometry [192]. Lee and co-workers, extended the use of auricular cartilage for vocal
fold augmentation injections [193, 194].

They reported that a mixture of minced

auricular cartilage and autologous fat injected 3 to 5mm deep into the vocalis muscle
(thyroarytenoid muscle) had a very high survival rate and allowed correction of glottic
incompetence even after 3 years. No foreign body reaction (granuloma formation) was
reported. Also, histological evaluation revealed no significant differences in implant
morphology, and host tissue reaction between 1 and 3 years. There was no evidence of
implant resorption since the implant volume remained the same even though the
chondrocytes seemed to have lost viability and there was some evidence of fibrosis
around the implant.
It seems counterintuitive that the presence of equal amounts of fat and auricular
cartilage (elastic cartilage) resulted in the implant maintaining its 3D bulk for 3 years
since it has been widely reported that resorption is the single largest reason for
autologous fat injections failing in the context of vocal fold tissue augmentation.
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2.7.4 Tissue engineering approach for regeneration of the vocal fold tissue
Extensive literature review suggests that voice therapy and surgical augmentation
are the primary methods for treating vocal fold scarring and subsequent dysphonias.
Although effective in improving vocal quality, neither technique achieves regeneration of
native tissue ultrastructure and composition or complete restoration of normal phonation.
The techniques discussed earlier were mainly aimed at curing glottic insufficiency
secondary to vocalis muscle atrophy due to unilateral vocal fold paralysis, and bowed
vocal folds. However, the materials based approach of these techniques encouraged
detailed discussion.

Ensuing discussion focuses mainly on the materials used or

proposed to be used to bring about regenerative-type repair of the human vocal folds.
Some of these materials are injected/proposed for injection into the vocal mucosa (LPs)
in an attempt to soften scar/prevent scarring, and thereby realize regenerative-type wound
healing in the vocal folds. Restoration of the native tissue matrix composition through
these methods may facilitate restoration of the normal phonatory voice.
(a) Hyaluronic Acid (HA) - HA is widely accepted to be the key molecule that regulates
vocal fold tissue viscoelasticity [7]. It has been demonstrated by Chan and co-workers,
that particular concentrations of HA have viscoelastic properties similar to that of the
human vocal mucosa and that removal of HA from the vocal fold tissue matrix
compostion by way of injury leads to alteration in tissue viscoelastic properties secondary
to scarring [195]. Dahlqvist and co-workers, reported results from a comparative study
which involved injecting rabbit vocal folds with HA and collagen separately [38]. It was
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observed that the viscoelastic properties of HA injected rabbit vocal folds very closely
approximated those of the normal tissue.
Hallen and co-workers, injected a mixture of dextranomere microspheres in a
sodium hyaluronan solution (carrier) (DiHA) into the vocalis muscle of rabbit vocal
folds

[196].

Both dextran based microspheres and HA are non immunogenic.

Indications for DiHA injections include unilateral vocal fold paralysis and bowed vocal
folds. It was observed that the carrier was resorbed within the first week whereas the
dextran microspheres persisted within the tissue 6 months after implantation.
Histological evaluation of excised tissue 6 months after implantation revealed that the
dextran microspheres were embedded in endogenous connective tissue comprising
mainly collagen.

These microspheres acted as an attractant for fibroblasts which

subsequently produced collagen thereby resulting in soft tissue augmentation. In 2001,
Hallen and co-workers, injected DiHA into the vocalis muscle of human subjects who
presented insufficient glottic closure arising from unilateral vocal fold paralysis and
bowed vocal folds [197]. In some patients, multiple injections were necessary due to
resorption of the carrier. It was reported in this study that over a period of 12 months the
physical aspects of voice as well as perceptual voice assessment showed considerable
signs of improvement.
In 2002 Hertegard and co-workers, used Hylan B gel (Hylaform®, Genzyme,
Biosurgery Inc.) to improve the laryngeal function of patients presenting laryngeal
dysfunction arising out of unilateral vocal fold paralysis [40]. Hylan B gel is a pure HA
gel crosslinked using Michael type addition reaction with divinyl sulfone. Hylan B gels
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retain the non allergic, non antigenic and non inflammatory properties of native HA.
This study involved comparison of results obtained by Hylan B gel injections to those
from bovine collagen injections. Both these materials were injected into the vocalis
muscle (thyroarytenoid muscle). A 20% correction was made for collagen injections
[180] as compared to a very small overinjection performed for the Hylan B gels (since
the resorption characteristics were unknown) [40]. Previously, the same group had
shown that the viscoelastic properties of augmented rabbit vocal folds tissue closely
approximated those of the normal rabbit vocal fold tissue [198].

Periodic patient

assessment (1, 6, and 12 months after injections) revealed improvements in phonation
time parameters, glottic closure, and patient‟s perceptual assessments of voice.
Resorption of the injected Hylan B gel was minimal in the first 6 months with no further
resorption between months 6 and 12.

The regeneration of collagen fibers based

connective tissue seemed to be similar to those observed by Hallen and co-workers [39].
This group proposes a 2 year study in the future to assess the long-term resorption
characteristics of Hylan B gel.
Finck and co-workers, injected esterified HA (Merogel) into the vocal mucosa
(LPs) after surgical removal of benign lesions caused by Reinkes‟s edema [199]. Post
removal of the edematic lesion a flap was created in the LPs by microdissection within
which esterified HA fibers were placed and then fibrin glue was used to seal the opening.
The main reason behind using esterified HA was to ensure that the material degrades with
time. The injection was made in the LPs of human patients to allow a physical barrier
between the submucosal BMZ and the vocal ligament which would thereby provide
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optimal healing conditions for the LPs. Briefly, the pliability of the mucosal shear wave
which underlies the quality of voice depends upon the matrix composition of the vocal
fold tissue. The purpose behind using esterified HA and not any other material is that
HA plays a vital role in eliminating scar formation and its elevated levels during the acute
stage of injury (immediately post surgery) would facilitate regenerative-type repair. This
material is resorbed within 3 to 4 weeks. The patients reported improved perceptual
voice assessments and better phonation times. Laryngoscopic examinations revealed
improvements in vibrational amplitudes, glottic closure, motion of the mucosal wave, and
no inflammation. The study did not report any histological analysis since implantation
procedures were performed in human subjects, each one of which reported alleviated
vocal pathology and perceptual voice improvements. A major shortcoming of the above
study was the lack of a control group in the absence of which obtained results cannot be
interpreted correctly. Evaluation of matrix composition of the endogenously formed
tissue could be of value. Assessment of the host/soft tissue response to the implanted
esterified HA fibers and their in vivo degradation products may provide valuable insight
about the efficacy of this material in vocal fold wound healing. It is widely accepted that
polymeric HA is non inflammatory. But one may tend to infer that degradation of high
molecular weight HA to lower molecular weights may lead to an inflammatory response.
An inflammatory response may ultimately lead to increased collagen deposition
following fibroblast recruitment. Restoration of normal voice secondary to regeneration
of the LPs using exogenous HA suggests mimicking conditions of fetal wound healing to
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achieve regenerative-like repair which is the “holy grail” for tissue engineering
researchers.
The HA injections and implants were found to be non toxic and free of foreign
body reactions.

Minimal inflammation was observed in some patients after the

administration of Hylan B gels. The main difference between Hylan B gels (Hylaform)
and esterified HA (Merogel) is that the Hylan gels are crosslinked, injectable liquids
whereas the Merogel is in the form of solid fibers. Also, Hylan B gels are injected into
the vocalis muscle (thyroarytenoid muscle) while the esterified HA is implanted into the
LPs.
Hansen and co-workers, have manipulated HA into injectable forms in an attempt
to aid vocal fold wound healing and to prolong residence in the tissues to help maintain
optimal viscoelasticity of the matrix [43]. The two injectable forms of HA used by this
group as proposed materials for alleviation of vocal fold tissue scar are:- (i) HA-DTPHPEGDA (thiol derivatized HA such that the free thiol groups can react and crosslink with
polyethylene glycol diacrylate (PEGDA)), (ii) Carbylan-SX (carboxylic acid groups on
HA are modified using carbodiimide chemistry to yield free thiol groups which facilitate
crosslinking). These crosslinked materials (crosslinking increases the tissue residence
time to approximately 2 weeks as opposed to 3 to 5 days with native HA) were aimed for
injection into the vocal mucosa [43]. Klemuk and Titze, compared the rheological
properties of ZCI-collagen, Cymetra, and HA-DTPH-PEGDA [200]. It was reported
that the viscoelastic properties of HA-DTPH-PEGDA very closely approximate those of
the human vocal mucosa. Prior to implantation, rheology revealed that Carbylan-SX had
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higher levels of elasticity and viscosity than HA-DTPH-PEGDA [43]. These materials
were injected into rabbit vocal folds following a biopsy injury.

Saline treated

contralateral vocal folds formed the controls. The animals were euthanized after 3 weeks
and the vocal fold tissues were subjected to rheology and ELISA. The extent of healing
and the effect of injected HA on tissue biomechanics were assessed by rheology.
Rheology revealed significant viscosity improvements in tissues injected with HADTPHA-PEGDA. However, elasticity of the tissues treated with HA-DTPH-PEGDA
was similar to that of the control group. In contrast, both elasticity and viscosity were
markedly improved in tissues treated with Carbylan-SX in comparison with the saline
treated control group. ELISA revealed similar HA levels in all the three groups (HADTPH-PEGDA, Carbylan-SX and saline treated control groups).

The authors

hypothesized that similar levels of HA detected by ELISA (after 3 weeks of implantation)
was due to complete degradation of the scaffold material within 2 weeks. Also, since
Carbylan-SX is less readily degradable than HA-DTPH-PEGDA it may contribute to
maintaining superior viscoelastic properties of the vocal fold tissues post 3 weeks. HADTPH-PEGDA may have degraded earlier than 2 weeks (acute phase of wound healing)
thus leading to degraded levels of HA similar to scar based wound healing of the vocal
fold tissue post injury. This is confirmed by histological evaluations which indicate
increased fibrosis in the HA-DTPH-PEGDA groups in comparison to Carbylan-SX
groups. Thus it was inferred that Carbylan-SX is a potential injectable material for
amelioration of scar tissue based vocal impairments.
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From the above observations one may infer that a long-term time course study
could lead to better evaluation of the soft tissue response to HA degradation products
since it is well known that oligomeric HA is pro-inflammatory. Use of a porcine, canine
or sheep models may facilitate assessment of the physical aspects of sounds produced
(for example voice intensity) because a rabbit does not vocalize effectively.
(b) Cell based regenerative approach - This is a regenerative approach aimed at
alleviating vocal impairments by altering the matrix composition of the tissue thereby
improving its functional outcome.
Fibroblasts - Vocal fold scarring is the main indication for injection augmentation
with autologous fibroblasts [201].

The fibroblasts are expected to bring about a

regenerative-like repair by reconstituting the matrix of the lamina propria in the site of
scar and thus influence restoration of normal mucosal wave motion [201]. Autologous
fibroblasts are harvested from the patient by skin or mucosal biopsy, and then expanded
in culture. The fact that injected fibroblasts do not migrate away from the site of
injection is encouraging.

It was reported that the administration of three weekly

injections of fourth, fifth and sixth passage mucosal fibroblasts (95% – 100% confluence)
into the scarred lamina propria (CO2 laser induced scar) of 9 beagle dogs (animals lack
vocal ligament) resulted in restoration of the mucosal wave [201]. The laser-induced
injury caused re-epithelialization but not regeneration of the damaged tissue resulting in
partial or total loss of the mucosal wave prior to fibroblast injections. Chhetri and coworkers, inferred that since fibroblast injections do not bring about appreciable alteration
of the tissue 3D bulk volume, the favorable functional outcome was a direct result of a
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replenished lamina propria [201]. Histological studies do indicate presence of native
matrix components but in aberrant concentrations. In fact histology indicated an increase
in the densities of collagen fibers and a corresponding decrease in elastin.

These

observations are similar to those of a scarred vocal fold tissue [150].
From the above observations one might infer that the study has scope for further
advancements.

It seems counterintuitive that though the technique is aimed at

eliminating the ill-effects of a scar tissue, therapy itself could lead to a more matured scar
in time to come. It is widely accepted that the cell density in the lamina propria is very
low. In this study each weekly injection involves introduction of 25 million mucosal
fibroblasts (suspended in 0.8 – 1ml of PBS) into the otherwise paucicellular lamina
propria. This is a very high cell density which may contribute to the irregular amounts of
matrix components detected.

The study was limited in the context of measuring

acoustical parameters like maximum phonation time, and dysphonia due to the use of a
canine model. Hence all observations are based on the videostroboscopic analysis of the
mucosal wave which may be inconclusive. No rheological data of the post mortem
beagle vocal fold tissues was provided to back up the claim that the fibroblast injection
helped to restore tissue viscoelastic properties. Future publications from this group
addressing issues like long-term results in human subjects could be really interesting.
Mesenchymal stem cells (MSCs) - It is a widely accepted fact that stem cells can
differentiate into a variety of cell types depending upon the epigenetic stimuli they are
subjected to. In 2003, Kanemaru and co-workers, injected mesenchymal stem cells into
injured vocal folds of a canine model and reported observations on wound healing in
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terms of morphological appearance and histological composition [202].

This study

comprised vocal fold tissue (animals lack vocal ligament) injection of bone marrow
derived stem cells dispersed in a 1% HCl atelocollagen scaffold. This is the first attempt
at vocal fold regeneration consistent with the tissue engineering approach.

The

mesenchymal stem cells were autologous, thereby eliminating fears of immunological
safety and ethical issues [202]. Four days post MSCs injection, the vocal fold tissue was
damaged with an electrocautery with the injury extending into the vocalis muscle in some
cases. Morphological examinations evaluating vocal fold surface irregularity and 3D
tissue bulk volume reveals that regeneration of the experimental group (MSCs injection)
was more encouraging than that of the control group (1% HCl atelocollagen i.e. scaffold
injection). Histological evaluations suggested that apart from cellular nuclei staining in
the experimental group (due to the presence of MSCs) there was no significant difference
between the control and the experimental groups. Tissue engineering aims to bring about
organ regeneration by manipulating the interaction between variables like the scaffold,
cells, regulating factors (exogenous/endogenous growth factors), and the appropriate
epigenetic stimuli [203-206]. From what was reported [202], the above study did not
include any exogenous growth factors like HGF or TGF-β1. It was reported that unlike
the left vocal fold there were no atrophic changes in the right vocal fold [202]. It seems
counterintuitive that despite marked differences in the bulk volume and tissue appearance
of the MSCs injected tissue, histology did not reveal any significant difference in terms
of matrix composition. It seems unlikely that MSCs injection could be causing the space
filling effect in the experimental group.
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One could interpret these findings in terms of glottic incompetence arising in a
manner similar to unilateral vocal fold paralysis. In unilateral paralysis motion of the
mucosal wave of both the vocal folds is partially or completely impaired. A similar
situation may be arising in this study wherein glottic incompetence due to atrophy in the
left vocal fold may be causing reduction of the mucosal wave in both the vocal folds thus
eliminating the epigenetic stimuli regulating the unique vocal fold tissue matrix
composition. This may be the reason behind no appreciable difference in the matrix
composition of the right and left vocal folds even though the right vocal fold tissue
morphologically appeared to have a much higher degree of regeneration than the left
(MSCs dispersed in a 1% HCl atelocollagen scaffold was injected into the right vocal
fold and the scaffold alone injected into the left vocal fold).
(c) Growth factor therapy - It is a widely accepted fact that growth factors are potent
regulators of cellular functions. Growth factors have been identified as one of the most
potent factors regulating cellular function in the vocal fold tissue [49]. Exogenous
application of growth factors to repair tissue injuries may require multiple injections to
maintain physiologically relevant levels of the growth factor in order to compensate for
losses due to rapid metabolization.
Hepatocyte growth factor (HGF) - It has been reported that HGF is responsible for
prevention of scarring in the lungs, liver, and kidneys of animal models [207]. HGF is a
potent mitogen for mature hepatocytes and is a multifunctional polypeptide involved in
embryogenesis, angiogenesis and tissue repair [207]. However, the role of HGF in vocal
fold wound healing is not well understood [208] though HGF has been implicated in
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suppressing expression of TGF-β1 and stimulating protease activity that is responsible for
degradation of the excess matrix laid down in case of scar formation [207]. HGF activity
in acute vocal fold tissue wound healing of rabbits was shown to be activated by day 10
and lowered slightly by day 15 [207]. In case of wound healing in artificial wounds
created in a rat model, the mRNA levels of HGF increased steadily form day 1 to day 14
[209]. Contrastingly, peak mRNA expression levels of HGF was reported at day 3 of
epithelial wound healing [210]. These observations suggest that HGF activation depends
upon the site and the extent of tissue damage.

Briefly, it is hypothesized that the

mechanism of action of HGF is paracrine [207], in that the fibroblasts in the lamina
propria produce HGF which is then transferred to epithelial cells with receptor cMet[208]. Once the HGF is bound to the c-Met it is said to modulate interactions
between stromal epithelial cells associated with scarring. Autocrine production of HGF
by epithelial cells is neither proven nor has it been ruled out. Thus, HGF functions to
regenerate the epithelial cells through stromal-epithelial interactions [48].
Hirano and co-workers, have demonstrated that HGF upregulates HA synthesis
and downregulates collagen synthesis by both canine and human vocal fibroblasts in vitro
thus strengthening claims that HGF prevents scar formation [46]. In another study, the
same group injected HGF into rabbit vocal folds to evaluate the effect of HGF on
scarring [48].

The procedure involved unilateral vocal fold stripping, immediately

followed by HGF administration into the injury site. In this study HGF was administered
only once in the beginning of the study.
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A similar study was undertaken by Hirano and co-workers, to study the
therapeutic effects of HGF injections on canine vocal fold tissue scarring [47]. In this
study, HGF was injected into the vocal fold tissue one month post induction of scarring
by stripping. Histological examination of tissues (from both the above studies) 6 months
later showed a reduction in both elastin and collagen deposition (precursor to scarring)
and a corresponding reduction in tissue contraction (onset of scarring) in comparison to
the untreated control group. Though the vibratory and viscoelastic properties of the
treated tissue were better than the untreated control group the phonation threshold
pressure and physical aspects of voice were still below normal levels.
One might infer that HGF should be introduced into the injury site as early as
possible to coincide with the onset of the proliferative stage of wound healing. Rapid
degradation in the levels of HGF may necessitate multiple injections.
Basic fibroblast growth factor (bFGF) - It has been reported that bFGF plays a vital
role in upregulating HA synthesis and downregulating collagen synthesis by aged rat
fibroblasts [211]. As we age, the collagen levels in our vocal fold tissue increase (due to
reduced rate of ECM turnover) and HA levels decrease leading to dysphonia secondary to
increased stiffness and altered viscoelastic properties of the vocal fold tissue. Hirano and
co-workers, attempted to reverse negative changes in the matrix protein levels leading to
presbyphonia by administering bFGF 4 times weekly in a time course study spanning 2
months [49]. At the various time points (1 week, 1 month, and 2 months) there was a
consistent increase in the HA levels of the bFGF treated tissue in comparison with
untreated tissue (control group). But comparison of HA levels across the 3 time points
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revealed that the HA levels in treated vocal folds was significantly reduced 2 months
after injections as compared to that after 1 week.

Collagen levels remained similar in

both the bFGF treated tissue and the untreated tissue across all the time points.
From the above observation, one may infer that therapy based on bFGF delivery
may require re-injections to bring about a favorable outcome. On the flipside, exogenous
growth factor injections result in their rapid metabolization in tissues before the desired
effect is achieved in most cases. In the aforementioned study, this may be a reason
behind unchanged collagen levels despite repeated injections.

In aged subjects,

depolymerization of collagen is time consuming since protease production by senescing
fibroblasts is less efficient. Rapidly degrading levels of exogenously applied growth
factors like bFGF and HGF therefore do not produce the desired stimulatory effect on
senescent fibroblasts.
The above study may incorporate the use of a canine model or even human
patients and then subjecting the excised tissues to rheological tests to see how well the
viscoelastic properties of the treated vocal fold tissue approximate those of the non
pathological native tissue.

Motion of the mucosal wave should be assessed by

videolaryngostroboscopy. In case of human subjects, where tissue excision is not a
possibility, the physical aspects of voice like phonation threshold pressure, maximum
phonation time, vocal efficiency, and voice intensity should be assessed.
Use of gene therapy or controlled release methods which may maintain elevated
growth factor levels in the tissue will enhance the efficacy of delivered growth factors in
vivo [49]. However, in the context of HGF and bFGF based attempts at vocal fold
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regeneration, one must bear in mind that there exists no example of single growth factor
delivery mediated alleviation of pathology.
(d) ECM scaffold - Porcine-derived xenogeneic ECM scaffolds have been used to bring
about repair and reconstruction in numerous animal and human studies [212]. These
porcine-derived scaffold materials maintain their 3D ultrastructure due to the presence of
fibrous proteins like collagen types I, III, IV, V, and VI, structural glycoproteins like
fibronectin, GAGs, growth factors like VEGF, TGF-β1 and bFGF [212]. These ECM
based scaffolds are acellular and so cell-mediated immune response is minimal if any.
Moreover, any persistent antigenic response is eliminated by the rapid degradation of the
scaffold. Head and neck reconstruction procedures and surgeries to alleviate laryngeal
cancer are indications for use of porcine derived ECM scaffold for laryngeal
reconstruction. In the time course study reported by Huber and co-workers [212], the
entire vocal fold tissue and 70% of the thyroid cartilage of a canine model were
surgically excised and replaced anatomically by the porcine-derived ECM scaffold as
correctly as possible. Interestingly at all time points beyond 3 months to 1 year, presence
of collagenous connective tissue with submucosal glands with an overlying intact
squamous epithelium marked the remodeling of the scaffold material.
One might hypothesize that either the scaffold showed good biointegration with
the native host tissue or the scaffold had been remodeled completely by host tissue since
it was reported that the boundary between the scaffold and the host tissue was invisible
after 3 months. This study claims that microstructure and macrostructure of the newly
formed tissue was similar to that of the original tissue. Since this review is focused on

81

the membranous vocal fold tissue, it must be pointed out that the canine vocal fold tissue
not only lacks the vocal ligament but also possesses a dense collagenous lamina propria.
This is vastly different from the composition of the human vocal fold tissue. Therefore
successful porcine-derived ECM based reconstruction of the 3D anatomic structure of the
human vocal fold tissue may not yield positive results to the extent reported in this study.
Also, this study aimed only to obtain an acceptable speaking voice in patients who
have lost phonatory ability due to surgical removal of lesions. It thereby clarifies that
restoration of normal voice was not a priority. Future long-term studies involving human
subjects post surgeries for removal of benign or cancerous lesions may tell us a lot more
about the ability of the human body to remodel the porcine-derived ECM scaffold into
functional vocal fold tissue. Another advantage of conducting such studies on human
subjects is that the physical aspects of voice such as voice intensity, maximum phonation
time, and fundamental frequency of phonation can be assessed.
(e) Collagen-HA and collagen-alginate hydrogels - From the observations, above one
could infer that due to problems associated with resorption and allergic response an
alternative to allogeneic and bovine collagen preparations needs to be found. Since
maintenance of tissue geometry is critical for production of normal voice it is important
for injectables to be able to maintain their 3D structure relatively intact in situ even when
being remodeled by the host or the encapsulated cells if any. Hahn and co-workers, have
reported the advantages of collagen-alginate hydrogels over collagen-HA hydrogels
which could be potentially useful for restoring normal matrix composition of the vocal
fold tissue in the future [44]. Briefly, this group encapsulated vocal fold fibroblasts in the
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collagen-HA as well as collagen-alginate hydrogels, and performed a time course study
in order to evaluate cell density and morphology, matrix (collagen and GAG synthesis)
production, lateral gel compaction and mass loss. After 28 days of culture, the collagenHA hydrogels showed extensively interconnected fibroblasts whereas those in the
collagen-alginate hydrogels were spindle shaped with few interconnections.

The

collagen-HA hydrogels showed significant mass loss (50%) associated with gel
compaction between weeks 4 and 7 with little evidence of matrix deposition (collagen
fibers and GAGs). Contrastingly, the collagen-alginate hydrogels resisted compaction
and mass loss for at least 6 weeks (last time point) in culture while facilitating ECM
deposition (elevated levels of collagen and GAGs in comparison to week 4).
Interestingly, the matrix protein levels detected in collagen-HA gels after 7 weeks were
comparable to those in porcine vocal fold tissue. Thus the collagen-alginate hydrogels
appear to be promising materials for vocal fold restoration.
From the above observations, one might hypothesize that the collagen-alginate
hydrogels are promising potential scaffolds for vocal fold tissue regeneration. It must be
pointed out that there exists a slight discrepancy in the assessment of cell density in the 2
hydrogel types at the end of week 4. It was reported that there was no significant
difference in cell density from day 0 to week 4. But the BrdU stain showed positive
results for the collagen-HA hydrogels, which indicates uptake of the stain by cells in the
“S” phase of the cell cycle which is when DNA duplication occurs. Cell proliferation
leads to heightened cell migration, and increased cellular interconnections within the
scaffolding (personal observations) resulting in heightened contractile forces exerted by
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the fibroblasts which explains the compaction of the collagen-HA hydrogels. A negative
BrdU stain in the collagen-alginate hydrogels corresponds to a lack of cell proliferation
(and therefore less cell migration) which explains single spindle shaped cells without any
interconnections eventually leading to maintenance of original gel dimensions even after
6 weeks of culture. One might hypothesize that a DNA quantitation analysis may be
performed for additional confirmation of the results previously obtained. In vivo studies
using canine models may provide additional insight into the performance of these
collagen based composite hydrogels in environments where hydrogel degradation rates
could be heightened due to elevated levels of proteases (in case of inflammation) and
macrophage activity.
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CHAPTER 3
PROJECT RATIONALE

3.1 Hypothesis
The techniques/approaches described earlier have been unable to achieve
complete restoration of voice quality due to their inability to bring about regeneration of
the native vocal fold tissue architecture/ECM composition. Our long-term hypothesis is
that rapid restoration of the mechnical microenvironment using mechano-mimetic
scaffolds will minimize scarring, facilitate vocal fold tissue-specific ECM production,
and ultimately restore normal phonation. The long-term objective of our research is to
prevent vocal fold scarring following injury, achieve regeneration of the vocal fold tissue
architecture/ECM composition and thereby restore normal phonation through the use of
mechano-mimetic scaffolds. Consistent with the tenets of tissue engineering we aim to
use 3D, biodegradable, polymeric scaffolds; in vivo vocal fold tissue manipulation with
which will yield biomechanically optimal functional results. We believe that minimally
invasive therapeutic intervention/manipulation of the acute stage of vocal fold tissue
injury using mechano-mimetic materials could potentially ameliorate vocal fold tissue
scarring sequelae and restore long-term normal phonatory voice. We aim to target the
acute stage of a vocal folds injury (which leads to the onset of fibrosis) by injecting :- (a)
HA-based hydrogels (aimed at restoring viscous shear properties of the vocal mucosa),
(b) polyethylene glycol diacrylate (PEGDA) based hydrogels (aimed at restoring elastic
integrity of the vocal ligament). Various studies have elucidated the use of in situ
photopolymerizable, water soluble macromers with functionalized end groups that can be
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crosslinked to realize hydrogels upon exposure to UV light using cytocompatible
photoinitiators [213-215]. We opted for HA due to its abundance in the lamina propria,
viscoelastic properties, chemical processability, enzymatic degradability, wound healing
properties and ability to interact with certain fibroblast cell surface receptors (CD44).
PEG has been selected as the starting material among other available synthetic materials
due to its FDA approved status, ease of chemical modification, lack of specific cellular
interactions and biocompatibility thus providing a “blank-slate” for inducing cellbiomaterial interactions by incorporating synthetic peptides [216]. Observations from
our preliminary experiments as well as previously reported studies [213, 217-219]
sufficiently indicated that cell viability, proliferation, and ECM production are not
adversely affected by UV based hydrogel photopolymerization processes. One must bear
in mind that though these in vitro studies dealt with direct UV illumination of the cellmacromer suspensions in order to realize cell encapsulated hydrogel constructs, the
efficacy of transdermal injections which assume importance particularly in the context of
the proposed vocal folds application has been amply demonstrated by Elisseeff et al [220,
221].

3.2 Specific Aims
Aim 1: To enhance cellular remodeling of PEGDA hydrogels through the
creation of PEG based semi-IPNs in order to facilitate improved cell spreading and
proliferation in the PEGDA based three dimensional networks. Based on previously
published studies [222-224] and observations from our preliminary cell culture
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experiments we inferred that the nanometer-scale mesh size of the PEGDA based
hydrogel networks restricts encapsulated cells to a rounded morphology that can inhibit
cellular processes such as proliferation and migration that are essential for the early
stages of remodeling and tissue formation. Hence in the intial phase of the vocal fold
regeneration project we aim to investigate an approach for accelerating cellular
remodeling based on the creation of semi-IPNs composed of hydrolytically degradable
PEGDA macromers and native, enzymatically degradable ECM components (collagen,
gelatin, and HA).
Aim 2: To create degradable hydrogels/semi-IPNs approximating the
mechanical properties of the vocal mucosa and the vocal ligament that may be
photopolymerized in situ following vocal fold injury or surgery using minimally
invasive techniques to fill defects. We aim to create mechano-mimetic, degradable,
PEG-based semi-IPNs (approximating the elastic stress-strain properties of the human
vocal ligament) and GMHA hydrogels (approximating the viscous shear properties of the
human vocal mucosa) that may be photopolymerized in situ using minimally invasive
methods. We aim to assess cytocompatibility and the ability of these potential scaffolds
materials to support cell proliferation and neo-matrix deposition by the resident cells.
Aim 3: To assess the ability of fibroblast encapsulated GMHA hydrogels to
support vocal mucosa-specific ECM deposition in response to physiologically
relevant high frequency vibration.

Consistent with our long-term hypothesis, we

believe that rapid restoration of the vibratory microenvironment using mechano-mimetic
scaffolds will facilitate vocal mucosa-specific ECM production and minimize scarring,
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thereby restoring normal phonatory voice in long-term. Towards this end, we aim to
assess the ability of the GMHA hydrogels to support human fibroblast formation of vocal
mucosa-like ECM in response to vibration. Fibroblast encapsulated GMHA hydrogels
will be subjected to physiologically relevant high frequency vibration over a time course,
using a custom-built vibrational bioreactor and Labview software.

3.3 Clinical significance
Voice is widely acknowledged as the “mirror of soul” and is significant in terms
of the quality of life. Voice is a primary “tool of trade” for 25% of the U.S. work force
(teachers, singers, telephone marketers, sales personnel, counselors, etc.) [1, 16]. The
quality of voice depends on the biomechanical properties of the vocal fold tissue which
derive from its highly differentiated ECM organization and composition. The wound
healing response to vocal fold injuries is characterized by scarring and subsequent
dysphonia due to alterations in the biomechanical properties of the tissue. Dysphonia
characterized by increased effort to sustain phonation, decreased vocal quality, and total
voice loss affects approximately 23% of the voice-dependent US workforce [14]; and
may jeopardize job security, employment opportunities, and social interaction [225, 226].
Scarring-induced dysphonias are currently treated by voice therapy and surgical
augmentation procedures which provide short-term improvement in voice quality.
Nevertheless, these techniques have been unable to achieve long-term restoration of
normal phonatory voice due to their inability to bring about regeneration of the native
vocal fold tissue architecture/ECM composition. The human vocal ligament is abundant
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in fibrous structural proteins like elastin and collagen that impart elastic stress-strain
properties to the vocal fold tissue. The human vocal mucosa is abundant in HA and
proteoglycans that impart viscous shear properties to the vocal fold tissue. The long-term
objective of our research is the in situ photopolymerization of autologous cell
encapsulated, mechano-mimetic, degradable hydrogels/semi-IPNs to fill defects in
specific layers of the human vocal fold tissue following injury. This approach may help
restoration of long-term normal phonatory voice by promoting regeneration of native
tissue architecture/ECM composition and minimizing fibrotic scarring.

Through our

research we aim to make a significant attempt to improve human lives that have been
negatively impacted by scarring related vocal pathology. Our contributions to vocal
fold tissue engineering are :- (a) the proposed use of mechano-mimetic scaffolds for
regenerating the human vocal mucosa (GMHA hydrogels) and the vocal ligament
(PEG-based semi-IPNs) in an attempt to restore appropriate mechanical integrity to
the vocal fold tissue following injury and (b) the demonstration of the importance of
restoring the vibratory mechanical microenvironment in regenerating the unique
ECM composition of the native tissue. In the context of other tissue engineering
applications these materials may serve as :- (a) a substrate for host cell infiltration and
colonization, (b) a delivery vehicle for autologous cells which will eventually bring
about regeneration of the native tissue ECM composition, thereby aiding soft tissue
repair.
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CHAPTER 4
INCORPORATION OF HYALURONIC ACID INCREASES FIBROBLAST
SPREADING AND PROLIFERATION WITHIN PEG-DIACRYLATE SEMI-IPNs

4.1 Introduction
Hydrogels are crosslinked polymer networks that have been widely studied as
tissue engineering matrices for cell transplantation and sustained, site-specific delivery of
bioactive molecules. Properties such as minimally invasive introduction as aqueous
solutions and in-situ gelation, conformation to irregular tissue geometry, high gas and
metabolite permeability, and viscoelastic mechanical properties have rendered hydrogels
useful for cartilage, bone, vascular, and soft tissue applications [214, 223, 227].
Hydrogel matrices have been prepared from a variety of naturally-derived proteins and
polysaccharides, as well as synthetic polymers. Although naturally-derived materials are
intrinsically degradable by physiological enzymes, limitations include availability,
reproducibility, and limited control over degradation rate and mechanical properties.
Hydrogels based on synthetic polymers offer an increased diversity of physicochemical
properties that may be tailored in a reproducible manner for specific applications [215].
Degradable synthetic hydrogels have been based on polymers incorporating or modified
with hydrolytically susceptible ester bonds, such as poly(ethylene glycol)-polyester block
copolymers [228-230], poly(propylene fumarate-co-ethylene glycol) (P(PF-co-EG))
copolymers [231], and poly(lactic acid)-grafted poly(vinyl alcohol) [232]. Although
these synthetic hydrogels are biocompatible, synchronizing the rate of hydrolytic
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degradation with cellular growth and matrix accumulation poses a challenge to the
realization of engineered functional tissue [223].
At early time points following encapsulation, the 15-35Aº mesh size of these
highly crosslinked matrices [222] has been shown to restrict cell spreading, resulting in a
rounded morphology that can delay cell proliferation, migration, and ECM production
[224]. Several approaches have been investigated for increasing cellular activity within
synthetic hydrogel matrices. Anseth‟s group demonstrated that appropriate tailoring of
hydrogel degradation rate by mixing macromers of varying chemistry can improve
cellular differentiated function and the synthesis and spatial distribution of ECM [233,
234]. Hubbell and West have developed several elegant systems based on crosslinking of
non-degradable polymers with synthetic peptides or recombinant proteins by
photopolymerization and Michael addition [235-239]. These peptides were designed
with reactive terminal groups that formed crosslinks in the polymer network and internal
sequences based on cleavage sites recognized by physiological proteases involved in cell
migration such as collagenase, elastase, and plasmin. These matrices are chemically
stable and undergo localized degradation in response to cellular proteolytic activity. In
combination with grafted cell adhesion peptides and incorporation of soluble growth
factors, these matrices successfully mimic multiple features of the native ECM and have
shown efficacy for in vivo regeneration of bone [240]. One limitation of this approach is
the small scale and high production cost of synthetic peptides and recombinant proteins.
Several groups have begun to investigate the utility of biosynthetic composite gels
composed of both synthetic polymers and naturally occurring ECM components.
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Almany and Seliktar have described a system comprised of chemically crosslinked
PEGylated fibrinogen [224]. The fibrinogen component provides bioactivity for cell
adhesion and enzymatic degradation, while variation in the content and structure of the
PEG component allows flexible control over degradation rate and mechanical properties
[241]. Compositions with appropriate degradation rate have been shown to support bone
formation in rat tibial defects [242].

Sefton and coworkers have described the

development of semi-synthetic collagen/poloxamine matrices that support the viability of
encapsulated cells and the adhesion and spreading of various cell types on the gel surface
[243, 244].
The objective of the current studies was to investigate an alternative approach for
accelerating cellular remodeling based on the creation of semi-IPNs of covalently
crosslinked,

hydrolytically degradable

PEG-diacrylate

macromers

with

native,

enzymatically degradable ECM components homogeneously dispersed in the network.
Low levels of hyaluronic acid (HA) are shown to facilitate 3-dimensional fibroblast
spreading and proliferation through a mechanism of cell-mediated enzymatic
degradation.

4.2 Materials & Methods
4.2.1 Materials
Polyethylene glycol (PEG, MW=3934) was purchased from Fluka (Seelze,
Germany) and 2-chloropropionyl chloride, triethylamine, dichloromethane (HPLC
grade), anhydrous sodium sulfate, and sodium acrylate were obtained from Aldrich (St.
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Louis, MO, USA). Dimethyl formamide (extra dry) and ethyl ether were purchased from
Acros (Morris Plains, NJ) and Fisher Chemical (Fair Lawn, NJ), respectively. 2-hydroxy1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I-2959) was purchased from Ciba
Specialty Chemicals (Basel, Switzerland).

Adult normal human dermal fibroblasts

(NHDF, CC-2511) obtained from a 39 year old Black woman were purchased from
Biowhitaker (Rockland, ME, USA). DMEM F-12 50/50,1X with L-glutamine, 15mM
HEPES/trypsin

EDTA

(0.05%

trypsin/0.53mM

EDTA

in

HBSS),

and

penicillin/streptomycin were obtained from Mediatech (Herdon, VA, USA). Bovine
growth serum was purchased from Hyclone (Logan, UT, USA). Gelatin and collagen
(Vitrogen 100) were purchased from Mallinckrodt Specialty Chemicals (Paris, KY, USA)
and Angiotech Biomaterials (Palo Alto, CA, USA), respectively. Hyaluronic acid (HA,
MW=1.4 x 106) was purchased from Genzyme (Cambridge, MA, USA).

4.2.2 Synthesis of degradable PEG-bis-(2-acryloyloxy propanoate) (PEG-bis-AP)
macromers
PEG-diacrylate macromers with hydrolytically degradable ester bonds were
synthesized by a two-step reaction as previously described [245].

4.2.2.1 Synthesis of PEG-bis-(2-chloropropanoate), (PEG-bis-CP)
15g of PEG (3.75mmol) was dissolved in 120ml of dry dichloromethane and
introduced in a dry, three-neck-250ml flask under inert (argon gas) conditions. Once the
PEG was completely dissolved, 0.94ml of triethylamine (6.75mmol) was added to the
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three-neck flask which was kept immersed in an ice bath. 1.5ml of 2-chloropropionyl
chloride (15mmol) was added to 30ml of dry dichloromethane in a dropping funnel.
Contents of the dropping funnel were introduced into the three-neck flask in a drop-wise
manner within 2hours under constant agitation. After approximately six hours, the ice
bath which was never replenished, was removed and the reaction was allowed to progress
overnight at room temperature. The TEA-HCl salt was removed by filtration of the
reaction mixture using a buchenel glass funnel (10 – 15µm pore size). The filtrate was
then reduced to 1/10th of its initial volume using a rotary vacuum evaporator (Buchi
Rotavapor®, Switzerland) and precipitated using 10X cold ethyl ether. The precipitate
was re-solubilized in 10X dry dichloromethane (150ml) and introduced into a 500ml
separating funnel. The product was washed twice with 15ml of 10% NaHCO3, followed
by 3 washes with 15 ml distilled water. At this point the pH of the product was neutral.
Residual water was removed by the addition of anhydrous sodium sulfate until the
physical state of sodium sulfate changed from clumps to a consistent powder. Once
again the dichloromethane was reduced to 1/10th of its initial volume by vacuum
evaporation and the product (PEG-bis-CP) was precipitated in 10X cold ether and washed
twice in 300ml of ether. PEG-bis-CP was then recovered, weighed, and stored in a
dessicator under a continuous vacuum. The structure of PEG-bis-CP and the degree of
substitution were determined from the 1H-NMR (Brucker 300 MHz, CDCl3) spectra as
previously described [246]. The reaction scheme for PEG-bis-CP is shown in figure 4.1.
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Figure 4.1 Chemical reaction scheme for PEG-bis-CP (intermediate product).
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4.2.2.2 Synthesis of PEG-bis-(2-acryloyloxy propanoate), (PEG-bis-AP)
10g of PEG-bis-CP (2.5mmol) was solubilized in a dry, three-neck-250ml flask
by the addition of 100ml anhydrous dimethylformamide in the presence of small amounts
of inhibitor 4-methoxyphenol. 1.18g of sodium acrylate (15mmol) was added to the
contents of the three neck flask under constant agitation in an inert atmosphere (argon
gas). The reaction was refluxed for 30 hours at 85ºC under inert conditions, followed by
cooling to room temperature and filtration of the reaction mixture through a buchenel
glass funnel (10 – 15µm pore size) in order to remove unreacted sodium acrylate. The
dimethylformamide was reduced to 1/10th of its initial volume by vacuum evaporation
and the remaining contents of the reaction were precipitated in 10X cold ether and
washed twice in 300ml ether. The product (PEG-bis-AP) was recovered, weighed and
stored under dark conditions in a vacuum dessicator. The structure of PEG-bis-AP and
the degree of acrylation were determined from the 1H-NMR (Brucker 300 MHz, CDCl3)
spectra as previously described [246]. The reaction scheme for PEG-bis-AP is shown in
figure 4.2.
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Figure 4.2 Chemical reaction scheme for PEG-bis-AP macromers.
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4.2.3 In vitro cell culture
NHDF were routinely cultured in 182 cm² T-flasks using DMEM F-12 50/50,1X
with L-glutamine and 15mM HEPES enriched with 10% v/v bovine growth serum and
50U/ml penicillin and 50µg/ml streptomycin. Culture medium was changed once every
two days and cells were passaged weekly. All experiments were performed with cells
from the 4th – 6th passages. For hydrogel encapsulation, monolayers of fibroblasts (ca.
95%

confluence)

were

trypsinized,

centrifuged,

resuspended,

counted

in

a

hemacytometer, and adjusted to a final concentration of 1.6 x 107cells/ml.

4.2.4 Hydrogel/Semi-IPN photopolymerization
PEG-bis-AP macromer solutions were prepared in 1X-PBS (0.1M, pH 7.4) and
sterile filtered. A 10% w/v stock solution of I-2959 was prepared in 70% ethanol. A
fibronectin-derived cell adhesion peptide, (GRGDS, Bachem, PA, USA) was conjugated
to acrylate-PEG-NHS (MW=3400, Nektar) as previously described [216]. GRGDSPEG-acrylate was prepared as a stock solution in 1X PBS (10 µmol/ml) and sterile
filtered. PEG-bis-AP hydrogels and semi-IPNs (final concentration 6% w/v) containing
varying types and concentrations of unmodified ECM molecules with 0.1% w/v I-2959
initiator were photopolymerized between glass microscope slides separated by a 1mm
Teflon spacer by exposure to low intensity UV illumination (365 nm, 10 mW/cm2, BlackRay B100-AP, Upland, CA) for 7½ minutes per side. For cell encapsulation studies,
acrylate-PEG-GRGDS and NHDF were included at final concentrations of 2.5µmol/ml
and 4 x 106cells/ml, respectively.
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4.2.5 Effect of various ECM molecules on fibroblast morphology in PEG-based
semi-IPNs
NHDF were encapsulated as described above in 6% w/v PEG-bis-AP based
hydrogels and semi-IPNs containing equal concentrations (0.12% w/v) of gelatin,
collagen, and HA (n = 4 samples/condition). Samples were cultured in 12 well plates for
7 days, and then stained with 1µM fluorescein diacetate (FDA, Molecular Probes,
Eugene, OR) and 2.5µM propidium iodide (PI, Molecular Probes), rinsed with PBS,
visualized by fluorescence microscopy (Zeiss Axiovert 200) and digitally imaged.

4.2.6 Effect of HA concentration on fibroblast morphology and proliferation in
PEG-based semi-IPNs
NHDF were encapsulated as described above in 6% w/v PEG-bis-AP based
hydrogels and semi-IPNs containing 0, 0.06%, 0.12%, and 0.18% w/v HA (n=9
samples/condition). Samples were cultured for 1 – 14 days.

4.2.6.1 Confocal analysis of morphology
After 14 days in culture, 3 samples from each group were fixed in 4%
paraformaldehyde (Sigma Chemical Co., St. Louis, MO, USA) in PBS, permeabilized
with 0.1% Triton X-100 (Sigma), and stained with Alexa 594-phalloidin (Molecular
Probes).

Samples were visualized and imaged using a Zeiss Confocal LSM510

microscope.
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4.2.6.2 Fibroblast proliferation
3 samples from each group were harvested at day 1 and day 14, rinsed twice with
sterile PBS, snap-frozen in an ethanol-dry ice bath, and stored at -80ºC.

DNA

solubilization and quantitation were based on modifications of previously described
methods [247]. Briefly, the samples were subjected to 3 freeze-thaw cycles in 1.4ml of
10mM EDTA, pH 12.3. Once the hydrogels were completely dissolved, the pH was
neutralized by the addition of 100µl 1M potassium phosphate (monobasic) solution. Total
DNA content was measured using the Picogreen DNA-binding dye (Molecular Probes)
and a fluorescence microplate reader (Tecan GENios, excitation: 485nm, emission:
535nm). DNA content was converted to cell number based on a DNA standard curve
prepared from serial dilutions of NHDF.

4.2.7 Volumetric swelling ratio
PEG-bis-AP hydrogels and semi-IPNs (6% w/v) containing varying amounts of
HA were photopolymerized as described above (n=4/group). Circular hydrogel samples
(1mm thick, 8mm diameter) were punched out using a hole punch and equilibrated in
distilled water for 24 hours to remove any unpolymerized macromer. Samples were
lyophilized and dry weights (Wd) were measured. The gels were immersed in distilled
water and allowed to swell for 24 hours in order to record the wet weights (Ws). The
volumetric swelling ratio and mesh were calculated as previously described [248, 249].
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4.2.8 Elastic Modulus
PEG-bis-AP hydrogels and semi-IPNs (6% w/v) containing varying amounts of
HA were photopolymerized and cut into dumbbell shaped samples (gauge length 30mm,
gauge width 5mm, and thickness 1mm). The samples (n=4/group) were subjected to 15%
strain at 5mm/min using an MTS Synergie 100 (MTS Systems Corporation) at room
temperature. Each sample was tested twice to prevent errors due to sample slippage.

4.2.9 Degradation studies
PEG-bis-AP hydrogels and semi-IPNs (6% w/v) containing varying amounts of
HA were photopolymerized, equilibrated with water, lyophilized, and weighed (Wd0) as
described above. Samples were incubated with 4ml of 1X-PBS containing 0.01% sodium
azide (Sigma) in scintillation vials under shaking at 37ºC. Buffer was changed once
every two days. At weekly intervals, samples (n=3/group/time point) were collected,
washed with distilled water three times, lyophilized, and weighed (Wdt). Percent mass
loss was calculated as ((Wd0 – Wdt)/Wd0) x 100.

4.2.10 Contribution of hyaluronidase activity to fibroblast spreading in PEG-bisAP/HA semi-IPNs
NHDF were encapsulated in 6% w/v PEG-bis-AP/0.12% w/v HA semi-IPNs as
described above and cultured in 12 well plates for 48 hours in the presence of the
hyaluronidase (HAse) inhibitors neomycin trisulfate hydrate (0.1mM, Sigma, 10mM
stock solution in PBS) and L-ascorbic acid 6-palmitate (0.1mM, Sigma, 10mM stock
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solution in 70% ethanol) [250, 251]. Controls consisted on semi-IPN samples cultured in
routine media without the addition of HAse inhibitors, as well as NHDF cultured on the
surface of 12 well plates with and without the presence of inhibitors. Cytotoxicity of the
inhibitors was assessed by FDA/PI staining of monolayer cultures.

Fibroblast

morphology and spreading within semi-IPNs was analyzed by confocal microscopy as
described above.

4.2.11 Reverse hyaluronan gel zymography
The effectiveness of the inhibitors was confirmed by reverse hyaluronan gel
zymography on two 10% polyacrylamide (Bio-Rad laboratories, Hercules, CA, USA)
gels each containing 3.4mg/ml HA. The procedure was adapted from two other
approaches previously described [252, 253]. Hydrogel samples were frozen and
homogenized in 200µl extraction buffer (20mM TRIS buffer pH 7.5, 0.5% (w/v) Triton
X-100, 1% sodium dodecyl sulfate (SDS, Fisher) containing 10µl/ml proteinase inhibitor
(Complete Proteinase Inhibitor, Roche, Germany) and kept on ice for 10 minutes. The
samples were centrifuged for 15 minutes at 15,000rpm and supernatants were collected.
The protein content of the gel extracts was determined by BCA assay (Pierce) and diluted
with extraction buffer to a final concentration of 40µg protein/60µl.

Pre-stained

molecular weight markers (10 – 250 kDa) and 60µl gel extract samples were mixed with
20µl Laemmli‟s sample buffer [254].

40µl aliquots were loaded on each gel and

electrophoresed under non-reducing conditions.

After electrophoresis, the gels were

washed in 2.5% w/v Triton X-100 for 30 minutes to remove SDS and then incubated in
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the substrate buffers. One gel was incubated in a pH 3.75 substrate buffer (50mM citric
acid, 50mM Na2HPO4, 0.15M NaCl, 0.02% w/v NaN3). The other gel was incubated in a
pH 7.6 substrate buffer (50mM TRIS, 5mM Cacl2, 200mM NaCl, 0.02% v/v Brij). The
gels were then stained with 0.5% Alcian blue (Anatech LTD, Battle Creek, MI, USA) in
20% methanol/10% acetic acid in distilled water, and then destained by rinsing with 20%
methanol/10% acetic acid in distilled water. Active HAse was visualized as clear/white
bands on the Alcian blue stained undigested HA background and imaged using an
imaging densitometer (BioRad, GS 700).

4.2.12 Statistical analysis
Quantitative data for volumetric swelling ratio and elastic modulus were
compared by ANOVA using Tukey‟s method for post-hoc comparisons. DNA content at
1 and 14 day time points were compared by two-tailed, unpaired t-tests. P values <0.05
were considered to be statistically significant.

4.3 Results
4.3.1 Synthesis of PEG-based macromers
4.3.1.1 Synthesis of PEG-bis-CP
PEG-bis-CP was synthesized by reaction of PEG and 2-chloropropionyl chloride
in the presence of TEA in dichloromethane and the structure was characterized by 1HNMR using CDCl3 as solvent(δ=3.4~3.90 (m, PEG backbone -CH2), δ=4.3 (t, 2H, PEG
terminal CH2), δ=4.45 (t, 1H, 2-CP -CH), δ=1.7 (d, 3H, 2-CP –CH3)). The degree of
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substitution of the 2-CP to the terminal alcohol groups of PEG was calculated as 97%
from the ratio of the integrals of the PEG back bone (δ=3.45~3.90) and the terminal PEG
methylene peaks (δ=4.3)

4.3.1.2 Synthesis of PEG-bis-AP
PEG-bis-AP was synthesized by reaction of PEG-bis-CP and sodium acrylate in
anhydrous DMF and the structure was characterized by of 1H-NMR using CDCl3 as
solvent (Figure 4.3, δ=3.45~3.90 (m, PEG backbone -CH2), δ=4.3 (t, 2H, PEG terminal
CH2), δ=4.45 (t, 1H, 2-CP -CH), δ=1.7 (d, 3H, 2-CP –CH3), δ=5.9 and 6.4 (d, 2H, acrylic
–CH2), δ=6.15 (q, 1H, acrylic -CH)). The degree of acrylation of the PEG-bis-AP was
calculated as 87% from the ratio of the integrals of the PEG back bone (δ=3.45~3.90) and
the acrylate peaks (δ=4.3).
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Figure 4.3 Structure and 1H-NMR spectrum of PEG-bis-AP macromer.

4.3.2 Fibroblast spreading and proliferation in PEG diacrylate-based semi-IPNs
NDHF were photopolymerized within PEG-bis-AP hydrogels and semi-IPNs
containing immobilized RGD cell adhesion peptides and enzymatically degradable ECM
components. Fibroblasts in hydrogel controls exhibited a rounded morphology at 7 days
(Figure 4.4A) and throughout extended periods in culture. Fibroblasts cultured in semiIPNs containing collagen (Figure 4.4B) and gelatin (4.4C) retained a rounded
morphology, similar to the hydrogel controls. Incorporation of HA resulted in fibroblast
spreading and the development of a polarized morphology with multiple thin processes
(Figure 4.4D).
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Based on this observation we performed a dose-response experiment to determine
the effect of varying HA content on fibroblast spreading. Confocal microscopy was
performed to ensure that fibroblast spreading was occurring within the three-dimensional
bulk of the materials as opposed to at the surface. Semi-IPNs containing 0.12% (Figure
4.5C) and 0.18% HA (Figure 4.5D) supported fibroblast spreading, while those
containing 0.06% HA (Figure 4.5B) were comparable to control hydrogels (Figure 4.5A).
Fibroblasts exhibited spread, polarized morphology throughout the threedimensional gel as shown in figure 4.6, which is a representative composite figure of
confocal image sections taken at 100 µm intervals from 0 to 500 µm and pseudo-colored
as a function of depth.
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Figure 4.4 Viability and morphology of fibroblasts encapsulated in 6% w/v PEG-bis–AP
hydrogels (A) and semi-IPNs containing 0.12 % w/v gelatin (B), collagen (C) and
hyaluronic acid (D) visualized by staining with fluorescein diacetate after 7 days in
culture. All scale bars are 200µm.
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Figure 4.5 Confocal analysis (200 µm depth) of fibroblast morphology and spreading
within 6 % w/v PEG-bis-AP hydrogels (A) and semi-IPNs containing 0.06% w/v (B)
0.12% w/v (C) and 0.18% w/v (D) hyaluronic acid after 14 days in culture. All scale bars
are 200µm.
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Figure 4.6 Representative pseudo-colored composite of confocal image sections of
fibroblasts at varying depths within 6% w/v w/v PEG-bis-AP based semi-IPN containing
0.12% w/v hyaluronic acid after 14 days in culture. Color scheme – red (0 µm), orange
(100 µm), yellow (200 µm), green (300 µm), pink (400 µm) and blue (500 µm). All
scale bars are 200µm.
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In order to determine whether the observed changes in fibroblast morphology
corresponded with changes in cellular bioactivity, fibroblast proliferation was determined
based on measurements of DNA content at 1 and 14 days. No significant difference was
observed in the number of encapsulated fibroblasts at the day 1 time point among the
varying gel formulations (Figure 4.7). After 14 days in culture, the number of fibroblasts
significantly decreased in PEG-bis-AP hydrogels and semi-IPNs containing 0.06% HA.
In contrast, a significant increase in cell number was observed for semi-IPNs containing
0.12% and 0.18% HA.
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Figure 4.7 Fibroblast proliferation within 6% w/v PEG-bis-AP hydrogels and semi-IPNs
containing varying amounts of HA.
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4.3.3 Physical properties of PEG-bis-AP hydrogels and semi-IPNs containing HA
The effect of HA incorporation on hydrogel physical/chemical properties was
assayed by measurements of swelling, tensile properties, and hydrolytic degradation.
Incorporation of HA (0.06%, 0.12%, and 0.18%) significantly increased the volumetric
swelling ratio of PEG-bis-AP/HA semi-IPNs relative to PEG-bis-AP hydrogels (Figure
4.8).
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Figure 4.8 - Volumetric swelling ratio and mesh size of 6% w/v PEG-bis-AP hydrogels
and semi-IPNs containing varying amounts of HA.

111

Similarly, PEG-bis-AP semi-IPNs containing 0.12% and 0.18% HA exhibited
significantly increased elastic modulus relative to hydrogel controls (Figure 4.9).
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Figure 4.9 - Elastic modulus of 6% w/v PEG bis-AP hydrogels and semi-IPNs containing
varying amounts of HA.

The hydrolytic degradation of PEG-bis-AP hydrogels and semi-IPNs containing
varying amounts of HA was characterized on the basis of mass loss. The addition of HA
did not significantly affect mass loss observed at varying time points during the study,
although semi-IPNs containing 0.12% and 0.18% HA were completely degraded at 32
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days versus 35 days for semi-IPNs containing 0.06% HA and control hydrogels (Figure
4.10).
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Figure 4.10 - Mass loss of 6 % w/v PEG-bis-AP hydrogels and semi-IPNs containing
varying amounts of HA.

4.3.4 Contribution of HAse activity to fibroblast spreading in PEG-AP/HA semiIPNs
In order to determine the contribution of HA enzymatic degradation to increased
fibroblast spreading within HA-containing semi-IPNs, fibroblasts were encapsulated in
PEG-bis-AP semi-IPNs containing 0.12% HA and cultured under routine conditions and
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in the presence of two HAse inhibitors, neomycin trisulfate and L-ascorbic acid-6palmitate. The presence of either inhibitor eliminated fibroblast spreading within HAcontaining semi-IPNs (Figure 4.11). The addition of comparable concentrations of each
inhibitor to cultures on fibroblasts in tissue culture wells did not alter cell viability,
spreading, or time to confluence relative to untreated controls (data not shown). Reverse
hyaluronan gel zymography confirmed substantial decreases in HAse activity of cell
lysates obtained from cells cultured in the presence of both inhibitors relative to untreated
controls (Figure 4.12).

Figure 4.11 - Confocal analysis of fibroblast morphology and spreading within (200 µm
depth) 6 % w/v PEG-bis-AP based semi-IPN with 0.12 % w/v hyaluronic acid after 48
hours culture in normal media (A) and media containing 0.1mM Neomycin sulfate (B)
and 0.1mM L-Ascorbic acid 6-palmitate (C).
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Figure 4.12 - Reverse HA gel zymography of extracts derived from fibroblasts
encapsulated within 6% w/v PEG-bis-AP based semi-IPN containing 0.12% hyaluronic
acid cultured with and without the presence of hyaluronidase inhibitors.

Lane 1-

molecular weight standard, lane 2-routine culture media, lane 3-extracts of fibroblasts
cultured in routine media, lane 4-extracts of fibroblasts cultured in media containing
0.1mM Neomycin sulfate, lane 5-extracts of fibroblasts cultured in media
containing.0.1mM L-Ascorbic acid 6-palmitate.

4.4 Discussion
Fibroblasts (~10µm diameter) encapsulated within hydrolytically degradable
PEG-bis-AP hydrogels with nanometer-scale mesh size maintained a rounded
morphology for up to 4 weeks of in vitro culture, consistent with results reported by
others [224]. Cell shape is strongly correlated with biochemical function. Specifically,
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rounded cell morphology is associated with limited proliferation and migration [255], key
cellular processes in the early stages of tissue formation. In an attempt to introduce cell
mediated degradability and enhance cell proliferation and migration, we have developed
semi-IPNs based on synthetic, hydrolytically degradable PEG-bis-AP macromers and
unmodified, enzymatically degradable ECM components such as collagen, gelatin, and
HA. All materials were selected based on their well characterized biocompatibility.
Hydrolytic degradation of ester bonds within the PEG network is expected to yield
polyacrylic acid, lactic acid, and PEG. The lactic acid will be metabolized by the body,
whereas the polyacrylic acid and the PEG will be eliminated by renal clearance [256].
Enzymatic degradation of collagen, gelatin, and HA produces simple amino acids and
sugars that can be recycled in cellular metabolic pathways.
Among the three ECM components tested, PEG-bis-AP semi-IPNs containing HA
supported extensive fibroblast spreading with the development of a multi-polar
morphology within 48 hours. PEG-bis-AP semi-IPNs containing HA also supported
significant increases in cell number, in contrast to control PEG-bis-AP hydrogels which
exhibited significant decreases in cell number. Although fibroblasts are not as sensitive
to apoptosis as epithelial or endothelial cells, these results may indicate that prolonged
restriction to a rounded morphology is detrimental to their survival. Collagen- and
gelatin-containing semi-IPNs did not support fibroblast spreading even at 2 and 4 week
time points (data not shown). Thus, incorporation of HA uniquely supported a transition
from a rounded to spread morphology and corresponding proliferative phenotype needed
in the early stages of regeneration of many tissues.
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Several previous studies have

examined the effects of addition of native ECM material to synthetic hydrogels.
Incorporation of collagen within a crosslinked network formed from acrylated Tetronic
copolymers improved cell adhesion and spreading on the surface of the gels [244].
However, encapsulated hepatocytes maintained a rounded morphology [243]. The
extensive remodeling observed in PEGylated fibrinogen networks [224] may result from
much higher concentrations of protein and its covalent incorporation into the network. In
the present studies, the concentration of ECM components in the semi-IPNs was kept low
in order to minimize effects on the physical properties of the networks.
Incorporation of HA may increase cellular activity through several potential
mechanisms affecting both the structure of the crosslinked network and cellular
biochemical processes. Since fibroblast dimensions are several orders of magnitude
greater than the typical mesh size of PEG diacrylate networks, the mesh size must
increase either locally or throughout the material to facilitate cell spreading. Hydrogel
porosity can be increased through the incorporation of leachable compounds, and it is
plausible that HA functions in this manner. Increased cell density was observed at the
sample edges after 2 weeks in culture (data not shown). This may result from localized
leaching near the sample edges or from incomplete polymerization due to oxygen
inhibition at the sample edges which were in contact with the ambient atmosphere.
However, confocal analysis confirmed that cell spreading occurred throughout the 1 mm
sample thickness. Since diffusional release of macromolecules from crosslinked hydrogel
networks is dependent on molecular weight and limited release of intermediate size
proteins such as IgG (150kDa) has been reported [257], it is unlikely that leaching of high
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molecular weight HA significantly contributed to the increased cell spreading observed
throughout the bulk of the semi-IPN materials.
Alternatively, HA could affect cellular activity by changing the network
physical/mechanical properties. Although significantly increased swelling was observed
in all HA-containing semi-IPNs, the corresponding change in mesh size is insufficient to
affect fibroblast spreading. Similarly, the increases observed in semi-IPN mechanical
properties were relatively small compared to order of magnitude changes previously
shown to affect cell spreading and proliferation [258, 259]. Incorporation of HA also did
not significantly affect hydrolytic degradation rate at early time points. Another potential
mechanism is localized increases in mesh size resulting from HA degradation. HA can
be degraded by both enzymatic and non enzymatic mechanisms [260]. Many studies
have reported free radical-mediated depolymerization of HA [261, 262], which could also
occur as a result of the free radical crosslinking method used in these studies. Enzymatic
degradation of HA is mediated by the family of HAse enzymes. Although the precise
mechanisms of HA degradation are still under investigation, the current model is based
on extracellular binding of HA by membrane-bound hyal-2, which cleaves high
molecular weight HA into approximately 20kDa fragments [263, 264].

Following

internalization by CD44 or receptor for HA mediated motility (RHAMM), HA is further
degraded into small oligosaccharides by hyal-1 and -2 in the lysosomal compartment at
acidic pH (3.7 – 4.0) [265]. The contribution of enzymatic HA degradation was
investigated by culturing fibroblasts in HA-containing semi-IPNs in the presence of two
HAse inhibitors, neomycin trisulfate hydrate (0.1mM) [251] and L-ascorbic acid 6-
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palmitate (0.1mM) [250].

Substantial reductions in HAse activity at approximately

50kDa were detected by reverse HA gel zymography developed at lysosomal pH as
previously described [266]. The absence of HAse activity at pH 7.6 is consistent with the
reported optimal activity of hyal-1 and -2 at lysosomal pH, however, hyal-2 activity at
physiological pH has been reported using highly sensitive fluorescent substrates [267].
HAse inhibition was accompanied by the complete elimination of fibroblast spreading,
demonstrating that enzymatic degradation of HA is a necessary mechanism of fibroblast
spreading in HA-containing semi-IPNs.
Exposure to high molecular weight HA and its degradation products may also
have multiple effects on cellular biochemical activity that vary as a function of HA
molecular weight, concentration and cell phenotype [268]. HA binding through the cell
surface receptors CD44, RHAMM, and ICAM-1 plays a vital role in the regulation of
morphogenesis, wound healing, metastasis, and inflammation [265, 269, 270]. However,
PEG/HA semi-IPNs without RGD peptides did not support fibroblast spreading (data not
shown), indicating that HA binding contributes little to cell spreading and additional,
exogenous adhesive ligands are required. An HA-rich pericellular sheath is vital for
vascular smooth muscle cell proliferation and migration [271]. At high concentrations,
high molecular weight HA has been shown to inhibit cell proliferation [268], while low
concentrations of oligomeric HA stimulate proliferation [260]. HA also has been shown
to stimulate the migration of epithelial cells and cardiac fibroblasts [272, 273], while
inhibiting endothelial migration [274]. Based on these studies, high molecular weight
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and degraded HA may also affect fibroblast proliferation and spreading, however, these
effects are secondary to the facilitation of enzymatic degradation.

4.5 Conclusion
In conclusion, these studies demonstrate that incorporation of HA to form semiIPNs with synthetic, hydrolytically degradable PEG diacrylate macromers improves
fibroblast spreading and proliferation, and that cell-mediated, enzymatic HA degradation
is the critical underlying mechanism. Addition of low levels of HA achieves substantial
changes in cellular activity, while causing only relatively small changes in the network
physical properties. This approach to accelerating the early stages of cellular remodeling
may be useful for a variety of hydrogel-based tissue engineering approaches for vocal
fold, vascular, and soft tissue applications. In addition, the angiogenic activity of low
molecular weight HA degradation products released from the gels may also enhance their
in vivo efficacy relative to conventional hydrogels [275].
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CHAPTER 5
MECHANO-MIMETIC HYDROGELS FOR VOCAL FOLD LAMINA PROPRIA
REGENERATION

5.1 Introduction
Voice is produced through the conversion of aerodynamic energy from exhalation
to acoustic energy for sound production by the vibrating vocal folds and the upper
respiratory tract. Voice is a primary “tool of trade” for teachers and sales personnel who
comprise 4.2 and 13% of the US workforce [16]. Dysphonia (voice and speech
impairment) characterized by increased effort to sustain phonation, decreased vocal
quality, and total voice loss affects approximately 23% of the voice-dependent US
workforce [14]; and may jeopardize job security, employment opportunities, and social
interaction [225, 226].
The quality of voice depends on the biomechanical properties of the vocal fold
tissue which derive from its ECM organization and composition [6]. The human vocal
folds are multi-layered tissues comprised of a matrix rich lamina propria anchored to the
vocalis muscle, and covered by a squamous epithelium. The fibroblast is the primary
ECM producing cell type in the vocal fold tissue and is responsible for maintaining tissue
homeostasis and regulating injury response [2]. The squamous epithelium and the
superficial lamina propria together form the vocal mucosa which is abundant in
hyaluronic acid, and proteoglycans like fibromodulin, decorin and versican which
regulate the water content of the tissue and impart viscous shear properties to it [3, 4].
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The vocal mucosa vibrates at frequencies between 100 – 1000Hz, and amplitudes of
~1mm [5]. In terms of mechanical properties the human vocal mucosa is characterized as
a viscoelastic solid [276].

The intermediate and deep layers of the lamina propria

together form the vocal ligament. The vocal ligament ECM is comprised mainly of
elastin fibers which impart flexibility to the tissue, and collagen fibers which impart
resistance to tensile stresses [6, 7]. The human vocal ligament shows non-linear stressstrain properties, characterized by 20 – 40kPa elastic modulus in the low strain linear
region (0 – 15% strain), and values increasing to 600kPa in the high strain region (40%
strain) [63]. It has been previously reported that the human vocal ligament can withstand
a maximum of 60% strain [63, 277]. However, the human vocal ligament operates at low
strain levels (0 – 15%) during normal phonation [8].
Vocal fold damage can be brought about by a multitude of factors like chronic
misuse of voice, surgical intubation, and surgical treatment of infectious laryngeal
diseases, laryngeal cancer, and benign pathologies like vocal folds polyps, nodules and
edema [13, 14]. Traumatic or surgical injury of the lamina propria elicits a wound
healing response that is characterized by the replacement of native parenchymal matrix
with fibrous scar tissue. This change in the ECM composition leads to alterations in the
tissue biomechanics which subsequently leads to dysphonia.
Voice therapy combined with the administration of steroids is the first line of
therapy when presented with vocal fold defects and scars [13, 278]. However, voice
therapy is ineffective when presented with scars in combination with pathologies like
vocal polyps, nodules and edema despite rigorous adherence to the prescribed habits [19].
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Synthetic, non degradable materials like pHEMA hydrogels [23], Teflon [20-22], ePTFE
[24, 25], calcium hydroxyapatite [26], dacron [27], polydimethylsiloxane [28, 31] have
been injected into the vocalis muscle in an attempt to overcome scarring-induced glottic
incompetence through vocal fold medialization. However, physiological limitations such
as migration from the site of implantation, foreign body granuloma formation, and
fibrous encapsulation posed by these materials, and the theoretical advantages of natural,
degradable biomaterials injected into the lamina propria have led to the use of materials
like collagen, fat, fascia and HA for vocal fold augmentation purposes. In human
subjects, though evaluations after six months of collagen injections indicated
improvements in vibrational amplitude of the mucosal wave and amelioration of glottic
incompetence, no perceptual improvement (acoustic analyses) was recorded [32].
Autologous fat [33, 35, 36] and fascia [37] injections yielded positive results short term
but reports of these studies are inconsistent in terms of evaluations of glottic closure,
amplitude of the mucosal wave and the effect on the stiffness of scar tissue. Injectable
crosslinked HA gels (Hylan B gels) have been shown to improve mucosal wave
amplitudes and glottic closure for approximately 12 months [38-40]. Material resorption
and need for re-injection were the disadvantages associated with the use of natural
materials like collagen, fat, fascia, and HA [41]. Current regeneration strategies have
investigated the use of crosslinked composites of polyethylene glycol diacrylate
(PEGDA)/derivatized HA [42, 43], composite collagen hydrogels [44], and HA-based
microgels [279] as scaffolds for cell transplantation and matrix formation, as well as the
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administration of hepatocyte growth factor (HGF) [46-48] and basic fibroblast growth
factor (bFGF) [49] to reduce scarring during natural healing.
Previous studies by Titze et al. [11] highlighted the importance of the vibratory
epigenetic stimulus in the vocal fold tissue. In vitro bioreactor experiments demonstrated
that fibroblasts cultured in 3D, macroporous, elastomeric scaffolds under vibratory
conditions exhibited significant differences in ECM-related gene expression relative to
static controls, including increases in HA synthase 2 and proteoglycan genes consistent
with the biochemical composition of the human vocal mucosa. Our overall hypothesis is
that rapid restoration of the vibratory microenvironment will minimize scarring and
facilitate tissue-specific matrix production, ultimately leading to restoration of normal
phonation. Towards this end, the objective of this study was to create hydrogel
formulations matching the viscous and elastic mechanical properties of the vocal mucosa
and vocal ligament, respectively.

These hydrogels will serve as:- (1) a model for

studying the effects of ECM and biomechanics on fibroblast biology (2) potential
injectable scaffolds for lamina propria regeneration.

5.2 Materials & Methods
5.2.1 Materials
Polyethylene glycol (PEG, MW=3934) was purchased from Fluka (Seelze,
Germany) and 2-chloropropionyl chloride, 4-chlorobutyryl chloride, triethylamine,
dichloromethane (HPLC grade), anhydrous sodium sulfate, and sodium acrylate were
obtained from Aldrich (St. Louis, MO, USA). Dimethyl formamide (extra dry) and ethyl
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ether were purchased from Acros (Morris Plains, NJ) and Fisher Chemical (Fair Lawn,
NJ), respectively. 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I2959) was obtained from Ciba Specialty Chemicals (Basel, Switzerland). A 10% (w/v)
stock solution of I-2959 was prepared in 70% ethanol. Adult normal human dermal
fibroblasts (NHDF, CC-2511) obtained from a 39 year old Black woman were purchased
from Biowhitaker (Rockland, ME, USA). DMEM F-12 50/50,1X with L-glutamine,
15mM HEPES/trypsin EDTA (0.05% trypsin/0.53mM EDTA in HBSS), and
penicillin/streptomycin were obtained from Mediatech (Herdon, VA, USA). Bovine
growth serum was purchased from Hyclone (Logan, UT, USA). Hyaluronic acid (HA,
MW=1.4 x 106) was purchased from Genzyme (Cambridge, MA, USA).

5.2.2 Synthesis of PEG-bis-(2-acryloyloxy propanoate) (PEG-bis-AP) and PEG-bis(2-acryloyloxy butyrate) (PEG-bis-AB) macromers
PEG-diacrylate macromers (PEG-bis-AP, Fiure 5.1A and PEG-bis-AB, Figure
5.1B) containing ester bonds with varying susceptibility to hydrolytic degradation were
synthesized by a two-step reaction as previously described [245]. In the first step, an
intermediate product was synthesized by activating the PEG hydroxyl groups with difunctional chemical intermediaries (2-chloropropionyl chloride or 4-chlorobutyryl
chloride) to form ester linkages with variable alkyl spacers. PEG-bis-AB, and PEG-bisAP were synthesized by adding terminal acrylate groups to the intermediate products by
nucleophilic substitution between the terminal alkyl chloride groups and sodium acrylate.
Final acrylation efficiencies of ~87 and ~94% for PEG-bis-AP and PEG-bis-AB,
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respectively, were calculated from 1H-NMR (Bruker 300 MHz, CDCl3) spectra based on
the ratio of peak integrals derived from acrylate and PEG backbone protons.

Figure 5.1 Chemical structures of PEG-bis-AP (A) and PEG-bis-AB (B)

5.2.3 Synthesis of methacrylated HA (GMHA)
GMHA (Figure 5.2) was synthesized by reacting sodium hyaluronate solubilized
in double distilled water with a 20-fold molar excess of glycidyl methacrylate in the
presence of triethylamine and tetrabutylammonium bromide as previously described
[280]. The GMHA was precipitated in acetone, and dialyzed against double distilled
water for 48 hrs. An ~7% degree of methacrylation was calculated from the 1H-NMR
(D2O) spectra (Figure 5.3) based on the ratio of peak integrals derived from the
methacrylate and HA carbohydrate protons, as previously described [281].
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Figure 5.2 Chemical reaction scheme for GMHA macromers
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Figure 5.3 Structure and 1H-NMR spectra of GMHA macromer

5.2.4 Cell culture
NHDF were routinely cultured in 182 cm² T-flasks using DMEM F-12 50/50,1X
with L-glutamine and 15mM HEPES enriched with 10% v/v bovine growth serum and
50U/ml penicillin and 50µg/ml streptomycin. Culture medium was changed once every
two days and cells were passaged weekly. All experiments were performed with cells
from the 4th – 6th passages. For hydrogel encapsulation, monolayers of fibroblasts (ca.
95%

confluence)

were

trypsinized,

centrifuged,

resuspended,

counted

hemacytometer, and adjusted to a final concentration of 1.6 x 107cells/ml.
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5.2.5 Hydrogel/Semi-IPN photopolymerization
Varying concentrations of PEG-bis-AP, PEG-bis-AB, PEG-bis-AB/AP (50:50
blend), and GMHA macromer solutions were prepared in 1X-PBS (0.1M, pH 7.4) and
sterile filtered. During PEG-based semi-IPN synthesis, 0.12%w/v native unmodified HA
was added to the PEG-bis-AP/AB macromer solution as explained previously [282]. A
fibronectin-derived cell adhesion peptide, (GRGDS, Bachem, PA, USA) was conjugated
to acrylate-PEG-NHS (MW=3400, Nektar) as previously described [216]. GRGDSPEG-acrylate was prepared as a stock solution in 1X PBS (10µmol/ml) and sterile
filtered. The macromer solutions with 0.1% w/v I-2959 initiator were photopolymerized
between glass microscope slides separated by a 1 mm Teflon spacer by exposure to low
intensity UV illumination (365nm, 10mW/cm2, Black-Ray B100-AP, Upland, CA) for
7½ minutes (PEGDA hydrogels) and 6½ minutes (GMHA hydrogels) per side . For cell
encapsulation studies, acrylate-PEG-GRGDS and NHDF were included at final
concentrations of 2.5µmol/ml and 4 x 106cells/ml, respectively.

5.2.6 Mechanical characterization of photocrosslinked hydrogels
5.2.6.1 Elastic Modulus
Mechanical characterization of the PEG-based hydrogels was performed using
hydrogels synthesized from the PEG-bis-AB macromer. PEG-bis-AB hydrogels (6, 8,
and 10% w/v) were photopolymerized and cut into dumbbell shaped samples (gauge
length 30mm, gauge width 5mm, and thickness 1mm). The samples were equilibrated in
1X-PBS overnight before testing. The samples (n = 4/group) were subjected to uniaxial
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tensile testing using two different strain rates : (a) single cycle, 15% strain at 5mm/min
and (b) multiple cycle (20 cycles), 15% strain at 1Hz using a 10N load cell in the MTS
Synergie 100 (MTS Systems Corporation) at room temperature. Also, the 6% w/v PEGbis-AB hydrogels were tested to failure at the 5mm/min strain rate. The sample ends
were covered with small pieces of KimWipe to improve clamping stability, and each
sample was tested twice to prevent errors due to sample slippage. Stress-strain curves
were plotted, and elastic modulus was calculated as the slope of the of the curve stressstrain curve (0 – 15% strain).

The PEG-bis-AB hydrogels were tested at room

temperature since testing at 37°C would require the samples to be immersed in a buffer
solution maintained at 37°C.

In our experimental setup, during tensile testing the

hydrogel samples were held in position using a Kim Wipe at both clamp ends to facilitate
effective gripping (prevent slippage). Immersion of the test samples in any kind of liquid
medium will result in significant inability to clamp the sample in place during the test.
Hence the tensile tests were carried out at room temperature and not at 37°C. We believe
that ~10°C increase in testing temperature will not have a significant effect on the elastic
modulus of the material.

5.2.6.2 Dynamic viscosity & Elastic shear modulus
GMHA hydrogel samples were exposed to small amplitude oscillations over
frequency sweeps from 0.01 to 15 Hz in conditions similar to those used to investigate
the rheological properties of the human vocal mucosa [12]. Rheological characteristics as
a function of polymer concentration (0.5, 1, 1.5, 2, 2.5 & 3% w/v) were investigated in a
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stress controlled “ARES” Rheometer using parallel plate geometry.

The hydrogel

samples were placed in the gap (0.8mm) between the stationary upper plate and the
rotating lower plate (diameter = 8mm), and the temperature was maintained at 37 ± 0.1ºC
by a „Peltier‟ water cooling system. In order to determine the region of linearity, strain
sweep tests were performed at fixed oscillation frequency (1Hz). Rheological tests were
performed in the linear strain region (strain amplitude – 0.01rad), over a frequency range
of 0.01 – 15Hz, covering 25 frequencies over 3 decades. The dynamic viscosities of the
varying % w/v GMHA hydrogels were calculated by dividing the observed values of the
loss moduli by the corresponding angular frequencies tested. The elastic shear moduli of
the varying % w/v GMHA hydrogels were also recorded and plotted at all frequencies
tested.

5.2.7 Degradation studies
PEG-bis-AP, PEG-bis-AB/AP50:50, and PEG-bis-AB hydrogels (6% w/v) were
photopolymerized, equilibrated with water for 24 hours to remove any unpolymerized
macromer, lyophilized, and weighed (Wd0). Samples were incubated with 4ml of 1XPBS containing 0.01% sodium azide (Sigma) in scintillation vials under shaking at 37ºC.
Buffer was changed once every two days. At weekly intervals, samples (n = 3/group/time
point) were collected, washed with distilled water three times, lyophilized, and weighed
(Wdt). Percent mass loss was calculated as ((Wd0 – Wdt)/Wd0) x 100. Mass loss
(degradation) studies were not separately conducted for the GMHA hydrogels since the
rate of degradation of these hydrogels depends on the amount of HAse produced by the
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encapsulated cells. Also, the degradation of GMHA hydrogels in the presence of HAse
has been previously reported by Leach et al [280].

5.2.8 Encapsulated fibroblast viability, morphology, and proliferation
NHDF were encapsulated in 6% w/v PEG-bis-AB/AP50:50 semi-IPNs containing
0.12% w/v HA [282] and 2% w/v GMHA hydrogels (n = 3 samples/experimental group).
Samples were cultured in 12 well plates for 1-28 days.

5.2.8.1 Viability assessment
After 7 days in culture, hydrogel samples were stained with 1µM fluorescein
diacetate (FDA, Molecular Probes, Eugene, OR) and 2.5µM propidium iodide (PI,
Molecular Probes), rinsed with PBS, visualized and imaged by fluorescence microscopy
(Zeiss Axiovert 200).

5.2.8.2 Confocal analysis of morphology
After 14 days in culture, samples from each group were fixed in 4%
paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, and stained with
Alexa 594-phalloidin (Molecular Probes). Samples were visualized and imaged using a
Zeiss Confocal LSM510 microscope.
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5.2.8.3 Fibroblast proliferation
Hydrogel/Semi-IPN samples from each group were collected at days 1, 7, 14 and
28, rinsed twice with sterile PBS, snap-frozen in an ethanol-dry ice bath, and stored at 80ºC. DNA solubilization and quantitation were based on modifications of previously
described methods [247]. Briefly, the samples were subjected to 3 freeze-thaw cycles in
1.4ml of 10mM EDTA, pH 12.3. Once the hydrogels were completely dissolved, the pH
was neutralized by the addition of 100µl 1M potassium phosphate (monobasic) solution.
Total DNA content was measured using the Picogreen DNA-binding dye (Molecular
Probes) and a fluorescence microplate reader (Tecan GENios, excitation: 485nm,
emission: 535nm). DNA content was converted to cell number based on a DNA standard
curve prepared from serial dilutions of NHDF.

5.2.9 Encapsulated fibroblast ECM production
5.2.9.1 Sample preparation
NHDF were encapsulated in 6% w/v PEG-bis-AB/AP50:50 based semi-IPNs
containing 0.12% w/v HA and 2% w/v GMHA hydrogels (n=6 samples/hydrogel type).
Samples were cultured for 14 and 28 days (n=3 per time point), rinsed with sterile PBS,
and fixed in 4% w/v paraformaldehyde. The fixed hydrogel samples were infiltrated,
embedded and sectioned partly as explained elsewhere [283]. Briefly, the hydrogel
samples were cryoprotected by rinsing with 5% sucrose in PBS for an hour followed by
infiltration with increasing concentrations of sucrose in PBS (mixing 5% and 20%
sucrose in PBS in the ratios 2:1, 1:1 and 1:2) for 3 hrs each. The cryoprotected samples
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were then infiltrated with an ascending series of mixtures of sucrose in PBS and OCT
(2:1, 1:1 and 1:2 ratios) for 6 hrs each at room temperature under constant vacuum. This
step was followed by embedding in the OCT mold using 100% OCT solution. 8µm thick
cryosections were cut and transferred to microscope slides for immunohistochemistry and
toluidine blue O staining.

5.2.9.2 Immunohistochemistry
The cryosections were fixed in chilled acetone, incubated for an hour at room
temperature with rabbit, α-human collagen type 1 IgG primary antibody (Chemicon,
dilution 1:400), rinsed, and incubated 1 hour with secondary antibody (goat, anti-rabbit
IgG, Alexa Fluor 488, dilution 1:220). Samples were coverslipped using Vectashield
(Vector laboratories, Burlingame, CA) mounting medium containing DAPI for
counterstaining cell nuclei.

5.2.9.3 Toluidine Blue O staining
Sulfated GAGs (s-GAGs) were stained by incubating the cryosections in an
aqueous Toluidine Blue O solution (0.0714% toluidine blue O, 0.0714% pyronin Y, and
0.143% borax) for 6 minutes as previously described [44].
The slides were digitally imaged and analyzed using a Zeiss Axiovert 200
microscope.
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5.2.10 Statistical analysis
All comparisons were made between binary data sets using two-tailed, unpaired t-tests
and “p” values less than 0.05 were considered statistically significant.

5.3 Results
5.3.1 Mechanical Characterization of photocrosslinked hydrogels
Hydrogels/Semi-IPNs described here were aimed at restoring mechanical integrity
and function for the vocal fold lamina propria.

Due to the distinct biomechanical

properties of the vocal mucosa and the vocal ligament, a two component system
comprised of methacrylated HA (viscous, vocal mucosa) and PEG-diacrylate (elastic,
vocal ligament) was developed. Variation of polymer concentration was investigated to
identify formulations approximating the native tissue biomechanics.

5.3.1.1 Tensile testing
Uniaxial tensile tests showed that PEG-bis-AB hydrogel elastic modulus
significantly increased with increasing macromer concentration (Figure 5.4). PEG-bisAB hydrogels prepared at 6% w/v concentration were found to exhibit elastic modulus
approximating the mean value (33.1 ± 10.4kPa ) reported for native human vocal
ligaments at low strains (0 – 15%) [63].
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Figure 5.4 Elastic modulus of the human vocal ligament [63] and varying concentrations
of the PEG bis-AB hydrogels. * indicates statistically significant differences relative to
the human vocal ligament.

Figure 5.5 shows the typical stress–strain hysteresis cycles for tensile loading –
unloading deformation of 6% w/v PEG-bis-AB hydrogels, tested to 15% strain at 1Hz.
The linear stress-strain curve of the PEG-based hydrogels is consistent with previously
reported stress-strain curves at low strain levels (0 – 15%) of the vocal fold ligament
specimens tested [63, 103, 277, 284] and other biological soft tissues [285]. At higher
strain levels the human vocal ligament indicated a non linear stress-strain response [63,
103, 277, 284]. Preconditioning is observed for excised biological tissues, with the
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stress-strain hysteresis cycles shifting downward from the 1st cycle and stabilizing at the
15th – 20th cycle due to stress relaxation [63, 277] and re-alignment of elastic and collagen
fibers following excision. However, preconditioning is not pronounced in the PEG-based
synthetic hydrogels tested since stabilization of the loading-unloading curves occurs
between the 1st and the 2nd cycles. The sharp reduction in stress levels at peak strain
(15% strain) during the unloading curve of 1st cycle may be attributed to severing of
weak crosslinks within the hydrogel mesh after which the material stabilized and
exhibited repeatable loading-unloading curves between the 2nd and the 20th cycles.
Linear curves with hysteresis, due to viscous energy loss were observed for all the
samples tested. Similar viscoelastic behavior was observed for all the 6% w/v PEG-bisAB hydrogels tested.
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Figure 5.5 Typical loading – unloading cycles of the 6% w/v PEG-bis-AB hydrogels
under tensile strain (strain rate = 1 Hz). The phenomenon of hysteresis is demonstrated,
for the 2nd cycle and the 20th cycle tested.

The 6% w/v PEG-bis-AB hydrogels tested at 5 mm/min exhibited linear stressstrain characteristics until failure (46 ± 2% strain) as shown in figure 5.6.
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Figure 5.6 Typical stress-strain curve for 6% w/v PEG-bis-AB hydrogels strained until
failure.

5.3.1.2 Rheological testing
Dynamic viscosities calculated over the range of the tested frequency sweep (0.01
– 15Hz) indicated that the 0.5 – 3% w/v concentrations of GMHA hydrogels
demonstrated a shear thinning response similar to many soft tissues (Figure 5.7). Our
results indicated that as the macromer concentration increased the magnitude of dynamic
viscosity increased over the entire frequency range tested. GMHA gels prepared at
concentrations ranging from 1.5 – 2.5 % w/v exhibited dynamic viscosities consistent
with the range of properties reported for native human vocal mucosa.
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Figure 5.7 Dynamic viscosities of varying concentrations of GMHA hydrogels.

However, the 1.5 – 2.5% w/v GMHA hydrogels exhibited elastic shear modulus
higher than that reported for the native human vocal mucosa (Figure 5.8).
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Figure 5.8 Elastic shear moduli of varying concentrations of GMHA hydrogels.

The dynamic viscosity of native HA, GMHA macromer, and crosslinked GMHA
hydrogels was also tested at fixed 2% concentration. Uncrosslinked GMHA macromers
exhibited an approximately order of magnitude decrease in dynamic viscosity relative to
the native HA, while crosslinking substantially increased dynamic viscosity relative to
both native HA and uncrosslinked GMHA (Figure 5.9).
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Figure 5.9 Dynamic viscosities of 2% w/v unmodified HA solution, GMHA solution and
GMHA hydrogels.

5.3.2 Degradation studies
While the GMHA hydrogels are susceptible to enzymatic degradation, the PEGdiacrylate macromers were synthesized to contain ester bonds with varying susceptibility
to hydrolytic degradation. The mass loss of three different photocrosslinked hydrogel
formulations (PEG-bis-AP, PEG-bis-AB/AP50:50, and PEG-bis-AB) at 6% w/v
concentration was examined on a weekly basis. The 6% w/v PEG-bis-AP, PEG-bisAB/AP50:50, and PEG-bis-AB hydrogels degraded completely within 7, 11, and 18 weeks
respectively (Figure 5.10).
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Figure 5.10 Mass loss of 6 % w/v PEG-bis-AP, PEG-bis-AP/AB50:50 blend and PEG-bisAB hydrogels.

5.3.3 Fibroblast viability and proliferation in PEG-bis-AB/AP50:50 based semi-IPNs
and GMHA hydrogels
NDHF were encapsulated within 2% w/v GMHA hydrogels, and 6% w/v PEGbis-AB/AP50:50 blend semi-IPNs (containing 0.12% w/v HA) containing immobilized
RGD cell adhesion peptides by photopolymerization. Fibroblasts encapsulated in the 6%
w/v PEG-bis-AB/AP50:50 semi-IPNs exhibited spreading and the development of
polarized morphology with multiple thin processes as shown in figure 5.11A. Fibroblasts
encapsulated within the 2% w/v GMHA hydrogels exhibited spreading and a stellate
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morphology as shown in figure 5.11B. High levels of viability were observed in all
samples. Confocal microscopy was performed to ensure that fibroblast spreading was
occurring within the three-dimensional bulk of the materials as opposed to at the surface.
Fibroblasts exhibited a spread, polarized morphology throughout the volume of the PEGbis-AP/AB50:50 blend semi-IPNs indicated by figure 5.11C which is a representative
confocal image section taken at 200 µm within the semi-IPN. Cell spreading and cellcell aggregation was detected throughout the bulk of the GMHA hydrogel as shown in
figure 5.11D.
In order to determine whether the observed changes in fibroblast morphology
corresponded with changes in cellular bioactivity, fibroblast proliferation was determined
based on measurements of DNA content at 1, 7, 14, and 28 days.

No significant

difference was observed in the number of encapsulated fibroblasts at the day 1 time point
among the PEG-bis-AB/AP50:50 semi-IPNs (0.12% w/v HA) and GMHA hydrogels as
shown in figure 5.12. After 7, 14, and 28 days in culture, a significantly increased
number of fibroblasts was observed in both PEG-based and GMHA gels relative to day 1.
However, both the hydrogel types exhibited a significant decrease in cell number at day
28 relative to day 14.
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Figure 5.11 Viability and morphology of fibroblasts encapsulated in 6% w/v PEG-bis–
AB/AP 50:50 blend semi-IPNs containing 0.12 % w/v HA (A) and 2% w/v GMHA
hydrogels (B) visualized by staining with fluorescein diacetate/propidium iodide after 7
days in culture.

Confocal analysis (200µm depth) of fibroblast morphology and

spreading within 6 % w/v PEG-bis-AB/AP 50:50 blend semi-IPNs containing 0.12% w/v
HA (C) and 2% w/v GMHA hydrogels after 14 days in culture (D). All scale bars
represent 200µm.
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Figure 5.12 Fibroblast proliferation within 6% w/v PEG-bis-AB/AP 50:50 blend semiIPNs containing 0.12% w/v HA (A) and 2% w/v GMHA hydrogels (B). * indicates
statistically significant differences relative to the corresponding cell number at day1. #
indicates statistically significant differences in cell numbers between days 14 and 28.

5.3.4 ECM synthesis
Encapsulated fibroblast synthesis of collagen (Figure 5.13) and s-GAGs (Figure
5.14) in PEG-based semi-IPNs (A,B) and GMHA hydrogels (C,D) was histologically
examined at 14 (A,C) and 28 days (B,D) in culture. The ECM deposition in the PEG
based semi-IPNs and the GMHA hydrogels was observed to be pericellular in nature.
However, there was a noticeable difference in the spatial organization of both

146

Figure 5.13 Immunohistochemical staining of collagen (green) and cellular nuclei (blue)
in 6% w/v PEG-bis-AB/AP 50:50 blend semi-IPNs (A,B) and 2% w/v GMHA hydrogels
(C,D) after 14 (A,C) and 28 (B,D) days in culture. All scale bars represent 100µm.

collagen and s-GAG deposition by the encapsulated fibroblasts with respect to the
different materials. In the PEG based semi-IPNs, the newly synthesized matrix was
relatively homogeneously dispersed, whereas in the GMHA hydrogel matrix its spatial
distribution was highly variable with regions of low and high density. The fibroblasts
encapsulated in the GMHA hydrogels exhibited increasing aggregation at later time
points (day 28). As a result the matrix produced by these cells appears to be concentrated
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at various locations in the hydrogel bulk associated with dense clusters of aggregated
cells as shown by the nuclear counterstaining in Figure 5.13D.

Figure 5.14 Histological staining of s-GAGs (dark purple) in 6% w/v PEG-bis-AB/AP
50:50 blend semi-IPNs (A,B) and 2% w/v GMHA hydrogels (C,D) after 14 (A,C) and 28
(B,D) days in culture. All scale bars represent 100µm.

5.4 Discussion
Vocal fold injury initiates a wound healing response resulting in alterations in
ECM composition and tissue biomechanics.
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The functional outcome of vocal fold

scarring is dysphonia due to increased phonation threshold pressure (subglottic pressure
required to initiate vibration) and reductions in vibrational amplitude of the mucosal
wave. Clinical signs include decreased voice intensity, vocal fatigue, breathlessness, and
increased phonatory effort [18]. Treatment of the scarred vocal folds is one of the most
challenging voice problems faced by otolaryngologists today [18] since none of the
current injectables and surgical techniques directly address restoration of the complex
ECM composition and biomechanical properties.
At birth, the human vocal fold is a homogeneous structure lacking the complex
layered organization and variable ECM composition observed in the adult [286, 287].
Recent analyses of pediatric human vocal folds from subjects ranging from near birth to
adolescence indicate that the vocal folds undergo extensive postnatal development and
maturation into the early teens [58, 82]. Consistent with the recognized contributions of
externally applied mechanical forces in the development and homeostatic maintenance of
many soft connective tissues, these results suggest that the complex mechanical forces
imposed during voice development may be an important epigenetic mechanism
regulating tissue ECM composition and biomechanics. As a basis for restoring structural
integrity and phonation-associated mechanical stimulation to the injured vocal folds, we
investigated the formulation of mechano-mimetic hydrogels approximating the
mechanical properties of the two major vocal fold components, the vocal mucosa
(viscous – GMHA) and the vocal ligament (elastic – PEG-diacrylate). These materials
were evaluated by rheological and tensile testing methods applied to characterization of
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the native tissue layers [63, 288], and tested for their ability to support encapsulated cell
viability, proliferation, and ECM synthesis.
Due to favorable properties such as non toxicity, non immunogenicity,
biocompatibility, and elastic mechanical properties following covalent crosslinking, PEG
was chosen to restore/regenerate the elastic properties of the vocal ligament.
Photopolymerized PEG-based hydrogels have also been shown to exhibit strong
adherence to tissue surfaces through mechanical interdigitation and hydrogen bonding
[216, 289]. Literature review suggests that the greatest stress applied to the vocal fold
tissues is the longitudinal tensile stress in the vocal ligament. The mean elastic modulus
of the human vocal ligament reported for the low-strain regions of the biphasic stressstrain curve was 33.1 ± 10.4kPa [63]. The 6% w/v PEG-bis-AB hydrogels provided an
elastic modulus of 26.4 ± 3.65kPa. Though the 6% w/v PEG-bis-AB hydrogels provided
an elastic modulus which approximated that of the human vocal ligament at low strain
levels (0 – 15%) it did not show a biphasic stress-strain curve which is characteristic of
the human vocal ligament [63, 277] and other soft tissues [285]. The 6% w/v PEG-bisAB hydrogels exhibited a linear stress-strain curve till failure at 46 ± 2% strain. The
linear and non linear patterns exhibited at low and high strains correlate to the unique
collagen ultrastructure of the human vocal ligament [113]. The helical collagen fibers
function as a buffer at low strains so that elongations of the vocal ligament occur without
much resistance [113]. At high strains, the unique collagen structure absorbs the stress
and serves as a shock absorber along the length of the fibers. The lack of a biphasic
stress-strain curve may be perceived as a limitation of these PEG-based hydrogels.
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However, since the vocal fold operates at low strain levels (0 – 15% strain) [8] during
normal phonation we propose the use of the 6% w/v PEG-based hydrogels during the
acute phase of wound healing during which the patient may be advised against strenuous
vocal activity. It must be noted that only the PEG-bis-AB hydrogels were subjected to
uniaxial tensile testing whereas the PEG-bis-AP/AB blends were used for cell culture
studies. The only difference between the 6% w/v PEG-bis-AP, PEG-bis-AB, and PEGbis-AP/AB hydrogels is the rates of degradation. We have previously reported that a
slight variation in chemistry that causes significant differences in degradation rates does
not affect mechanical properties of these PEG-based hydrogels [245]. The relatively
small mesh size of hydrolytically degradable PEG-based hydrogels initially restricts cell
spreading which may be detrimental to cell growth and tissue formation. We have
previously shown that incorporation of 0.12% w/v HA substantially increases cell
spreading and proliferation without significantly altering the elastic properties [282].
The abundance of HA in the vocal mucosa imparts viscous shear properties to the
vocal fold tissue, and helps produce and sustain vibration over a vast range of frequencies
(100 – 1000Hz) [7].

HA also plays a vital role in wound healing [269].

In the

acute/proliferative phase of adult wound healing, fibroblasts migrate into the site of
injury, and actively synthesize ECM consisting mainly of type I collagen [126]. The
balance between matrix macromolecules (collagen vs HA) produced during the
proliferative phase is one critical difference between scar formation (adult wounds) and
regenerative-type wound healing (early fetal wounds) [128].

HA being a space

occupying molecule in the ECM, influences collagen fibrillogenesis [127]. Adult dermal
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wound healing is characterized by scar formation attributed to decreased/degraded HA
levels by day 10 [129]. Scarless fetal wound healing is attributed to consistent elevated
levels of HA leading to regenerative repair [128, 130, 269]. It has been reported that HA
levels in the vocal fold wounds decrease to subnormal levels after day 5 of injury
resulting in vocal folds scarring [131]. Therefore, our GMHA hydrogel scaffolds may
help to sustain HA levels throughout the wound healing process, and potentially reduce
scar formation through regulating collagen fibrillogenesis. On comparing our data with
literature studies of the viscous shear properties of the human vocal mucosa, we observed
that the magnitude of dynamic viscosity of the 1.5 – 2.5% GMHA hydrogels at all the
tested frequencies lies in the same range as that of the human vocal mucosa [103, 195,
276, 288]. The broad range of the magnitude of dynamic viscosity of the vocal mucosa
(100 – 1000Pa.s) has been attributed to intersubject differences in sex and age [288].
However, the elastic shear modulus of the 1.5 – 2.5% GMHA hydrogels at all the tested
frequencies is slightly higher than the average values reported for the human vocal
mucosa [276]. This may not be perceived as a limitation of the GMHA hydrogels since
the elastic shear modulus data reported for the human vocal ligament has a high degree of
variability.
Rheological studies indicated an order of magnitude difference among the
magnitude of dynamic viscosities of the 2% w/v unmodified HA solution, 2% w/v
GMHA solution, and 2% w/v GMHA hydrogels at all the frequencies tested. This
suggests a decrease in the molecular weight of the GMHA macromer (in comparison to
native unmodified HA), likely attributable to degradation during the methacrylation
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process. The degree of reduction in the molecular weight of the GMHA conjugates was
not quanitified using other methods since it is beyond the scope of the present study, and
subsequent covalent crosslinking achieved mechanical properties approximating the
native vocal mucosa. Rheological tests were not performed at physiologically relevant
frequencies (>100 Hz) since at these frequencies the inertial effects of the sample and the
rheometer‟s plate become significant due to which the stress-strain linearity cannot be
maintained. However, it has been previously reported that low frequency data can be
extrapolated to physiologically relevant frequencies based on constitutive modeling or
time-temperature superposition [276].
Data from our degradation tests as well as previous studies [245] demonstrated
the ability of PEG-based macromers synthesized with chemical intermediaries containing
variable length alkyl spacers to form hydrogels with controlled variation in hydrolytic
degradation rate. At 6% w/v, the PEG-bis-AP and PEG-bis-AB compositions and their
50:50 blend provided degradation times ranging from 7 – 18 weeks. Previous studies
using naturally-derived matrices have observed 2 – 3 week time-frames for in vivo
degradation following implantation into animal models of vocal fold injury [42, 43]. As
the optimal kinetics of scaffold remodeling and degradation has not been fully
determined, the synthetic component described here for the vocal ligament offers a range
of possibilities. The mass loss of GMHA hydrogels was not characterized unlike the
PEG-based hydrogels since these HA based hydrogels are subject to enzymatic (HAse)
degradation which depends on the number of cells encapsulated within the hydrogels.
Any mass loss studies conducted with encapsulated cells would confound results due to
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the presence of cells and neo-matrix produced by the encapsulated/proliferating cells.
However, the enzymatic degradation of GMHA hydrogels in the presence of HAse has
been previously reported by Leach et al [289, 290]. In case of our proposed in vivo
application the degradation of the GMHA hydrogels solely depends on the amount of
HAse produced by the transplanted/endogenous cells.
A significant increase in encapsulated fibroblast number at days 7 and 14 in both
6% PEG-based semi-IPNs and 2% w/v GMHA hydrogels indicated the cytocompatibility
of these materials. The reduction in cell number at day 28 can be attributed to semiIPN/hydrogel degradation, which resulted in the release of cells and their adhesion to the
underlying culture substrate (data not shown). Histological and immunohistochemical
analysis demonstrated that both 6% w/v PEG-based semi-IPNs and 2% w/v GMHA
hydrogels supported the synthesis and accumulation of type I collagen and s-GAGs.
Since the final application involves the use of the 2% w/v GMHA hydrogel as a scaffold
for the vocal mucosa that is comprised mainly of proteoglycans/GAGs, the production of
collagen in these materials may be viewed as a negative observation. This result suggests
that tissue-specific mechanical properties may not be sufficient to completely direct
tissue-specific ECM production by the encapsulated cells. However, previous work
showing that externally applied vibration significantly upregulated MMP-1 and HA
synthase 2, but not type I collagen suggests that vibratory stimulation may be an effective
tool in combination with these materials to more effectively regulate ECM composition
[11].
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5.5 Conclusion
These studies demonstrate that appropriate formulations of chemically modified
PEG and HA can produce hydrogel matrices with mechanical properties consistent with
the native human vocal mucosa and ligament.

These degradable matrices may be

crosslinked in the presence of cells and support cell viability, proliferation, and ECM
synthesis. Bearing in mind the slight limitations of these materials and the significance
of mechanical forces associated with phonation, it is expected that physiologically
relevant mechanical stimulation will further improve scaffold remodeling and tissuespecific ECM expression. Future studies will investigate the gene and protein expression
of fibroblasts encapsulated in 2% w/v GMHA hydrogels, cultured in a vibrational
bioreactor at physiologically relevant frequency and amplitude.
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CHAPTER 6
THE EFFECT OF VIBRATION ON GENE AND MATRIX EXPRESSION OF
FIBROBLASTS ENCAPSULATED IN HYALURONIC ACID HYDROGELS

6.1 Introduction
Voice is critical to the quality of life and is the primary “tool of trade” for 25% of
the US work force (teachers, singers, sales personnel etc) [1].

Phonation (voice

production) is a co-ordinated biological process involving the vocal folds, lungs, brain,
peripheral nervous system, and muscles of the respiratory tract synergistically
transducing aerodynamic energy from exhalation to acoustic energy. The vocal folds are
the dynamic mechanical element of the phonatory system and possess a spatially
organized ECM composition that is fundamental to the tissue biomechanics and in turn
the quality of voice [2]. The human vocal folds are multi-layered, consisting of a
squamous epithelium, lamina propria composed of fibroblasts and ECM, and the
thyroaretenoid muscle. The squamous epithelium and the superficial lamina propria
together form the vocal mucosa.

The vocal mucosa is abundant in HA, small

proteoglycans like fibromodulin and decorin, and large proteoglycans like versican that
regulate the water content of the tissue and impart viscous shear properties to it [2-4, 92].
The intermediate and deep layers of the lamina propria together form the vocal ligament.
The intermediate layer is abundant in elastin fibers which impart flexibility and
distensibility to the vocal fold tissues during repeated deformation from phonation [2, 3,
92, 110]. The deep layer is abundant in collagen fibers which are relatively inextensible,
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resist and transmit tensile stresses and are responsible for the maximum dimensions of
the vocal fold tissues [2, 92, 119]. The vocal mucosa is the vibratory element of the
structurally/functionally differentiated vocal fold tissue that sustains high frequency
vibration during phonation. The human vocal fold mucosa vibrates at frequencies of 100
– 1000Hz, at amplitudes of ~1mm during phonation [5]. Vocalization times can vary
between 1 to 2hrs per day for heavy voice users like classroom teachers and opera singers
[9-12].
The most commonly/severely afflicted site in terms of vocal pathologies is the
vocal mucosa.

Injuries to the vocal mucosa brought about by chronic vocal tissue

overuse, laryngeal cancer, chemical or thermal injury, non phonatory mechanical trauma,
and attempted repair lead to a wound healing response which is characterized by
conversion of the GAG-based tissue to fibrous scar tissue [13-15, 123].

Structural

changes due to changes in ECM composition of the vocal mucosa lead to altered
vibratory biomechanics which ultimately causes dysphonia. Dysphonia characterized by
increased effort to sustain phonation, decreased vocal quality, and total voice loss affects
approximately 23% of the voice-dependent US workforce [16]; and may jeopardize job
security, employment opportunities, and social interaction [225, 226]. It is estimated that
approximately 9% of the population suffers from voice related problems at any given
point in time [15]. Scarring induced dysphonias are currently treated by voice therapy
and surgical augmentation procedures. Current treatment techniques, although effective
in improving short term voice quality, have been unable to achieve complete restoration
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of normal voice due to their inability to bring about regeneration of the native vocal fold
tissue architecture/ECM composition.
The ECM composition and biomechanical properties of many human tissues are
regulated by their mechanical environment during both developmental morphogenesis
and adult homeostasis [50, 51]. Using 3D culture systems and bioreactors, application of
physiologically relevant mechanical stimulation has been shown to elicit tissue-specific
ECM expression and increases in corresponding mechanical properties relative to static
controls. Examples include application of cyclic strain to smooth muscle cells [291] and
fibroblasts [292], and dynamic compression/hydrostatic pressure to chondrocytes [293,
294]] and annulus fibrosus cells [295, 296].

While the effects of cyclic

strain/compression have been widely investigated, the response of cells to vibratory
stimulation has been relatively less explored. Tanaka and co-workers reported increased
expression of osteocalcin and MMP-9 by osteoblasts cultured in collagen gels subjected
to various vibratory regimes relative to static controls [55]. Titze and co-workers [11]
observed significant increases in mRNA expression of proteoglycan/GAG genes in
tracheal fibroblasts cultured under vibratory stimulation within 3D, porous, elastomeric
tecoflex substrates.
Our long-term

hypothesis

is

that rapid

restoration of the vibratory

microenvironment using mechano-mimetic scaffolds will facilitate vocal mucosa-specific
ECM deposition by the resident/infiltrating cells, ultimately leading to improved
functional outcomes by reducing fibrotic scarring during the acute stage of wound
healing. Towards this end, we have previously reported the preparation of injectable
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GMHA hydrogels with rheological properties approximating those of the native human
vocal mucosa [297].

However, fibroblasts encapsulated within GMHA hydrogels

synthesized an ECM rich in both collagen and s-GAGs under static conditions. The
objective of this study was to investigate the ability of physiologically relevant high
frequency vibration to stimulate vocal mucosa-like gene expression and ECM
accumulation by human fibroblasts encapsulated in mechano-mimetic GMHA hydrogels.

6.2 Materials & Methods
6.2.1 Materials
Sodium hyaluronate (MW = 1.4x106) was purchased from Genzyme (Cambridge,
MA). Polyethylene glycol diacrylate (PEGDA) (MW=258) and tetrabutylammonium
bromide, triethylamine, and glycidyl methacrylate were obtained from Aldrich (St. Louis,
MO, USA). Dichloromethane (HPLC grade) was obtained from Acros organics (NJ,
USA). Acetone was purchased from Fisher Chemical (Fair Lawn, NJ). 2-hydroxy-1-(4(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I-2959) was obtained from Ciba
Specialty Chemicals (Basel, Switzerland). A 10% w/v stock solution of I-2959 was
prepared in 70% ethanol. Adult normal human dermal fibroblasts (NHDF, CC-2511)
obtained from a 39 year old Black woman were purchased from Biowhitaker (Rockland,
ME, USA). DMEM F-12 50/50,1X with L-glutamine, 15mM HEPES/trypsin EDTA
(0.05% trypsin/0.53mM EDTA in HBSS), and penicillin/streptomycin were obtained
from Mediatech (Herdon, VA, USA).

Bovine growth serum was purchased from

Hyclone (Logan, UT, USA).
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6.2.2 Synthesis of GMHA
GMHA was synthesized by reacting sodium hyaluronate solubilized in double
distilled water with a 20-fold molar excess of glycidyl methacrylate in the presence of
excess triethylamine and tetrabutylammonium bromide as previously described [280].
The GMHA was precipitated in acetone, dialyzed against double distilled water for 48
hours, and recovered by lyophilization. An ~7% degree of methacrylation was calculated
from the 1H-NMR (D2O) spectra based on the ratio of peak integrals derived from the
methacrylate and HA carbohydrate protons, as previously described [281].

6.2.3 Cell culture
NHDF were routinely cultured in 175 cm² T-flasks using DMEM F-12 50/50,1X
with L-glutamine and 15mM HEPES enriched with 10% v/v bovine growth serum and
50U/ml penicillin and 50µg/ml streptomycin. Culture medium was changed once every
two days and cells were passaged weekly. All experiments were performed with cells
from the 4th – 6th passages. For hydrogel encapsulation, monolayers of fibroblasts (ca.
95%

confluence)

were

trypsinized,

centrifuged,

resuspended,

counted

in

a

hemacytometer, and adjusted to a final concentration of 1.6 x 107cells/ml.

6.2.4 Bioreactor construction
A vibrational bioreactor module comprising a modified 75cm2 T-flask and a voice
coil actuator (BEI Kimco) was constructed partly as explained previously [11]. The
vibrational bioreactor assembly is shown in figure 6.1. A sinusoidal waveform from a
function generator (BK Precision, CA) was fed to the input terminal of a reed switch.
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The reed switch was connected at the collector terminal (+5V from a PC) of a NPN
transistor, the base terminal of which was connected to the output from a custom
Labview program (National Instruments) and an analog output board running on a PC.
The variables controlled by the Labview software were the total number of work days,
active vibration intervals (on and off times) and inactive (rest) time per day. The output
from the reed switch stimulated the voice coil which ultimately controlled the vibration
actuator bar. The voltage level of the sinusoidal wave was set so as to maintain 1mm
vibrational amplitude at the actuator bar which was verified using a digital stroboscope
before every experiment.

Figure 6.1 A vibrational bioreactor module with a modified 75cm2 T-flask.
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6.2.5 Bioreactor cell culture
6.2.5.1 Tecoflex film fabrication
The cell encapsulated hydrogel samples were crosslinked to elastomeric Tecoflex
films mounted on “U” shaped plastic frames (40mm x 15mm). Briefly, Tecoflex SG80A (Thermedics) was dissolved in methylene chloride at a 5% concentration and films
were made by solvent casting. The Tecoflex films were subjected to oxygen plasma
treatment for 8 mins at 300mTorr afterwhich they were immersed in PEGDA (MW=258)
for 30 mins to introduce free vinyl groups on the film surface.

6.2.5.2 Hydrogel photopolymerization and vibrational culture
4% w/v GMHA macromer solution was prepared in sterile 1X-PBS (0.1M, pH
7.4). A fibronectin-derived cell adhesion peptide, (GRGDS, Bachem, PA, USA) was
conjugated to acrylate-PEG-NHS (MW=3400, Nektar) as previously described [216].
GRGDS-PEG-acrylate was prepared as a stock solution in 1X PBS (10µmol/ml) and
sterile filtered.

For cell encapsulation studies, the final concentrations of GMHA,

acrylate-PEG-GRGDS, and NHDF were 2%, 2.5µmol/ml, and 4x106cells/ml,
respectively, unless mentioned otherwise.

The cell-macromer-peptide suspension

(200µl) containing 0.1% w/v I-2959 initiator was crosslinked on the modified Tecoflex
film by exposure to low intensity UV illumination (365nm, 10mW/cm2, Black-Ray
B100-AP, Upland, CA) for 6½ minutes (Figure 6.2A). N=4 hydrogel samples were
mounted between the support pins in the bioreactor flask (figure 6.2B, C and D) and the
frames cut to allow the samples to move freely in the axial and longitudinal directions.
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The hydrogel samples were allowed to equilibrate to the new environment overnight
before the vibratory stimulus was applied. The samples were then stimulated by a
100Hz, 5.3Vrms sinusoidal waveform from a function generator in a 2sec on/2sec off
regimen for 4hours/day. N=4 fibroblast encapsulated hydrogel samples cultured in a
Petri dish under static conditions served as controls.

Figure 6.2 A 2% w/v GMHA hydrogel encapsulated with cells and immobilized on an
elastomeric Tecoflex film by photopolymerization (A), different views of GMHA
hydrogels mounted in a modified 75cm2 T-flask of the vibrational bioreactor module (B),
(C), and (D).
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6.2.6 Encapsulated fibroblast viability, morphology, and proliferation within the 2%
w/v GMHA hydrogels
6.2.6.1 Viability assessment
After 5 and 10 days in culture, hydrogel samples (N=4/time point) from both the
vibrational and static groups were collected from the study, rinsed three times with sterile
1X-PBS, and stained with 1µM fluorescein diacetate (FDA, Molecular Probes, Eugene,
OR) and 2.5µM propidium iodide (PI, Molecular Probes). The samples were once again
rinsed with sterile 1X-PBS, visualized, and imaged by fluorescence microscopy (Zeiss
Axiovert 200).

6.2.6.2 Confocal analysis of morphology
After 1, 3, 5, and 10 days in culture, samples (N=4/time point) from both the
vibrational and static groups were fixed in 4% paraformaldehyde in PBS, permeabilized
with 0.1% Triton X-100, and stained with Alexa 594-phalloidin (Molecular Probes).
Samples were visualized and imaged using a Zeiss Confocal LSM510 microscope.

6.2.6.3 Fibroblast proliferation
N = 4 hydrogel samples each from the vibratory and static groups were collected
at days 1, 5, and 10, rinsed twice with sterile PBS, snap-frozen in an ethanol-dry ice bath,
and stored at -80ºC. DNA solubilization and quantitation were based on modifications of
previously described methods [247]. Briefly, the samples were subjected to 3 freezethaw cycles in 1.4ml of 10mM EDTA, pH 12.3. Once the hydrogels were completely
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dissolved, the pH was neutralized by the addition of 100µl 1M potassium phosphate
(monobasic) solution. Total DNA content was measured using the Picogreen DNAbinding dye (Molecular Probes) and a fluorescence microplate reader (Tecan GENios,
excitation: 485nm, emission: 535nm). DNA content was converted to cell number based
on a DNA standard curve prepared from serial dilutions of NHDF and compared to the
cell number at the end of day 1.

6.2.7 Gene expression
The hydrogel-encapsulated fibroblast samples (N=4 samples/time point) from
both the vibrational and static groups were harvested from culture after 1, 3, 5, and 10
days; and stored in 1ml Trizol reagent (Aldrich) at -80 °C. The frozen hydrogel samples
were thawed, homogenized, centrifuged at 13,000g for 15mins at 4°C, and the
supernatant removed and collected in clean PCR tubes.

Total RNA was isolated

according to the manufacturer‟s protocol and finally redissolved in 20µl RNAse-free
water.

The samples were treated with RNAse-free DNAse I (Turbo, Ambion) to

eliminate genomic DNA contamination. Using a UV spectrophotometer, concentration
and purity of the total RNA was determined based on absorbance at 260nm and 280nm.
Samples containing 1µg of total RNA was reverse transcribed to cDNA in a 20µl reaction
using the Retroscript cDNA Synthesis Kit (Ambion), and the Rotorgene 3000 light
thermal cycler (Corbett Research, Mortlake, NSW, Australia).

Realtime PCR was

performed using custom-designed sense and anti-sense primers (Table I) and the
QuantiTect SyBr Green PCR kit (Qiagen). Briefly, after an initial heat activation at 95°C
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for 15 minutes, cDNA products were amplified through 35 cycles, each consisting of a
denaturation step at 94°C for 15 seconds, an annealing step at 54°C for 20 seconds, and
an extension step at 72°C for 20 secs. Melt curve analysis was performed at the end of
all reactions to verify formation of single product. Amplification efficiencies were tested
using serial dilutions of cDNA covering four orders of magnitude and found to range
from 0.94-1 for all products. Relative expression levels of target genes were quantified
by the ΔΔCT method using β2microglobulin (β2M) as an internal control and the day 1
static samples as reference condition (calibrator) [298]. Data for days 3 and 5 represent
the combined results of two independent experimental replicates.

Target gene

Accession ID

Sense primer

Antisense primer

Collagen 1

NM_000088.2

Tgctggtgctcctggtactc

tccagagggaccttgtttgc

Elastin

NM_000501.1

Gccctacaccacagggaaac

accgaactttgctgctgctt

HA Synthase 2

NM_005328.1

cataaagaaagctcgcaacacg

cacacttcgtcccagtgctc

Decorin

NM_001920.3

Gtgtcagccggattgtgttc

gcaggtgtggaaaggaggag

Fibromodulin

NM_002023.3

Tgataaggtgggcaggaagg

tggttgtggtcgagatggag

MMP-1

NM_002421.2

Tgctgaaaccctgaaggtga

cttggcaaatctggcgtgta

Beta-2-

NM_004048.2

Tgtgctcgcgctactctctc

cggatggatgaaacccagac

microglobulin

Table 6.1 Target Genes and Primers for Real Time RT-PCR Analysis.
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6.2.8 Encapsulated fibroblast ECM production
In order to quantify ECM production by the encapsulated fibroblasts, N=4
samples/time point from both the vibrational and static groups were collected from the
study after 5 and 10 days of culture. The samples were digested using 1ml HAse
(40U/ml) per hydrogel under constant agitation for 4hours. Following digestion, the
samples were transferred to 2ml tubes, and stored at -80°C.

6.2.8.1 s-GAG synthesis (DMMB Assay)
s-GAG accumulation was measured using the 1,9-dimethylmethylene blue
(DMMB) assay as previously described [299]. Briefly, the assay was performed by
adding 20µl of the sample to 200µl of the DMMB reagent stock solution (16mg DMMB
+ 5ml 95% ethanol + 3ml formic acid + 25.6ml NaOH + 966.4ml distilled water, pH 3.5)
in a 96-well plate. DMMB dye binding to s-GAGs produced a pink color which was
measured by absorbance at 525 nm using a microplate reader (Bio-Tek Instruments,
Winooski, VT) and was quantified relative to a linear standard curve prepared from
chondrotin-4-sulfate standards (0 – 100µg/ml). The absorbance of cell-free 2% w/v
GMHA hydrogels was subtracted from the absorbance values of vibrational/static groups
in order to account for absorbance of the GMHA material alone. For data analysis, sGAG values were normalized to total DNA values.
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6.2.8.2 Collagen synthesis (Hydroxyproline analysis)
Collagen accumulation by the encapsulated fibroblasts in both the vibratory and
static groups was quantified by the hydroxyproline assay as previously described [300].
The total collagen content was calculated based on the estimation that hydroxyproline
makes up about 13.2% of the total collagen [301]. The total collagen values were
normalized to total DNA values.

6.2.9 Rheological characterization of cell-free and cell-encapsulted 2% w/v GMHA
hydrogels following 10 day vibrational bioreactor culture
In order to investigate the effect of the vibrational regimen and neo matrix
synthesis on the mechanical properties of the 2% w/v GMHA hydrogels, two cellencapsulated hydrogel groups (4x106cells/ml and 2x106cells/ml), and cell-free hydrogels
were photopolymerized and exposed to vibratory stimulation for 10 days. The hydrogel
samples (vibrational samples and static controls) from both the cell-encapsulated and
cell-free experiments were collected after 10 days in culture, rinsed two times with 1XPBS sterile PBS, and immediately subjected to rheological testing under conditions
similar to those used to investigate the rheological properties of the human vocal mucosa
[12].

Rheological characteristics as a function of mechanical stimulus and

presence/absence of cells were investigated in a stress controlled “ARES” Rheometer
using parallel plate geometry. The hydrogel samples were placed in the gap (0.8mm)
between the stationary upper plate and the rotating lower plate, and the temperature was
maintained at 37 ± 0.1ºC by a “Peltier” water cooling system. In order to determine the
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region of linearity, strain sweep tests were performed at fixed oscillation frequency
(1Hz). Rheological tests were performed in the linear strain region (strain amplitude –
0.01rad), over a frequency range of 0.01 – 15Hz, covering 25 frequencies over 3 decades.
The dynamic viscosities of the 2% w/v GMHA hydrogels tested were calculated by
dividing the observed values of the loss moduli by the corresponding angular frequencies
tested. The elastic shear moduli of the 2% w/v GMHA hydrogels tested were also
recorded and plotted at all frequencies tested.

6.2.10 Statistical analysis
All data sets are represented in terms of means ± standard deviation with n=4. All
data sets were statistically compared by ANOVA using Tukey‟s method for post hoc
testing with “p” values less than 0.05 considered significant.

6.3 Results
6.3.1 Encapsulated fibroblast viability, morphology, and proliferation in 2% w/v
GMHA hydrogels
Fibroblasts were encapsulated within 2% w/v GMHA hydrogels containing
immobilized RGD cell adhesion peptides by photopolymerization and cultured under
static or vibratory conditions for up to 10 days. Encapsulated fibroblast viability was
observed to be substantially greater in the static controls at day 5 (Figure 6.3A) and day
10 (Figure 6.3C) than in the corresponding vibrational samples (Figures 6.3B and D).
Cell viability was largely uniform throughout the bulk of the hydrogel constructs.
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Fibroblasts in the static controls exhibited clustering and aggregation (Figure 6.3C) in
various areas throughout the bulk of the hydrogel constructs to a much higher degree than
in the vibrational samples (figure 6.3D) at the same time point.

Figure 6.3 Viability of fibroblasts encapsulated in 2% w/v GMHA hydrogels and
cultured under static (A,C) and vibratory (B,D) conditions for 5 (A,B) and 10 days (C,D).
Cells were stained with fluorescein diacetate (green)/propidium iodide (red). All scale
bars = 200µm.
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Confocal microscopy was performed to visualize fibroblast morphology within
the 3D hydrogel networks. Encapsulated fibroblasts exhibited spreading within 3 days
(data not shown) and development of stellate morphology at day 5 in the static controls
(Figure 6.4A) and the vibrational samples (Figure 6.4B).

Stellate cell morphology

persisted for the entire duration (day 10) of the experiments in the static (Figure 6.4C)
and the vibrational samples (Figure 6.4D).
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Figure 6.4 Confocal microscopy images (200µm depth) of fibroblast morphology and
spreading within 2% w/v GMHA hydrogels. Samples were stained with Alexa 594phalloidin and imaged after culture under static (A,C) and vibratory (B,D) conditions for
5 (A, B) and 10 days (C,D). All scale bars = 200µm.
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The cell number (DNA content) of the hydrogel constructs at days 5 and 10 is
shown in figure 6.5. Relative to the initial cell number measured at day 1, significant
increases in cell number were observed in 5 day static controls and 10 day static and
vibrational groups. Although cell proliferation was observed in the 10 day vibrational
group (relative to day 1), cell numbers measured in vibrational samples were significantly
lower than corresponding static controls at both time points (days 5 and 10) assayed.
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Figure 6.5 Time course fibroblast proliferation within the 2% w/v GMHA hydrogels
under vibratory stimulus and static conditions. * indicates significant differences relative
to the corresponding cell number at day 1. # indicates significant differences relative to
the corresponding static control at the same time point.
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6.3.2 Gene expression
Fibroblast mRNA expression levels of several ECM-related genes relevant to the
human vocal mucosa were examined after 1, 3, 5, and 10 days of culture under vibratory
and static conditions. In general, fibroblasts exposed to vibratory stimulation exhibited
increased expression of HA Synthase 2 (Figure 6.6A), decorin (Figure 6.6B),
fibromodulin (Figure 6.7A), and MMP-1 (Figure 6.7B) relative to static controls for
corresponding time points at days 1, 3, and 5. In addition, significant temporal increases
in HA synthase 2 (day 3 and 5), fibromodulin (day 3), and MMP-1 (day 5) were observed
relative to day 1 among sample groups exposed to vibration. Interestingly, expression
levels of all 4 genes in vibration-treated sample groups were significantly reduced at day
10 relative to days 3 and 5. In contrast to these results, expression levels of type I
collagen and elastin were relatively insensitive to vibratory stimulation.

Reduced

collagen and elastin expression levels were observed in samples exposed to vibratory
stimulation relative to static controls at all time points, although the differences were only
significant at day 5 (Figure 6.8E and F).
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Figure 6.6 mRNA expression levels of HA Synthase 2 (A) and decorin (B). * indicates
significant difference relative to day 1 of the corresponding group. # indicates significant
differences relative to the corresponding static control at the same time point. **
identifies significant differences observed among other experimental groups.
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Figure 6.7 mRNA expression levels of Fibromodulin (A) and MMP-1 (B). * indicates
significant difference relative to day 1 of the corresponding group. # indicates significant
differences relative to the corresponding static control at the same time point.
identifies significant differences observed among other experimental groups.
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Figure 6.8 mRNA expression levels of Collagen I (A) and Elastin (B). * indicates
significant difference relative to day 1 of the corresponding group. # indicates significant
differences relative to the corresponding static control at the same time point.
identifies significant differences observed among other experimental groups.
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6.3.3 ECM expression
Consistent with the significant upregulation of HA Synthase 2 and proteoglycan
genes at days 1, 3, and 5, the amount of proteoglycan accumulation (normalized to cell
number) measured in the hydrogel constructs at days 5 and 10 was significantly higher in
the vibrational groups relative to the static controls (Figure 6.9). Also, proteoglycan
levels in the vibrational groups significantly increased between days 5 and 10.
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Figure 6.9 Picograms of sulfated-GAGs per encapsulated cell in the 2% w/v GMHA
hydrogels after 5 and 10 days of static and vibrational culture. # indicates significant
differences relative to the corresponding static control. ** indicates a significant
difference among experimental groups.
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Total collagen accumulation (normalized to cell number) measured in the
hydrogel constructs at days 5 and 10 was significantly lower in the vibrational group
relative to the static controls (Figure 6.10). In addition, total collagen levels measured in
the vibrational groups significantly decreased from day 5 to day 10.
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Figure 6.10 Picograms of collagen per encapsulated cell in the 2% w/v GMHA hydrogels
after 5 and 10 days of culture. # indicates significant difference relatives to the
corresponding static control. ** indicates a significant difference among experimental
groups.
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6.3.4 Rheological characterization of cell-free and cell-encapsulted 2% w/v GMHA
hydrogels following 10 day vibrational bioreactor culture
In order to investigate the effect of physiologically relevant high frequency
vibration on the mechanical properties of the 2% w/v GMHA hydrogels, 10 day
experiments were performed using cell-free and cell-encapsulated hydrogel constructs.
Dynamic viscosities (Figure 6.11) and elastic shear moduli (Figure 6.12) calculated over
the range of the tested frequency sweep (0.01 – 15Hz) indicated that the cell-free static
contols and the corresponding vibrational samples were similar. However, the dynamic
viscosities of the cell-encapsulated vibrational samples were significantly lower than the
corresponding static controls and the cell-free vibrational samples (Figure 6.11). The
elastic shear moduli of the cell-encapsulated vibrational samples were similar to that of
the cell-free vibrational samples (Figure 6.12). Interestingly, the elastic shear moduli of
the cell-encapsulated static controls were significantly higher than that of the cell-free
static controls (Figure 6.12). However, when the encapsulated cell number was reduced
by half, the difference in the magnitudes of dynamic viscosities (Figure 6.13) and elastic
shear moduli (Figure 6.14) between the static controls and the vibrational samples
became minimal over the range of frequencies tested.
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Figure 6.11 Dynamic viscosities of cell-free and cell encapsulated (4x106cells/ml) 2%
w/v GMHA hydrogels (static controls and vibrational samples) cultured for 10 days.
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Figure 6.12 Elastic shear moduli of cell-free and cell encapsulated (4x106cells/ml) 2%
w/v GMHA hydrogels (static controls and vibrational samples) cultured for 10 days.
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Figure 6.14 Elastic shear moduli of cell encapsulated (2x106cells/ml) 2% w/v GMHA
hydrogels (static controls and vibrational samples) cultured for 10 days.
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6.4 Discussion
The highly differentiated organization of the vocal fold tissue helps to produce
and sustain the high degrees of mechanical stresses (vibratory and cyclic strain) it is
subjected to for many waking hours, daily, over an entire lifetime. Proper vocal fold
tissue function being a prerequisite to normal phonation, otolaryngologists when
presented with voice related problems associated with vocal fold tissue injury, must
investigate the effect of the wound healing process on the native vocal fold tissue
architecture/ECM composition.

Previously, we have described 2% w/v GMHA

hydrogels and 6% w/v PEG-based semi-IPNs aimed at restoring the architecture of the
human vocal mucosa and the vocal ligament, respectively, which will facilitate long-term
restoration of normal voice by preventing fibrosis during the acute stage of wound
healing [297].
In the current study fibroblasts encapsulated in 2% w/v GMHA hydrogels
(viscous shear properties similar to the human vocal mucosa) were subjected to
physiologically relevant high frequency vibrational stimulation (100Hz sine wave, 1mm
amplitude) using a vibrational bioreactor. The 2sec on/2 sec off regimen simulates a
situation wherein an individual vocalizes and inhales alternately. The 2 hours/day (net
vibration on time) mechanical stimulation regimen is selected in order to approximate the
2 hour average vocalization period for a classroom teacher in a 6 – 7hr working day [912]. Our results indicated that physiologically relevant, high frequency vibration alters
fibroblast viability, proliferation, expression levels of some ECM related genes, and their
corresponding proteins. Previously, Titze and co-workers have reported that although
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6hours vibrational stimulation influenced the ECM deposition and spatial distribution of
cells it did not have a significant effect on cell viability [11]. However, our results
indicated that a net vibrational stimulation of 2 hours/day applied over 5 to 10 days
resulted in significant reduction of cell viability [11]. The reduction in cell viability at
days 5 and 10 can be attributed to the physical trauma inflicted on the encapsulated
fibroblasts by the high frequency vibration over time.

Also, the vibratory regimen

significantly stimulated fibroblast proliferation. This is consistent with results reported
previously by other researchers [11, 291, 302].

Real time RT-PCR analyses have

indicated a temporal manner in the changes of mRNA expression levels of ECM related
genes. Upregulated mRNA expression levels (days 1 – 5) of HA Synthase 2, decorin,
fibromodulin, and MMP-1 in response to vibrational stimulation is similar to the ECM
composition of the vibratory component of the human vocal mucosa. The reduction in
gene expression levels at day 10 may be attributed to cellular adaptation to the vibrational
regimen. High frequency vibrational stimulation has a profound effect on the expression
of proteoglycans, but contrastingly it has a very mild effect on the expression of
structural proteins like collagen. A significantly higher degree of proteoglycan-rich (sGAGs) ECM deposition in the vibrational group (relative to static controls) represents an
overall upregulation of ECM synthesis in response to vibrational stimulation since a
decreased cell density was observed in the vibrational group (relative to the static
controls) at all times points assayed.
Benign vocal fold lesions which represent the end of the wound healing cascade
(nodules), or an incomplete process beyond the initial/acute inflammatory stage (polyps)
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may place the vocal fold tissue at increased risk for repeated injury, leading to scarring
[15]. In contrast to fetal wound healing (regenerative type), adult wound healing is
characterized by scar formation attributed to decreased/degraded HA levels by day 10
[129]. Vocal fold scarring in the initial stages is associated with disorganized collagen
deposition [15] and decreased amounts of HA [15], decorin [303], and fibromodulin
[304]. Collagen found in scarred vocal fold tissue is reduced in density in addition to
having a disorganized/compromised architecture [134]. This can be attributed to the low
levels of decorin in the scarred vocal fold tissue since decorin binds collagen and
regulates fibrillogenesis [15]. It has been reported previously that HA levels in the vocal
fold wounds decrease to subnormal levels after day 5 of injury resulting in vocal fold
tissue scarring [131]. However, chronic vocal folds scars (2 to 6 months post injury)
reveal HA levels similar to that of normal tissue [131-134]. Scarring brought about by a
change in the ECM composition of the vocal mucosa during the acute phase of wound
healing alters vibratory biomechanics of the tissue which ultimately results in dysphonia.
Vocal fold scarring and associated pathologies are the most challenging voice related
problems otolaryngologists are faced with today [18].

Apart from voice therapy,

treatment of vocal fold scarring involves surgical techniques which rely mainly on
implanting natural/synthetic biomaterials to improve vocal mucosa pliability and alleviate
glottic incompetence. However, none of the existing treatment techniques achieve longterm success due to their inherent inability to restore the native tissue architecture/ECM
composition.
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Regenerative-type repair in fetal wounds is attributed to sustained high levels of
HA throughout the wound healing phase [128, 130, 269]. Our results indicated that in
addition to approximation of the viscous shear properties of the human vocal mucosa, the
2% w/v GMHA hydrogel formulation may serve to sustain elevated levels of HA and
proteoglycans at the site of injection during the acute phase of wound healing. Also,
exogenous HA is reported to decrease collagen synthesis and deposition in the ECM
without affecting de novo HA synthesis [127].

Our results indicated a significant

reduction in total collagen synthesized in the vibrational samples after 5 and 10 days of
culture. The upregulation of mRNA levels of HA Synthase 2, decorin, and fibromodulin
and the corresponding proteins have an effect on collagen fibrillogenesis [127] as
indicated by our results. It is logical that increased proteoglycan synthesis and decreased
collagen synthesis could play a vital role in averting scar formation.

Thereby, a

significant increase in the proteoglycan content and a decrease in the collagen content of
the vibrational samples relative to the static controls is an indication that the 2% w/v
GMHA hydrogel formulations may prevent scarring and facilitate vocal mucosa specific
ECM deposition under vibrational stimulation in vivo.
Rheological analyses did not reveal any significant differences in the magnitudes
of dynamic viscosities and elastic shear moduli between the vibrational samples and the
static controls in the cell-free group over the range of frequencies tested. Thereby, one
may infer that the vibrational regimen had minimal effect on the crosslinking density of
the GMHA hydrogels. We hypothesize that reduction in the dynamic viscosities of the
cell-encapsulated vibrational samples (relative to corresponding static controls) despite
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significant upregulation of proteoglycan synthesis per cell, can be attributed to
accelerated cellular remodeling of the hydrogel scaffold and faster ECM turnover rate
over a 10 day time course under vibration. During the eventual in vivo application, the
neo-matrix synthesized by the transplanted/endogenous cells, will be held in place more
efficiently due to bonding with the surrounding tissue. Interestingly, the rate of cellular
remodeling of the GMHA hydrogel matrix was reduced by encapsulating half the original
cell number, as a result of which the difference in the dynamic viscosities and elastic
shear moduli between the vibrational samples and the static controls was minimal.
Higher magnitudes of elastic shear moduli recorded for the static controls relative to
corresponding vibrational samples (original cell number) may be due to significant
increases in the cell density and the amount of collagen synthesized per encapsulated cell
in the static controls.
Due to distinct biomechanical properties of the human vocal mucosa and
approximation of these properties by the 2% w/v GMHA hydrogel formulation, use of
these hydrogels was aimed at restoring mechanical integrity and vocal mucosa function
following injury [297].

Our results suggested that restoration of the vibratory

microenvironment using the 2% w/v GMHA hydrogels, will facilitate regeneration of the
native human vocal mucosa ECM matrix composition and thereby normal phonatory
behavior. We are cognizant of the importance of the biological environment within the
human body in terms of the occurrence of inflammation and its effect on scaffold
degradation post implantation. A classic case of inflammation may lead to minimal
cellular infiltration/colonization and a thick collagen based capsule isolating the scaffold.
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We hypothesize that this kind of adverse inflammatory reaction may not occur in
response to vocal fold tissue augmentation using GMHA hydrogels since the vocal fold
lamina propria is minimally vascular.

6.5 Conclusion
Through the use of a vibrational bioreactor to condition fibroblast differentiation,
we have shown that the 2% w/v GMHA hydrogel encapsulated-cell formulation may help
restore native vocal fold tissue (vocal mucosa) architecture following injury and thereby
restore long-term normal phonatory voice.

Functional vocal mucosa regeneration

following injury may provide a rational basis for the structural/functional design of
engineering tissues for an eventual clinical application.
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CHAPTER 7
CONCLUSION AND RECOMMENDATIONS

7.1 Conclusion
The inability of current treatment techniques to restore long-term normal
phonatory voice following scarring related vocal pathology, has given rise to the need for
the “Vocal Fold Regeneration Project” in the Micro-Environmental Engineering
Laboratory (µEEL). This project is based on the hypothesis that rapid restoration of the
mechanical microenvironment using mechano-mimetic scaffolds will facilitate vocal fold
tissue-specific ECM production and ultimately restore normal phonation by preventing
scarring sequelae. Towards this end, we created in situ photopolymerizable, degradable,
cytocompatible PEG-based semi-IPNs and GMHA hydrogels that approximated the
elastic (vocal ligament) and rheological (vocal mucosa) properties of the highly
differentiated human vocal fold tissue.
During the course of our preliminary experiments and literature review we
realized that the nanometer-scale mesh size of the PEG-based hydrogel networks restricts
encapsulated cells to a rounded morphology that can inhibit cellular processes such as
proliferation, migration, and ECM production that are essential for the early stages of
remodeling and tissue formation. Therefore, the first phase of the vocal fold regeneration
project was dedicated to investigating an approach for accelerating cellular remodeling
based on the creation of semi-IPNs composed of hydrolytically degradable PEG
diacrylate macromers and native, enzymatically degradable ECM components (collagen,
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gelatin and HA. Among the three ECM components investigated, addition of HA at
concentrations of 0.12% w/v and greater supported fibroblast spreading throughout the 3dimensional network and significantly increased proliferation relative to control
hydrogels without HA. Incorporation of HA resulted in relatively small changes in
hydrogel physical/chemical properties such as swelling, degradation rate, and elastic
modulus.

Fibroblast spreading was eliminated by the addition of HAse inhibitors,

demonstrating that cell-mediated enzymatic degradation of HA is a necessary mechanism
responsible for the observed increases in fibroblast activity.

By accelerating early

cellular remodeling and growth, these PEG-based semi-IPNs may be useful vehicles
for cell transplantation in a variety of tissue engineering applications in addition to
vocal fold tissue repair.
The objective of the second phase of this project was the development of
mechano-mimetic, degradable hydrogels that may be photopolymerized in situ following
vocal fold injury or surgery using minimally invasive techniques to fill vocal fold defects.
PEG diacrylate based semi-IPNs (6% w/v) and GMHA hydrogels (2% w/v) were
found to provide elastic and rheological properties consistent with the human vocal
ligament and the vocal mucosa, respectively. Cell culture studies indicated that these
semi-IPN/hydrogel materials supported cell spreading, cell proliferation, and ECM
deposition throughout the 3-dimensional crosslinked network.
The third phase of this dissertation investigated the hypothesis that rapid
restoration of the vibratory microenvironment will facilitate vocal mucosa-specific ECM
production, and ultimately restore normal phonation. Towards this end, we assessed the

190

ability of the 2% w/v GMHA hydrogels to support human fibroblast formation of vocal
mucosa-like ECM in response to physiologically relevant high frequency vibration using
a custom-made vibrational bioreactor. Exposure of GMHA hydrogel-encapsulated
fibroblasts to physiologically relevant high frequency vibration stimulated a pattern
of ECM expression (upregulation of GAGs, downregulation of fibrous matrix
proteins) consistent with the composition of the native human vocal mucosa. Studies
analyzing vibration-induced changes in hydrogel mechanical properties and quantitative
analysis of proteoglycans and collagen synthesis following long-term vibrational
bioreactor studies indicated that these GMHA hydrogels introduced into the human vocal
mucosa during the acute phase of wound healing by minimally invasive methods may
bring about regeneration of the native vocal mucosa-ECM composition, and thereby
restore normal phonation.
In the broad context of tissue engineering, the data presented in this dissertation
indicates that GMHA- and PEG-based hydrogel/semi-IPN encapsulated fibroblasts may
be useful, site-specific, autologous cell delivery matrices for a variety of soft tissue
repair/regeneration applications. The ability to tailor mechanical properties/degradation
rates to suit the eventual application, which derives from the vast range of macromers
(and possible blends) synthesized, in addition to metabolizable degradation products,
lends versatility to these matrices. Although several groups have investigated the effect
of cyclic strain/compression on cell behavior, few have investigated the effect of
physiologically relevant high frequency vibration on cellular function. Through our
vibrational culture studies over a 10 day time course, we have significantly contributed to
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the understanding of the effect of physiologically relevant high frequency vibration on
the gene/protein expression of cells cultured in 3-dimensional crosslinked substrates.

7.2 Limitations
These GMHA / PEG diacrylate-based hydrogels / semi-IPNs are not intended to
soften existing mature scar tissue. These materials are intended to fill critical size defects
following some kind of injury or surgery in an attempt to reintroduce the vibrational
stimulus that may help restoration of the normal tissue matrix composition. In case of
mature scars, the scar tissue can be excised followed by use of these GMHA / PEG-based
hydrogels / semi-IPNs to fill the resulting defect.
Few existing biomaterials can replicate the complex, nonlinear stress-strain
response of the human vocal ligament. For this application, PEG hydrogels were chosen
based on their well-documented biocompatibility and elastic mechanical properties,
which are consistent with the linear stress-strain properties of the vocal ligament at low
strain levels (0-15%). The mechanical properties of hydrogels in the swollen state are
primarily a function of the crosslinking density, which may be controlled through
variation of polymer molecular weight, concentration, and degree of functionalization
[305, 306]. In this study, the crosslinking density and subsequent tensile properties of
PEG-diacrylate

hydrogels

were

manipulated

through

variation

of

macromer

concentration. At 6% w/v concentration, PEG hydrogels closely approximated the linear
stress-strain response and elastic modulus reported for the human vocal ligament at low
strains [63]. Although strain to failure approached physiological levels (Figure 5.6), the
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nonlinear stress-strain response observed in native tissue between approximately 15 and
45% strain was not achieved. These results are consistent with the rubberlike behavior of
such highly crosslinked polymer networks, which exhibit viscoelastic behavior only at
very low temperatures [306]. The in vivo functional efficacy of these materials will be
dependent on physiological strain levels experienced during phonation.

To our

knowledge, no studies have obtained direct, empirical measurements of vocal ligament
strains during phonation. Previous reports in the literature have described physiological
strain levels as ranging from 0 – 15% [8] to as high as 45 – 60% [277, 307]. Titze et. al.
recently reported a mathematical model of vocal ligament vibration that extended
conventional vibrating string models to include bending stiffness and variable cross
section; this model predicted higher frequencies (1000 Hz) can be attained at lower
strains (50%) than previously expected [308]. Based on this model, it is possible that at
typical phonation frequencies (100 – 300 Hz) [12], ligament strains may remain close to
the 15% range in which PEG hydrogels closely approximate the native tissue properties.
In the present study, elastic shear modulus and dynamic viscosity of hydrogels
crosslinked from methacrylated HA varied as a function of macromer concentration. Due
to HA‟s high molecular weight, these results are likely to be attributable to concentrationdependent effects on both the covalent crosslinking density and polymer chain
entanglement [101]. GMHA hydrogels crosslinked from 1.5 – 2.5% solutions exhibited
dynamic viscosities approximating the range of values reported for native human vocal
mucosa [103, 195, 288], which was highly variable due to intersubject differences
attributed to age and gender [103]. However, the elastic shear moduli values were
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several fold higher than the average values reported for human vocal mucosa [276].
These results, consistent with other reports describing rheological analysis of chemically
crosslinked HA hydrogels [43, 200], suggest that the degree of covalent crosslinking in
these materials may exceed the molecular-bonding interactions in native tissue, resulting
in increased stiffness. Elastic modulus values above the physiological range may in fact
be advantageous for in vivo applications. Enzymatic degradation of naturally derived
biomaterials during the acute inflammatory phase following implantation is likely to
produce a transient decrease in mechanical properties before effective synthesis and
organization of new matrix by colonizing or transplanted cells. A limitation of our
rheological testing is that data could not be obtained at physiologically-relevant
frequencies.

Several studies have recently described equipment and methods for

performing accurate rheological analysis at physiological frequencies [200, 309, 310].
Our rheological studies indicated approximately an order of magnitude difference
between the dynamic viscosities of the 2% w/v unmodified HA solution and the 2% w/v
GMHA solution at all frequencies tested. Since HA viscosity is largely a function of
molecular weight at fixed concentration [311], this observation probably indicates that
some degree of HA degradation and reduction in molecular weight occurred during the
methacrylation and purification processes. Although partial degradation could pose a
challenge to reproducibility, swelling and rheological properties of hydrogels prepared
from various batches of GMHA were highly consistent (data not shown). While at least
two alternative synthetic routes using methacrylic anhydride and N-3-aminopropyl
methacrylamide have been described [281, 312], the effect of these procedures on HA

194

molecular weight or rheological properties relative to the native polymer have not been
reported.
Normal human dermal fibroblasts (NHDF) were used in these studies as a model
cell type. Due to its limited intrinsic cellularity, cell transplantation may be important for
efficient restoration of vocal fold ECM. Limited cellularity combined with potential
scarring complications following biopsy of healthy autologous tissue suggests that vocal
fold fibroblasts may not be a feasible cell source for transplantation. In contrast, dermal
fibroblasts are readily available in vast quantities. To our knowledge, no study at present
has fully characterized the phenotypic differences between fibroblasts derived from the
vocal folds relative to other tissues, or identified an optimal cell source for vocal fold
transplantation.

We use these cells to demonstrate that our materials support cell

proliferation and matrix synthesis, but do not claim that these cells behave identically to
vocal fold fibroblasts.

7.3 Recommendations
Based on observations and data analyses from our research till date, I would like
to make the following recommendations aimed at furthering the scope of our research
efforts.

7.3.1 Specific aims
Aim 1: To characterize the downregulation of newly synthesized collagen by
the GMHA hydrogel encapsulated cells in response to high frequency vibration in

195

terms of the architecture/spatial organization. Also, investigate the mRNA expression
levels of TGF-β1, TGF-β1 receptor, hyal-1, hyal-2, lysyl oxidase, and HGF. This is vital
if we are to conclusively prove that restoration of the vibratory microenvironment using
the GMHA hydrogels immediately following injury can prevent fibrotic scarring.
Aim 2: To investigate the effect of physiologically relevant cyclic strain on :(a) the ECM synthesis of 6% w/v PEG-based semi-IPN encapsulated fibroblasts and
(b) the mechanical properties of these PEG-based matrices following long-term
bioreactor studies.
Aim 3: To model vocal overuse using the vibrational bioreactor and to
investigate the gene/ECM expression of GMHA hydrogel encapsulated fibroblasts in
response to the extended mechanical loading over a time course.
Aim 4: To investigate the hypothesis that application of localized high
frequency vibration is a potential anti-fibrotic treatment. Briefly, high frequency
vibration applied periodically to fresh wounds through carbon nanotubes (using DNA or
electrolytes as a power source) encapsulated in GMHA/PEG based hydrogels may :- (a)
stimulate infiltrating fibroblasts to produce native tissue-like ECM and (b) alter growth
factor profiles in the wound which may help prevent fibrotic scarring.
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